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1 SUMMARY 
 
Limb development is a complex mechanism involving many molecular factors 
and signaling pathways, which orchestrate during embryogenesis the transformation 
of the limb bud to the complete extremities. Posterior-anterior patterning is directed 
by the sonic hedgehog signal molecule, which acts upon transcriptional activity of 
target genes via the GLI transcription factors. Time, location, and amount of the 
transcription of GLI-genes are of critical importance. Mutation affecting the 
availability of the appropriate amounts of these factors in limb bud cells as well as 
mutations impairing their function can result in developmental defects and 
tumorigenesis. 
To contribute to the detection and functional characterization of cis-acting regulatory 
elements for GLI3 and their potential relevance for pathogenity three questions were 
adressed in this thesis. 
• How is the expression of human GLI3 regulated? 
• Do GLI2 and GLI3 share similar regulatory elements? 
• Are mutations in GLI3 regulatory elements involved in pathogenity? 
Towards this end, 24 patients with limb defects classified as potential GLI3 
morphopathies were screened for mutations. 20 cases, which cannot be attributed to a 
mutation in coding sequences of the gene, are candidates to be searched for mutations 
in cis-regulatory elements. 
The transcriptional control of GLI3 gene expression involves promoter as well as cis-
acting sequences, such as enhancers. A minimal promoter was defined and tested 
functionally. Two initiator sites were identified by using templates from placenta and 
skeletal muscle. By mutagenesis, sequence elements involved in control of GLI3 
expression were identified. 
Functional studies in transgenic mice suggest that GLI2 and GLI3 might have greatly 
overlapping expression domains. The 5’ transcribed region of human GLI2 was 
extended by about 1 kb of noncoding DNA, however, sequence comparison of human 
and murine GLI2 or GLI3 did not detect homologies of regulatory elements. 
Evolutionary genomic sequence comparisons were applied to guide the search for 
highly conserved non-coding elements, which might represent cis-regulatory elements 
for GLI3. Three potential enhancer elements were tested for their regulatory capacity 
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on reporter genes with foreign as well as the original GLI3 minimal promoter in 
transiently transfected cell cultures and in transgenic mice. Mutagenesis followed by 
tests for retention of their regulatory capacity in cellular reporter gene assays 
pinpointed particularly critical sites. Transcription factors that could be involved in 
GLI3 regulation, such as NFATp, await independent confirmation. In transgenic 
mouse embryos it was determined, that one of the potential enhancer elements directs 
an expression pattern, which follows part of the time course and the spatial pattern of 
the endogenous mouse GLI3, in particular the brain, mandibles, nostrils and heart.  
The results obtained contribute to our understanding of the spatial and temporal 
control of the expression of GLI3, a key factor of the hedgehog signaling cascade and 
provide insight into the potential role of highly conserved non-coding sequence 
elements in the human genome.  
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2 ZUSAMMENFASSUNG 
 
 Die Entwicklung der Gliedmaßen ist ein komplexer Vorgang, der zahlreiche 
molekulare Faktoren und Signalwege involviert. Diese dirigieren während der 
Embryogenese die Umwandlung der Gliedmaßenknospe zu den fertigen Extremitäten. 
Die antero-posteriore Musterbildung wird vom Signalmolekül „sonic hedgehog“ 
gesteuert, das über die GLI-Transkriptionsfaktoren die Transkriptionsaktivität von 
Zielgenen reguliert. Zeit, Lokalisierung und Menge der GLI-Transkription sind von 
kritischer Bedeutung. Mutationen, die das Vorhandensein der notwendigen Menge 
dieser Faktoren in den Zellen beeinflussen oder ihre Funktion stören, können in den 
Gliedmaßenknospen zu Wachstumsdefekten und andernorts zur Krebsentstehung 
führen.  
Um einen Beitrag zum Nachweis und zur funktionellen Charakterisierung von cis-
regulatorischen Elementen von GLI3 und deren potentieller Bedeutung für die 
Pathogenität zu liefern, wurden in dieser Dissertation drei Fragen bearbeitet:  
• Wie wird die Expression von humanem GLI3 reguliert? 
• Besitzen GLI2 und GLI3 ähnliche regulatorische Elemente? 
• Sind Mutationen in regulatorischen Elementen von GLI3 an der Pathogenität 
involviert? 
Um letzteres vorzubereiten wurden 24 Patienten mit Gliedmaßendefekten, die als 
potentielle GLI3-Morphopathien klassifiziert waren, auf Punktmutationen hin 
untersucht. 20 Fälle, bei denen keine Mutation in der kodierenden Sequenz gefunden 
werden konnte, sind Kandidaten für eine Mutationssuche in cis-regulatorischen 
Elementen. 
An der Kontrolle der Transkription des GLI3-Gens sind die Promoterregion und 
andere cis-aktive Sequenzen, wie Enhancer, beteiligt. Ein minimaler Promotor wurde 
definiert und funktionell getestet. Zwei Initiationsstellen der Transkription wurden mit 
cDNA aus Plazenta und Skelettmuskeln identifiziert. Durch Mutagenese wurden 
Sequenzelemente, die an der Kontrolle der GLI3-Expression beteiligt sind, 
eingegrenzt.  
Funktionelle Studien an transgenen Mäusen hatten gezeigt, dass die 
Expressionsdomänen von GLI2 und GLI3 in großen Bereichen überlappen. Die  
transkribierte Region von GLI2 wurde im 5’-Bereich gegenüber der bekannten cDNA 
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um 1 kb nicht kodierender DNA ausgedehnt. Trotzdem konnten Sequenzvergleiche 
zwischen Mensch und Maus keine Homologie zwischen regulatorischen Elementen 
von GLI2 oder GLI3 entdecken.  
Die genomische Sequenz von GLI3 wurde für evolutionäre Vergleiche benutzt, um 
nach hochkonservierten, nicht-kodierenden Elementen zu suchen, die eventuell cis-
regulatorische Elemente repräsentieren. Drei so entdeckte potentielle 
Enhancerelemente wurden in transient transfizierten Zellen daraufhin untersucht, ob 
sie die Transkription eines Reportergens unter der Kontrolle des minimalen GLI3-
Promoters steuern konnten. Durch Mutagenese vorhergesagter Bindungssequenzen 
für Transkriptionsfaktoren und nachfolgende Analyse der regulatorischen Kapazität 
der Elemente in zellulären Reportergentests wurden funktionell besonders bedeutsame 
Stellen definiert. An diese Bereiche bindende Transkriptionsfaktoren, die in die 
Regulation von GLI3 involviert sein könnten, wie NFATp, müssen noch bestätigt 
werden. Die drei Elemente wurden ebenfalls auf ihre Fähigkeit hin untersucht, in 
transgenen Mäusen ein Reportergen zu aktivieren. In transgenen Mausembryonen 
konnte beobachtet werden, dass eines der potentiellen Enhancerelemente ein 
Expressionsmuster steuerte, das zeitlich und räumlich einem Teil des endogenen 
Maus-GLI3-Musters entsprach, vor allem im Gehirn, den Mandibeln, im 
Nasenbereich und im Herzen.  
Die erzielten Ergebnisse tragen zum Verständnis der räumlichen und zeitlichen 
Expressionskontrolle von GLI3 bei, dem Schlüsselfaktor der „sonic hedgehog“- 
Signalkaskade, und verschaffen einen Einblick in die potentielle Rolle 
hochkonservierter, nicht-kodierender Sequenzelemente im menschlichen Genom. 
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3 INTRODUCTION 
 
Limb development is a complex mechanism involving many molecular factors 
and signaling pathways, which orchestrate during embryogenesis the transformation 
of the limb bud to the complete extremities. The same or homologous signaling 
molecules and mechanisms are used to regulate development of many organs and 
tissues of the body. There, they are not easily accessible for genetic studies in humans 
since mutations leading to serious malformation syndromes generally do not segregate 
in large pedigrees. Limb defects, however, often do not seriously affect viability in 
humans and, consequently, are observed in extended families. In addition, limbs are 
easily accessible in model animals for analysis and experimental manipulation. 
Therefore, limbs are a preferred model for developmental biology, and the basic 
mechanisms of development unveiled for limbs in many cases apply for development 
of organisms in general.  
 
3.1 The hedgehog (hh) signaling cascade  
 
Hedgehog (Hh) signalling is important for the development of the limb and 
many other tissues and organs, and damage to components of the Hh signal-
transduction pathway can lead to birth defects and cancer in man. The significance of 
this pathway for the development is shown by the fact that it is represented in many 
different organisms of the animal kingdom, both vertebrates and invertebrates.  
The hedgehog pathway has been originally elucidated for the model organism D. 
melanogaster [reviewed by (Hooper and Scott 2005)]. Whereas the basic Hh-
regulatory mechanism has been conserved between fly and vertebrates, some 
important differences emerge: One crucial distinction is that single genes in D. 
melanogaster are represented by gene families in mammalian species. For example, 
there is only the one Hh in Drosophila, whereas in mammals there exist three different 
hedgehog paralogs, sonic, Indian, and desert hedgehog, with different patterns of 
expression. Sonic hedgehog (Shh) is expressed in the ventral neural tube and its lateral 
somites. It is involved in the establishment of the left–right asymmetry, the 
polarization during the limb development, and it functions as a morphogen for the 
development of the eyes, lungs, hair, organs of the digestive system, and the nervous 
system (Krauss et al. 1993; Riddle et al. 1993; Fan et al. 1995; Roelink et al. 1995; 
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Marti and Bovolenta 2002; Salinas 2003; Donner and Maas 2004; Ishibashi et al. 
2005). Indian hedgehog (Ihh) is expressed in the embryonic lung, in the developing 
cartilage, and in the adult kidney and liver (Marigo et al. 1995; Iwamoto et al. 1999). 
It coordinates the proliferation and the maturation of the chondrocytes during the 
development of the cartilage skeleton. Ihh regulates partly the same target genes as 
Shh, such as Hoxd11, Hoxd13 and Bmp2, but also the parathyroid hormone-related 
peptide in the perichondrium cells (PTHrp) (Bitgood and McMahon 1995; Vortkamp 
et al. 1996; Iwamoto et al. 1999; St-Jacques et al. 1999). Finally, Desert hedgehog 
(Dhh) plays a role in the spermatogenesis (Bitgood et al. 1996).  
The patched (ptc) receptor of the HH signaling molecule of  D. melanogaster is 
represented by two ptc receptors in mammals, Ptc1, which is expressed adjacent to the 
hedgehog genes, and  Ptc2, which is less well studied but appears to be not so widely 
expressed. Whereas the pathogenic effects of PTC1 deficiency has been well 
characterized, few phenotypes could be attributed to the malfunction of PTC2 
(Rahnama et al. 2004).  
Finally, the Drosophila transcription factor Cubitus interruptus (Ci) that translates HH 
signaling into regulation of gene expression, is represented in vertebrates by the GLI 
gene family, which consists of three members (Gli1, Gli2, and Gli3).  
The current view of steps implicated in hedgehog signaling is presented in figure 3-1 
for SHH 
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Figure 3-1:  Shh signaling pathway 
A selection of factors participating in the Shh signaling pathway. Autocatalytic cleavage and 
cholesterol binding is essential for the transport of Shh out of the signaling cell and to the target 
receptor as well as the action within the responding cell. Inactivation of the receptor Ptc after Shh 
binding releases and activates Smo. This event triggers a series of only partly understood reactions, 
and, eventually, to the transduction of the signal to the GLI proteins, which can act on their target genes 
 
As a first step, Hh is autocatalytically processed and its N-terminal domain is 
covalently attached with a cholesterol and a palmitic acid molecule that plays an 
important role in its secretion and function in vertebrates (Pepinsky et al. 1998; 
McMahon 2000). Its receptor, the Ptc molecule, inhibits another transmembrane 
protein, the Smo molecule, in absence of Hh. This repression has the effect that Ci in 
Drosophila and Gli genes in vertebrates are maintained in a full length status, which 
can act as transcriptional activator. In the case of Drosophila, Smo is constitutively 
active but is inhibited by Ptc when Shh is not bound to it. The signaling by Hh causes 
the endocytosis of Ptc and the phosphorylation of Smo that transduces the signal into 
the cytoplasm (Chuang and Kornberg 2000; Denef et al. 2000; Incardona et al. 2000; 
Kalderon 2000; McMahon 2000; Karpen et al. 2001). The factor Fu, which is a part of 
a multiprotein complex, bound to the microtubules receives the signal from Smo. This 
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complex consists of the proteins Fu, Su(fu), Cos-2 and Ci (Ingham 1998) but factors 
such as PkA, Slmb and Cbp also participate in this signal transduction pathway 
(Perrimon 1995; Aza-Blanc and Kornberg 1999). The Su(fu) is an antagonist for Fu 
and interacts directly with Cos-2 (Monnier et al. 1998). Cos-2 shows a high affinity to 
microtubules which is influenced by its phosphorylation status (Robbins et al. 1997; 
Sisson et al. 1997). Ci is the only DNA binding factor in this cascade and is associated 
with the microtubules through Cos-2 (Alexandre et al. 1996; Aza-Blanc and Kornberg 
1999; Wang and Holmgren 1999). It is cleaved following the Hh signal. The N-
terminal part of the molecule retaining the zinc-fingers and a regulatory domain enters 
the nucleus and represses the transcription of target genes. The phosphorylation status 
of Fu, Cos-2 and Ci is influenced by the PkA (Perrimon 1995; Chen et al. 1998) 
whereas Slmb plays a role in the ubiquitin mediated proteolysis through the 
proteasom and is connected with the activity of Ci (Ingham 1998; Jiang and Struhl 
1998; Aza-Blanc and Kornberg 1999). Finally, Cbp is a general co-activator and 
repressor of many transcription factors (Giles et al. 1998).  
In the absence of Hh, Ci represses its target genes whereas in the presence of Hh 
signaling it acts as an activator (Alexandre et al. 1996; Aza-Blanc et al. 1997). In 
vertebrates, this pathway is not as well elucidated as in Drosophila. 
Ci and its vertebrate homologs, the GLI proteins, are regulated post-translationally in 
a similar way. Both of them are situated in the cytoplasm, and in the absence of Hh 
signaling they remain there bound to Sufu and Cos2 in D. melanogaster and to the 
Sufu and the KIF7 in vertebrates. Proteolytic cleavage of these proteins follows and a 
truncated form of them, missing the C’ transactivating domain, represses the 
downstream target genes of this cascade (Kogerman et al. 1999; Methot and Basler 
2000; Cheng and Bishop 2002; Merchant et al. 2004; Paces-Fessy et al. 2004; Tay et 
al. 2005). Pka processes Gli3 and perhaps Gli2 into a transcriptional repressor (Ruiz i 
Altaba 1999). Nevertheless, the GLI proteins can have different roles. Gli3 acts more 
as a repressor (Dai et al. 1999; Wang et al. 2000; Motoyama et al. 2003), Gli2 more as 
an activator and Gli1 only as an activator (Karlstrom et al. 2003). Hh signals activate 
the transcription of Gli1 through Gli2 and Gli3 (Bai et al. 2004) 
 
Differences between the D. melanogaster and the vertebrates can also be found for the 
phosphorylation and regulation of the Smo molecule, as well as for the Cos2 factor. 
Orthologs of Cos2 in vertebrates are the KIF27 and KIF7 factors, members of the  
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kinesin family. KIF7 has been shown to bind GLI1 and to repress SHH signaling 
(Katoh and Katoh 2004; Tay et al. 2005). Another member of the KIF family, the 
KIF3a as well as the intraflagellar transport proteins (IFT88 and IFT172) play Cos-2 
like roles in vertebrates, taking part in repression and activation of Hh signalling 
(Huangfu et al. 2003; Tay et al. 2005). 
Some genes in the Hh signaling cascade of the vertebrates do not have any orthologs 
in D. melanogaster, some have orthologs with an unknown role and some have 
orthologs with completely different functions. “Missing In Metastasis” (MIM/BEG4), 
a actin-binding protein, functions as a Shh-responsive gene as well as a regulator of 
Gli transcription (Callahan et al. 2004). Two factors of the Hh pathway with positive 
regulatory activity that do not have orthologs in D. melanogaster are megalin and 
iguana. The first is a low-density lipoprotein-receptor protein that associates with 
SHH whereas the latter is a zinc-finger protein that participates in the nuclear 
localization of GLI1 (McCarthy et al. 2002; Sekimizu et al. 2004; Wolff et al. 2004). 
Two negative regulatory factors exclusively for the vertebrate pathway are FKBP8, an 
antagonist of SHH in the nervous system and SIL, a cytosolic protein with a function 
downstream of PTC (Izraeli et al. 2001; Bulgakov et al. 2004). One example of a 
factor that exists both in flies and vertebrates, but does not seem to affect the Hh 
pathway in D. melanogaster is Rab23. It is a vesicle transport protein and a negative 
regulator of the mouse Shh cascade (Eggenschwiler et al. 2001). Finally, an example 
of ortholog factors with different functions between the phyla is the Wnt inhibitory 
factor (WIF), which binds Wnt proteins and facilitates the Wnt signaling. Its 
vertebrate ortholog Shifted (Shf) is a secreted protein that binds Hh and takes part in 
its signaling. (Hsieh et al. 1999; Han et al. 2004; Glise et al. 2005; Gorfinkiel et al. 
2005) 
Some of the differences between organisms of the different phyla can be attributed to 
the fact that non-homologous factors have similar functions. HIP, the mammalian 
membrane glycoprotein Hh-interacting protein and Pxb of D. melanogaster probably 
have the same function despite the lack of sequence similarity. Both factors are 
transcriptionally regulated by Hh and both decrease the Hh responses, for example 
through direct binding to SHH in case of HIP (Chuang and McMahon 1999; Inaki et 
al. 2002).  
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3.2 The human GLI family  
GLI proteins are the vertebrate transcription factors involved in the translation 
of hedgehog signals into gene regulation. 
 The first gene of this family to be described, GLI1, was identified as an over-
expressed gene in a malignant glioma (Kinzler et al. 1988). Homology searches 
detected two more paralogs, GLI2 and GLI3. All GLI genes encode proteins that 
contain five highly conserved tandem C2-H2 zinc fingers that are connected with a 
histidine-cysteine linker (Ruppert et al. 1988). The DNA-target sequence for the GLI1 
and GLI3 proteins is a conserved GACCACCCA found in the promoters of the GLI 
target genes (Kinzler and Vogelstein 1990; Ruppert et al. 1990; Pavletich and Pabo 
1993; Vortkamp et al. 1995), whereas GLI2 has been reported to bind to a conserved 
GACCACCCCA region (Tanimura et al. 1998).  
 
In humans, all of the three genes have been mapped to separate chromosomal loci by 
FISH (Arheden et al. 1989; Ruppert et al. 1990; Kas et al. 1996; Matsumoto et al. 
1996). Human GLI1 resides in the 12q13.3 chromosomal region, spanning 13 kb of 
DNA sequence. It includes 12 exons with 3648 bp in total and is translated into a 
1106 aa protein. It is regulated like its Drosophila homologue ci through a TATA-less 
promoter, lacks a CCAAT consensus sequence, has a high GC content, includes a 
CpG island, and contains several GC boxes (Schwartz et al. 1995; Liu et al. 1998). 
The human and mouse proteins are 85% conserved. Human GLI2 resides in 2q14, but 
its genomic sequence and structure has not yet been unequivocally characterized. A 
100% identity can be observed at the protein level between human and mouse GLI2 
proteins for the “GLI-homology domain 1” and for the DNA binding region (Hughes 
et al. 1997).  
GLI3, finally, extends over a genomic region of 240 kb on chromosome 7p13. It 
consists of 15 exons with a 3 kb 3’ untranslated fragment and gives rise to a 8,5 kb 
mRNA with a 5055 bp ORF, which corresponds to a protein of 1580 aa (Kinzler and 
Vogelstein 1990; Ruppert et al. 1990; Vortkamp et al. 1995; Wild et al. 1997). The 
GLI3 gene expression is promoted by a 230 bp fragment within a CpG island, which 
resides adjacent to the 5’ end of the 1st exon, whereas the translation start site is 
located in the 2nd exon (Jacobsen 1996). By comparing the GLI protein sequences it 
appears that GLI3 and GLI2 are functionally and structurally more similar to each 
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other than to GLI1. Sequence comparison between human GLI3 and mouse GLI2 
showed that in addition to seven homologous domains they share with GLI1, they 
contain five more regions that cannot be found in GLI1. One resides before the 1st 
domain and the others after the domains 1, 4, 5 and 7. Also, in comparison to other 
factors of the GLI/Kruppel family, these two genes show the highest similarity (48%) 
on the protein level (Hughes et al. 1997). Due to the fact that both proteins interact 
with the CREB-binding protein (CBP) and have a similar expression patterns, it has 
been postulated that beside their unique roles they might possess also redundant 
functions. In the mouse, indeed redundancy has be shown with single and double 
GLI2/GLI3 knock-out animals (Mo et al. 1997; Hardcastle et al. 1998). Expression 
studies for the GLI genes have been conducted preferentially on mice (Buscher and 
Ruether 1998; Motoyama et al. 1998; Brewster et al. 2000; Schweitzer et al. 2000).  
Gli3 is regarded as a mediator of Shh signaling and takes part in the development of 
the limbs, the lungs, and the brain. It is expressed in a wide variety of normal adult 
tissues, including lung, colon, spleen, placenta, testis, and myometrium. It has been 
shown that Gli3 plays a crucial role in the antero-posterior prepatterning of the 
forming limb, and it participates in the positioning of the limb through interactions 
with dHand and Tbx3 (Rallis et al. 2005) as well as the determination of the digit 
number and identity (Litingtung et al. 2002), the formation of scapular blade (Kuijper 
et al. 2005), the formation of skeletal muscles (McDermott et al. 2005), the patterning 
of the spinal cord (Warburton and Lee 1999; Jacob and Briscoe 2003), the lung 
(Warburton and Lee 1999), and  the eye development (Tyurina et al. 2005). 
3.3 Pathogenic effects of GLI mutations 
 
Changes in the expression of GLI genes due to regulatory defects or mutations 
affecting the function of the proteins are associated with pathogenic phenotypes both 
in man and mouse. 
GLI1 is overexpressed in glioblastomas, osteosarcomas, rhabdomyosarcomas, B cell 
lymphomas and basal cell carcinomas (Kinzler et al. 1987; Roberts et al. 1989; 
Dahmane et al. 1997; Werner et al. 1997; Ghali et al. 1999). Ectopic expression of 
human GLI1 in mice has been observed to cause developmental defects, failure to 
thrive and Hirschsprung-like dilatation of the gastrointestinal tract (Yang et al. 1997).  
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 Defects in GLI2 in mouse can cause basal cell carcinomas and skeletal disorders 
(Sasaki et al. 1999; Grachtchouk et al. 2000; Park et al. 2000). In humans, loss-of-
function mutations can lead to pituitary anomalies and holoprosencephaly-like 
features (Roessler et al. 2003). 
Point mutations, translocations and deletions throughout and flanking the GLI3 gene 
can cause various autosomal dominant polysyndactyly syndromes such as the Greig 
cephalopolysyndactyly syndrome (GCPS), which is featured mainly by 
preaxial polydactyly, syndactyly, broad thumbs and toes, and facial deformities such 
as hypertelorism and frontal bossing (Vortkamp et al. 1991; Wild et al. 1997; Kalff-
Suske et al. 1999). Frameshift and nonsense mutations can also lead to Pallister-Hall 
syndrome (PHS) which is characterized by hypothalamic hamartoma, central or 
postaxial polydactyly, syndactyly, imperforate anus, anteverted nares and other facial 
abnormalities, and, occasionally, associated HPE and malformations of the axial 
skeleton (Kang et al. 1997). Finally, nonsense and missense GLI3 mutations can cause 
postaxial polydactyly type A, preaxial polydactyly type IV and postaxial polydactyly 
type A/B. Until lately, it was supposed that there was no correlation between the site 
and the type of the mutation and the phenotype (Kalff-Suske et al. 1999), but recently 
it has been postulated that the site of frameshift and nonsense mutations can actually 
play a role in the determination of the syndrome. If the mutation happens in the first 
third of the GLI3 gene it may cause GCPS, whereas mutations in the second third are 
associated with PHS. Some GCPS patients have been found to be mutated in the third 
part of the gene, however, no PHS patients are associated with changes in this section 
(Johnston et al. 2005).  
 
Developmental defects, generally associated with limb deformities, can be caused also 
by mutations in other factors of the Shh pathway (figure 3-2). Thus, one might 
postulate that syndromes showing among other peculiarities changes in the shape or 
the number of digits should be caused by mutations in genes functionally related to 
the HH signaling cascade. 
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Figure 3-2: Shh pathway and associated syndromes 
Diagram showing a shortened version of the vertebrate Shh pathway and a list of inherited diseases that 
are caused when the different parts of this pathway are mutated (Villavicencio et al. 2000).   
 
3.4 Transcriptional regulation of genes of the Hh signaling cascade 
 
Shh signaling governs the development of a long list of tissues and organs 
such as the limbs, the lungs, neural tube and brain, eyes, and muscles. It is present in a 
wide variety of normal adult tissues, including lung, colon, spleen, placenta, testis, 
myometrium and the formation of skeletal muscles (McDermott et al. 2005), 
(Warburton and Lee 1999), (Tyurina et al. 2005). However, little is known about the 
transcriptional regulation of genes of the Hh cascade. Most likely, a sophisticated 
system must exist that coordinates the up- and downregulation of the expression of 
different genes on different chromosomes in the correct spatiotemporal manner. For 
example, the expression of the members of the GLI family appears to be controlled by 
SHH (Marigo et al. 1996; Sasaki et al. 1999).  
In the neural tube, Gli1 is restricted to the most ventral regions, Gli2 extends from the 
ventral region above the Gli1 domain to the most dorsal region, where the expression 
of Gli3 takes place. A similar expression pattern can be found in the limb buds 
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(Marigo et al. 1996; Buscher and Ruether 1998) where Gli1 is expressed posteriorly, 
Gli2 in the whole limb bud, and Gli3 anteriorly. Cis regulatory elements are expected 
to play a major role in the correct positional and temporal expression of the GLI 
family, orchestrating the different expression patterns and finally the polarizing 
activity of the SHH in these tissues.  
As an example for such a regulatory element an enhancer for Shh, which is associated 
with preaxial polydactyly, has been identified 1 Mb upstream of the gene (Lettice et 
al. 2003). By mutating this region it has been shown that limb specific expression of 
Shh in mice is completely lost and degeneration of skeletal elements distal to the 
stylopod/zygopod junction is observed (Sagai et al. 2005). 
 
3.5 Transcriptional regulation of coexpressed genes 
 
Another question that arises concerning the transcriptional regulation is 
whether there are similar cis elements that regulate the expression of different genes 
in the same tissue. This problem was already addressed in 1986 when Buckingham 
and co-workers observed that the two murine myosin light chains (MLC1F and 
MLC3F), which are transcribed from two different promoters, as well as the α-cardiac 
actin gene have an enhancer element upstream of their promoters. This enhancer 
element and flanking nucleotide sequences is conserved between these genes. It was 
suggested that this whole structure is responsible for their correct spatiotemporal 
expression in the fetal skeletal muscle (Buckingham et al. 1986) 
In 1995, Gomez-Skarmeta and colleagues identified a parallel regulation of two 
members of the AS-C complex, the proneural achaete (ac) and scute (sc) genes in D. 
melanogaster. Their simultaneous expression by groups of cells (the proneural 
clusters) located at constant positions in discs is orchestrated by enhancer-like 
elements distributed along a 90kb region of the AS-C. These elements could drive 
expression of the lacZ reporter gene only in specific proneural clusters (Gomez-
Skarmeta et al. 1995). 
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3.6 Highly conserved regions outside of coding sequences 
 
The situation encountered in SHH appears to be relevant for transcriptional 
control of many genes, in particular transcription factors. Spatiotemporal and 
quantitative regulation of eukaryotic gene expression can be governed by elements 
residing upstream, downstream or in the introns of the gene. These “long range cis 
regulatory elements”, that can be either enhancers or silencers, may exist far away for 
some genes that play key developmental roles. For example, an enhancer for Shh 
which is associated with preaxial polydactyly has been identified 1Mb upstream of the 
gene (Lettice et al. 2003). The significance of such long range elements is shown by 
the fact that they are conserved in many different species and they are associated with 
inherited diseases (Kleinjan and van Heyningen 2005). 
 
3.7 Evolutionary sequence comparison facilitates the detection of long-range 
regulatory elements 
 
Sequence comparison for identification of common transcriptional regulation, 
although not a recent idea, is a method being applied only recently to a greater extent. 
Novel computational programs and algorithms being developed can help to identify 
sequence similarity in transcription binding sites in order to better understand the 
regulation of coexpressed genes (Cora et al. 2005). 
The complete sequence of man and other organisms, as well as the development of 
computational programs such as VISTA or PIPMAKER (Schwartz et al. 2000; Frazer 
et al. 2004) facilitates the genomic comparison of different species (figure 3-3). 
Conserved regions that reside outside of exons have been shown to contain 
functionally important elements such as cis regulators of transcription (Nobrega and 
Pennacchio 2004). By aligning genomes of evolutionary related species, such as 
human and other primates or mouse, one can find a large number of highly conserved 
regions. However, by comparing evolutionary distant species, such as human and the 
pufferfish Fugu rubripes, the conserved regions are narrowed down, potentially to the 
functionally most basic ones. Due to its very compact genome, which has lost much 
of most likely nonessential DNA and the presence of vertebrate specific orthologs for 
genes that have duplicated in the fish lineage, fugu is an excellent model for 
functional comparisons. It is ideal for identifying conserved elements of genes that 
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play important similar functional roles in many distantly related species. These 
elements can be easily tested for their function in transgenic systems such as 
zebrafish, Xenopus, and rodents (Venkatesh and Yap 2005).  
 
 
 
 
 
 
 
 
Figure 3-3: A vista plot depicting the conservancy of sequences.  
The genomic sequence of the 5’ part of the human GLI3 gene (from exon 1 to intron 2) is compared 
with the corresponding sequence of mouse and fugu. The gray arrow shows the orientation of the gene, 
the blue boxes the 1st and the 2nd intron and the rest of the colored boxes stand for different repetitive 
elements. The higher the peak the higher the similarity of the sequences. By comparing sequences of 
evolutionary distant species, the conserved sequences are narrowed down to the ones that most 
probably contain elements essential for the function of the gene throughout different organisms. 
Regions highly conserved even in fugu (>75%) appear in the 1st and 2nd exon of the GLI3 gene as well 
as in introns. 
 
3.8 Transcriptional regulation of paralog genes 
 
Paralog genes originate from duplication steps during the evolution of 
genomes. Such events result from duplication events within chromosomes (HOX 
cluster, hemoglobin and keratin clusters) from translocation of duplicated elements to 
other chromosomes, and/or from polyploidization phenomena that repeatedly 
occurred during evolution. They generated gene families, members of which are 
structurally and frequently still functionally related. Depending on the time point 
when these events occurred, similarities might apply to nongenic sequence, as well. 
Coding sequences, which were inherited as separate entities following a duplication 
step early in evolution, should only retain high sequence similarity if there are strong 
functional restraints. Whereas these restraints may have conserved protein sequence 
similarity between orthologs from pro- to eukaryotes, paralog genes might have 
developed sequence and functional divergency over time.  
Human/mouse 
Human/Fugu 
Mouse/Fugu 
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The classical model for the creation of paralogs suggests that originally the duplicated 
genes have identical roles. Mutations can either turn one of the two genes into a 
pseudogene, if they are deleterious, or rarely give novel attributes to it, if they are 
beneficial, while the other copy preserves the initial function (Ohno 1970). 
Duplication-degeneration-complementation (DDC) process is another model trying to 
explain the creation of paralog genes (figure 3-4). By this, one of the two genes can 
become nonfunctional by accumulation of null mutations in the coding or regulatory 
region, or it can get a new function by mutations, which will be preserved by the 
natural selection. Finally, degenerative mutations can occur for different subfunctions 
in the two genes, thus the combined action of both of them is needed for the normal 
function of the cell. In this way, the paralog genes are preserved during evolution 
(Force et al. 1999).  
 
 
 
Figure 3-4: The DDC model for the development of paralog genes (Force et al. 1999). 
Duplicated genes have three different possible fates. One copy can completely lose its activity due to 
mutations in the coding regions or in its regulatory elements, and thus become a pseudogene. Mutations 
on regulatory regions can also give one ortholog a new function, and if this change happens at the 
expense of an otherwise essential function, both copies are preserved. Finally, different mutations on 
the two copies can lead to the necessity of the combined function of both copies so that the function of 
the original gene is preserved.  The long boxes represent the coding region whereas the small ones 
depict the regulatory sequences. 
 
 
If, however, as is the case for GLI genes, the paralogs continue to maintain a 
coordinated expression pattern, one might expect that in addition to similarities in the 
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coding parts of the genes, regulatory, non-coding DNA sequence elements might be 
conserved, as well.  
Promoter sequences of such genes appear to be different, and there have not been 
many reports of common homologous, potentially cis regulatory regions between 
paralogs, in addition to the coding sequences. One example of transcriptional 
regulation by conserved enhancers can be found for Hoxa3 and Hoxb3. Both genes 
contain in their enhancers binding sites for Krml-1 but in different copy numbers, 
resulting in similarities and differences in the expression pattern of Hoxa4 and Hoxb3 
in mice hindbrain (Manzanares et al. 1999). Hoxa4, Hoxb4 and Hoxd4 also share 
enhancer elements for mesodermal and neural regulation. These regulators are 
conserved also in the orthologs between human and mouse (Morrison et al. 1997). 
The NDP kinase family also shows conservation of regulatory regions but with 
varying binding motifs, explaining the spatiotemporal differences in the expression of 
the different paralogs of this family (Ishikawa et al. 2003). Five cis-acting elements 
(SRE, MyoD binding site, Elk-1 binding site, positive and negative YY1 binding 
sites) have been found to regulate six actin paralog genes, the beta and gamma 
cytoplasmic actins, alpha and gamma smooth muscle actins and alpha skeletal and 
alpha cardiac actins. Although one or more of these elements are present in all of the 
paralogs, their numbers, sequences and distribution patterns vary remarkably. Similar 
distribution patterns of elements can be found in coexpressed paralogs. This means 
that the sequence and the architecture of the cis regulatory elements can dictate the 
tissue and temporal specificity of the expression of different gene family members. 
(Liu et al. 2000). 
These examples show that paralog genes can share common regulatory elements for 
overlapping expression. Still, differences in their placement and usage might allow 
distinct functions as well.  
 
3.9 Objectives of the study 
 
The aim of this thesis was to contribute to the detection and functional 
characterization of cis-acting regulatory elements for GLI3 and their potential 
relevance for pathogenity in man by answering the following questions: 
• How is the expression of human GLI3 regulated? 
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• Do GLI2 and GLI3 share similar regulatory elements? 
• Are mutations in GLI3 regulatory elements involved in pathogenity? 
Towards this end, studies were undertaken to enlarge the list of cases with GLI3 
morphopathies, which cannot be attributed to mutation in coding sequences of the 
gene. These cases are candidates to be searched for mutations in cis-regulatory 
elements upstream, downstream or in the introns of the gene.  
The transcriptional control of GLI3 gene expression involves promoter as well as cis-
acting enhancer sequences. As a first step, a minimal promoter was to be defined and 
tested functionally as well as by mutagenesis. Factors potentially binding to this 
minimal promoter and specifically governing GLI3 expression were to be identified. 
Functional studies in transgenic mice suggest that GLI2 and GLI3 might have greatly 
overlapping functions, however, sequence comparison of human and murine GLI2 
suggested, that human GLI2 might not act in a similar way. To prepare for a 
functional comparison of human GLI2 and GLI3 expression, it was a task of this study 
to search the DNA and putative coding sequences for homologies. 
The focus in the search for conserved cis-regulatory elements was set on GLI3. 
Evolutionary genomic sequence comparisons were to be applied to guide the search 
for potential enhancers. Predicted regions had to be tested for their regulatory capacity 
on reporter genes with foreign as well as the original GLI3 minimal promoter in 
transiently transfected cell cultures as well as in transgenic mice. In mouse embryos it 
was to be determined, if the expression patterns follow the time course and the spatial 
pattern of the endogenous mouse GLI3. Mutagenesis of potential enhancers followed 
by tests for retention of their regulatory capacity should pinpoint particularly critical 
sequences, and potentially binding transcription factors specifically regulating GLI3 
expression should be identified.  
The answers should contribute to our understanding of the spatial and temporal 
control of the expression of a key factor of the hedgehog signaling cascade and 
provide insight into the potential role of highly conserved non-coding sequence 
elements in the human genome. 
 
 
 
 
  Materials and methods 
  20 
4 MATERIALS AND METHODS 
 
4.1 MATERIALS 
 
4.1.1 Devices and accessories 
12 Well Plate Cellstar   Greiner bio-one, Frickenhausen 
ABI Prism 310 Genetic Analyzer  Applied Biosystems, USA 
ABI Prism 377 DNA-Sequencer  Applied Biosystems, USA 
Autoclave   Grössner, Hamburg 
AutoLumat LB 953     Berthold, Bad Wildbad 
Balance AE 240     Mettler, Switzerland 
Balance PM 2000     Mettler, Switzerland 
Cell Counter      Neubauer, Marienfeld 
Celloshaker Variospeed    Biotec Fischer, Reiskirchen 
Centrifuge 5415C     Eppendorf, Hamburg 
Centrifuge 5415 R     Eppendorf, Hamburg 
Centrifuge 5417C     Eppendorf, Hamburg 
Centrifuge Labofuge 400    Heraeus, Hanau 
Centrifuge Sorvall GLC-2B    Du Pont, Dreieich 
Centrifuge Sorvall RC-5b    Du Pont, Dreieich 
Centrifuge Sorvall RT6000    Du Pont, Dreieich 
Eissmachine ZBE 70-35    Ziegra, Isernhager 
Electrophoresis Hoefer apparatus SE 600  Hoefer Pharmacia Biotech, USA 
Electrophoresis Horizontal tank A2   Owl Scientific Inc. Wobum, USA 
Electrophoresis Horizontal tank B14   Owl Scientific Inc. Wobum, USA 
Falcon Tubes 14ml     Falcon, USA 
Falcon Tubes 15ml     Falcon, USA 
Falcon Tubes 50ml     Falcon, USA 
Gel Documentation System E.A.S.Y. RH-3  Herolab, ST. Leon Rot, Wiesloch 
Incubator Cytoperm     Heraeus, Hanau 
Incubator shaker      New Brunswick Scientific, USA 
Incubator type B5042 E    Heraeus, Hanau 
Laminair HA 2448 GS    Heraeus, Hanau 
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Laminair Microflow     Stolco, Düsseldorf 
Micro-Shaker      Flow Laboratories, Meckenheim 
Microwave Oven     Bosch, Gerlingen-Schillerhöhe 
Minisart filter NML 0.45μM    Sartorius GmbH, Göttingen 
Multitemp II Thermostatic Circulator 2219  LKB Bromma 
Nunc Cryotube Vials  Nalge Nunc International, 
Neerijse, Belgium 
Optic Microscope Diavert    Leitz, Wetzlar 
PCR Strip Tubes     Starlab, Ahrensburg 
PH Indicator Paper Neutralit    Merck, Darmstadt 
Photometer GeneQuant II Pharmacia Biotech, Uppsala, 
Sweden 
Pipette Tips Biosphere 10μl    Sarstedt, Nümbrecht 
Pipette Tips Biosphere 200μl    Sarstedt, Nümbrecht 
Pipette Tips TipOne 101-1250μl    Starlab, Ahrensburg 
Pipettes: 
 Eppendorf Pipettes    Eppendorf, Hamburg 
 Electric pipette Accu Jet   Brand, Wertheim 
 Hamilton Pipette    Hamilton, Bonaduz, Sweden 
Power Supply EPS 500/400    Pharmacia, Uppsala, Sweden 
Power Supply LKB ECPS 3000/150   Gibco, BRL, USA 
Power Supply Powerpad 200    BioRad, USA 
Reaction tubes 3810 1,5ml    Eppendorf, Hamburg 
Safe-lock tubes 0,5ml     Eppendorf, Hamburg 
Sarstedt tube 5ml     Sarstedt, Nümbrecht 
Shaker RT-1S, Rocky    Kobe, Marburg 
Syringe needle 20 gauge    BD, Heidelberg 
Tissue Culture Flasks 250ml Cellstar   Greiner bio-one, Frickenhausen 
Thermocycler I cycler    BioRad, USA 
Thermocycler Perkin Elmer 2400   Applied Biosystems, USA 
Thermocycler Perkin Elmer 9600   Applied Biosystems, USA 
Thermocycler Trio Thermoblock   Biometra, Göttingen 
Vortex VF2      IKA Labortechnik, Staufen 
Waterbath type 1086     GFL, Grossburgwedel 
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Waterbath type 1083     GFL, Grossburgwedel 
Whatman 3M filter paper    Whatman Lab Sales, USA 
 
4.1.2 Chemicals 
All chemicals that are not described in this list were purchased from Gibco BRL 
(USA), Merck (Darmstadt), Riedel-de-Haen (Seelze), Roche Diagnostics 
(Mannheim), Roth (Karlsruhe), Serva (Heidelberg), Sigma (München) 
 
40% Acrylamid                                         Pharmacia Biotech, Freiburg 
2% Methylenbisacrylamid                               Pharmacia Biotech, Freiburg 
Agar Gibco BRL, USA 
Agarose      Invitrogen, Groningen, 
Netherlands 
Bacto Yeast Extract BD, Le Pont de Claix, France 
Bactotryptone BD, Le Pont de Claix, France 
Bromophenol Blue Merck, Darmstadt 
Coomassie Blue Carl Roth, Karlsruhe 
Cryoprotective medium Cambrex, Verviers, Belgium 
DMSO (Dimethylsulfoxide) Serva Reinbiochemica, Heidelberg 
D-PBS       Gibco BRL, USA 
EDTA       Diagnostic International, USA 
Fetal Calf Serum     Boehringer Mannheim, Mannheim 
Formamid                                                               Merck, Darmstadt 
Glycine  Riedel de Haen, Seelze 
L-Glutamine Cambrex, Verviers, Belgium 
Long Ranger Gel Solution  BioWhittaker Molecular 
Applications, USA  
MEM Non Essential Aminoacids Gibco BRL, USA 
Penicillin/Streptomycin  Gibco BRL, USA 
Phenol Red Serva, Heidelberg 
Rotiphorese ® NF-Acrylamide/Bis Carl Roth, Karlsruhe 
RPMI 1640 Medium – L Glutamine Gibco BRL, USA 
SDS  Merck, Darmstadt 
Temed  Carl Roth, Karlsruhe 
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Tris – Cl  Carl Roth, Karlsruhe 
Triton X-100 Serva, Heidelberg 
Tween-20 Sigma, Deisenhofen 
KOH  Merck, Darmstadt 
MOPS Sigma, Deisenhofen 
NaCl  Riedel de Haen, Seelze 
NaOH  Merck, Darmstadt 
Water -for PCR, Sequencing: HPLC  Merck, Darmstadt 
           -for SSCA: Ampuwa                 Fresenius, Oberursel 
 
4.1.3 Buffers and standard solutions 
All buffers and solutions were made with MilliQ water. 
 
4.1.3.1 DNA Isolation 
P1    15 mM Tris/HCl (pH 8.0)  
10 mM EDTA  
100 µg/ ml RNase A  
 
P2    200 mM NaOH  
1% SDS (w/v) 
 
P3     3 M Potassium acetate, pH 5.5  
 
QBT     750 mM Sodium chloride  
50 mM MOPS (pH 7.0)  
15% isopropanol (v/v)  
0.15% Triton X-100 (v/v)  
 
QC     1 M Sodium chloride  
50 mM MOPS (pH 7.0)  
15% isopropanol (v/v) 
 
QF     1.25 M Sodium chloride  
50 mM Tris/HCl (pH 8.5)  
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15% Isopropanol (v/v) 
 
TE    10 mM Tris-Cl (pH 8.0) 
    1 mM EDTA 
 
TES    10 mM Tris-Cl, pH 7,5 
1 mM EDTA, pH 7,5 
0.1% (w/v) SDS 
 
4.1.3.2 Gel Electrophoresis 
50x TAE    2 M Tris base 
    5.71% Acetic acid (v/v) 
    50 mM EDTA (pH 8) 
 
4.1.3.3 Bacterial culture 
All media are autoclaved for 20min before use.  
 
LB Medium 1% Bactotryptone (w/v) 
 0.5% Yeast Extract (w/v) 
  1% NaCl (w/v) 
 
LB Agar 1% Bactotryptone (w/v) 
 0.5% Yeast Extract (w/v) 
  1% NaCl (w/v) 
 1.5% Agar (w/v)  
 
DYT-Glycerin  1.6% Bactotryptone (w/v)  
 1% Yeast Extract (w/v) 
  0.5% NaCl (w/v) 
 80% Glycerin (v/v) 
 
4.1.3.4 Cell culture 
RPMI Medium 4% or 10% 90% RPMI Medium (v/v) 
 1% L-Glutamine (v/v) 
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 4% or 10% Fetal Calf Serum (v/v) 
  1% Non Essential Aminoacids (v/v) 
  2% Penicillin/Streptomycin (v/v) 
 
PBS + EDTA pH 7,5 0.8% NaCl (w/v) (Merck)  
  0.02% KCl (w/v) (Merck) 
 0.14% Na2HPO4 (w/v) (Merck)  
 0.02% KH2PO4 (w/v) (Merck) 
 0.02% EDTA (w/v) (Roth) 
 0.1% Phenol red (v/v) (Serva) 
 
4.1.4 Enzymes 
BD Powerscript Reverse Transcriptase BD Biosciences, 
Heidelberg 
Taq DNA polymerase     Promega, Madison, WI, 
USA 
Herculase enhanced DNA polymerase   Stratagene, Cedar Creek,  
USA 
PfuTurbo DNA polymerase     Stratagene, Cedar Creek,  
USA 
Klenow polymerase      MBI Fermentas, St Leon- 
Rot 
Calf Intestinal Alkaline phosphatase    NEB, Beverly, USA 
Rnase A       Qiagen, Hilden 
T4 DNA ligase      Invitrogen, Groningen, 
Netherlands 
 
4.1.5 Loading dye 
6x Agarose Gel Loading Dye 2.5 mg/ml Bromophenol 
blue 
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4.1.6 Primers 
 
4.1.6.1 Primers for SSCA 
Exon 
Size of 
exon in 
bp 
Primer 5’-3’ primer sequence 
Forma
mide 
Annealing 
temperature 
Length 
of PCR 
product 
Position in cDNA 
or intron 
sequence 
ExIIfor1 AGA TGA CAG GTG AAG TGG AC 5’ intron 
ExIIrev1 CTC GCT CAC ATC TGT TCG AGT G 
- 60οC 211 
Until nt 39 
ExIIfor2 GAA GAC ATC ATG GAG GCC CAG From nt –10 
II 166 
ExIIrev2 CGC TCA ATT CAC AAG GAA TGC 
- 66οC 217 
3’ intron 
ExIIIfor1 CGA GAA TGA GAC CTA ATT GAT 5’ intron 
ExIIIrev1 CAT GGC AAA CAC CGT CCC 
- 55οC 293 
Until nt 333 
ExIIIfor2 CTT CAA CAT CGA GTG ACG AG From nt 224 
III 243 
ExIIIrev2 CCA TAC CTC CTG AAC AAG TG 
+ 54οC 185 
3’ intron 
ExIVfor GTT GCT TTG TGA ATC GGA ATG 5’ intron 
IV 106 
ExIVrev AGC CAG CAT CTC GTT CCA TTT C 
- 58οC 226 
3’ intron 
ExVfor1 GAG ACA GCC ATA GCC TGT G 5’ intron 
ExVrev1 GAG CGG ATA TAG TCC ATG TAG 
- 61οC 215 
Until nt 617 
ExVfor2 CTA CGT ATC CGG ACC TGC From nt 497 
V 206 
ExVrev2 AGG AGG CTG CAT GAT CTC 
- 63οC 228 
3’ intron 
ExVIfor GAC TCT GAG ATG CCT CAA GA 5’ intron 
VI 147 
ExVIrev* GCC ATT TCC CAA GAC TC 
- 62οC 264 
3’ intron 
ExVIIfor1 TGG TAT AGA GTC CAA CTG CA 5’ intron 
ExVIIrev1* GCT GAA GAG CTG CTA CGG 
- 64οC 215 
Until nt 989 
ExVIIfor2 GTC CAT ATC ACC ACT CTC CG From nt 901 
VII 202 
ExVIIrev2 GCA AAC AAG TGC TGA CAT TA 
- 56οC 205 
3’ intron 
ExVIIIfor1 GTG TAC TTG TCT GAG CTC AGC 5’ intron 
ExVIIIrev1 CTG GAA TAG GCC TCT GTG TTG G 
- 62οC 248 
Until nt 1183 
ExVIIIfor2 CTC TCT CCA CAT GCA TCA GCA From nt 1065 
VIII 214 
ExVIIIrev2 CAA CTG ACG TGG TGG CCT GC 
- 66οC 216 
3’ intron 
ExIXfor TGC CCG AGT TGG CAA GG 5’ intron 
IX 114 
ExIXrev GAC CCA AAG ACA CCA GTC TTG 
- 61οC 265 
3’ intron 
ExXfor CCT CCT GTT GTG TCT GAT TC 5’ intron 
X 141 
ExXrev GTC ACA GAG CTG TAA AGC TCG 
- 55οC 247 
3’ intron 
ExXIfor* TGA TGA ATA CGT TTC CAT TTG 5’ intron 
XI 150 
ExXIrev* AAG GAC CCA AGT GTG CCT G 
+ 51οC 231 
3’ intron 
ExXIIfor CGT GTT AGG CAT AAG CTG CTG 5’ intron 
XII 164 
ExXIIrev* CCT TAT GCA AGC TCC ATG CC 
- 59οC 265 
3’ intron 
ExXIIIfor1 CTT TTG GGA TGG GGC ATA GTC 5’ intron 
ExXIIIrev1* GAC CTG GAC TGT GAA TGG CTG 
- 64οC 246 
Until nt 1991 
ExXIIIfor2 GCC CAG AGG CTC ATG TCA CC From nt 1898 
XIII 291 
ExXIIIrev2 GGC CTG CTG TGA AGT CAG AAG 
- 65οC 243 
3’ intron 
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ExXIVfor1 CAT GAG CTC TCA TTA TTG GCT 5’ intron 
ExXIVrev1 GTG GAA ATG GTT GAG TCC ATG 
- 60οC 239 
Until nt 2267 
ExXIVfor2 CAT CAG CAA CTA TTC CAA CAG From nt 2157 
ExXIVrev2 CTA TGA GAG GAG AGA CCG CAG 
- 60οC 223 
Until nt 2425 
ExXIVfor3 CGG CAG GGA CCA AAT GGA TG From nt 2306 
XIV 328 
ExXIVrev3 GGA CTG GTG GAG AAA CTA 
- 60οC 223 
3’ intron 
ExXVfor1 GTG TAA GTC ATG CTC GAA GGG 5’ intron 
ExXVrev1 GAG CTG ATG GTG CTG GCG C 
+ 61οC 198 
Until nt 2567 
ExXVfor2 CAA CAC CTG CAG CTT GGG TG From nt 2445 
ExXVrev2 CTC ACG TTC TGC GGC CGG C 
+ 57οC 224 
Until nt 2669 
ExXVfor3 GCA GCC GCC GCT CCT CAG G From nt 2579 
ExXVrev3 GCC TTG AGG CGG TAC TGC TG 
+ 62οC 214 
Until nt 2792 
ExXVfor4 CAT CTC CAC CGA CGC CTC From nt 2691 
ExXVrev4 CAC GCC AGG CTC GAG GGC 
+ 60οC 213 
Until nt 2904 
ExXVfor5 CAA GTA CGC GGC TGC CAC From nt 2793 
ExXVrev5 GTC GCT GGC CCT CCT CAC G 
+ 57οC 228 
Until nt 3021 
ExXVfor6 CCG AGG AGG TGC AGC GAC G From nt 2926 
ExXVrev6 GCC GCG TGT AAT TCT GAA GCA C 
+ 65οC 228 
Until nt 3154 
ExXVfor7 CTC GTG TGC CGC GCT TCA G From nt 3056 
ExXVrev7 CTG CAC CAC GTC GTC CGG C 
+ 62οC 238 
Until nt 3294 
ExXVfor8 CAG CAT CAC CGA GAA CGT CAC From nt 3201 
ExXVrev8 TGC TGC CCT CGG GGC AGG 
+ 63οC 262 
Until nt 3463 
ExXVfor9 CCA CGG GCC CGG TGA CTT TG From nt 3369 
ExXVrev9 CAG CAG GCC CGC TCC TCA AG 
+ 64οC 262 
Until nt 3631 
ExXVfor10 CAA GTG TGG GCC GCG GCC From nt 3531 
ExXVrev10 GGC TGC CTG TTG AGA CAG TTC 
- 64οC 254 
Until nt 3785 
ExXVfor11 CTT GAT GCT CCA CAA CAG CC From nt 3684 
ExXVrev11 CAC CAT GCT GCC AGC TGA CTC 
+ 63οC 243 
Until nt 3927 
ExXVfor12 GCC TCA AAG CTG AAG AGC AC From nt 3832 
ExXVrev12* CTT GGT AGA TGT TGA TGT GTG 
+ 57οC 244 
Until nt 4075 
ExXVfor13 CGA CAG CAT GCA GCA CCC From nt 3997 
ExXVrev13 CAT TCA CCC TGC AGG TCT G 
+ 62οC 271 
Until nt 4258 
ExXVfor14 CAG CCA TGT GCC AGC TTT G From nt 4150 
ExXVrev14 CTG TAG CAG GCA GCT GGC G 
- 68οC 260 
Until nt 4410 
ExXVfor15* CTA TGA CCA AAC CGT GGG C From nt 4329 
ExXVrev15 GTT CTG AAT GAT ACT TGG GC 
- 61οC 261 
Until nt 4590 
ExXVfor16 GGT ACA GAT TGA CTT CGA TGC From nt 4503 
ExXVrev16* GAT TTC CGT TGG TTG CAG TC 
- 61οC 276 
Until nt 4779 
ExXVfor17 GAG TTC TTT GCT GAC CTC From nt 4687 
XV 2570 
ExXVrev17 CTC CCT AGA ATA CTT TAG G 
+ 50οC 247 
3’ UTR 
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4.1.6.2 Primers for cloning 
Primer 
Annealing 
temperature 
5’-3’ primer sequence 
Restriction 
site tag 
Ex1cut for 80.4 0C GCCTCGAGTGGCGGTGTGGAGAGAGAAGAG XhoI 
Ex1cut rev 80.1 0C GCCTCGAGGCTTTCTCGCTCCTTCCAGG XhoI 
Ex1cut 
forwnew 
81.2 0C GCCTCGAGCAGACGAGTCCGGTGGAGAG XhoI 
Ex1prom
Atrunc F 
80.60C GCCTCGAGGCAGGCATGAATGTGTCTGTG XhoI 
Hom2New
F 
77.6 0C GCAAGCTTGAGCAATTGCAGAGTGCAGG HindIII 
Hom2New
R 
74.3 0C GCAAGCTTCACCTCTCTCCAACCAGCTAG HindIII 
Hom3forn
ew 
79.1 0C GCAAGCTTGAATGTCGCAGGGCAGAAAATG HindIII 
Hom3 rev 72.9 0C GCAAGCTTCATGGTGCCTTGTACAGGTG HindIII 
3’cutHom
3rev 
78.1 0C GCGGTACCCTGAACAACAGCAGCAGACC KpnI 
5’cutHom
3for 
75 0C GCGGTACCCAAGACAATCACAGTAGTGGTG KpnI 
Hom4 
forwnew 
73.3 0C GCAAGCTTCATCAACGATATGGTGCAG HindIII 
Hom4 rev 69.9 0C GCAAGCTTGTCTGTAATTGCAGTTGTTC HindIII 
Hom3Kpn
Ifor 
81.4 0C GCGGTACCGAATGTCGCAGGGCAGAAAATG KpnI 
Hom3Kpn
Irev 
78.2 0C GCGGTACCCATGGTGCCTTGTACAGGTG KpnI 
Hom4Kp
nIfor 
76 0C GCGGTACCCATCAACGATATGGTGCAG KpnI 
Hom4Kp
nIrev 
72.8 0C GCGGTACCGTCTGTAATTGCAGTTGTTC KpnI 
Hom2Ne
wKpnI F 
80.1 0C GCGGTACCGAGCAATTGCAGAGTGCAGG KpnI 
Hom2Ne
wKpnI R 
76.8 0C GCGGTACCCACCTCTCTCCAACCAGCTAG KpnI 
Ex1cutp12
30for 
81.2 0C GCCTGCAGTGGCGGTGTGGAGAGAGAAGAG PstI 
Ex1cutp12
30rev 
80.9 0C GCCTGCAGGCTTTCTCGCTCCTTCCAGG PstI 
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4.1.6.3 Primers for mutagenesis 
Primer 
Annealing 
temperature 
5’-3’ primer sequence 
Restriction 
site 
Hom2mut1 
F 
78.6 0C GACACTGCGGGAGGATCCAGGACTTTGAAAC BamHI 
Hom2mut1 
R 
78.6 0C GTTTCAAAGTCCTGGATCCTCCCGCAGTGTC BamHI 
Hom2mut2 
F 
76.9 0C 
GACTTTGAAACTTGAGGATCCAGAGCTTGCTT
TCAAC 
BamHI 
Hom2mut2 
R 
76.9 0C 
GTTGAAAGCAAGCTCTGGATCCTCAAGTTTCA
AAGTC 
BamHI 
Hom2mut3 
F 
78.4 0C 
CCTCAAAAGCTAGGGATCCAGGGCTCTGAAA
TTTG 
BamHI 
Hom2mut3 
R 
78.4 0C 
CAAATTTCAGAGCCCTGGATCCCTAGCTTTTG
AGG 
BamHI 
Prommut1 
F 
88.0 0C GAGGGCGCGGGTAAGCTTACGCCCGGGCCC HindIII 
Prommut1 
R 
88.0 0C GGGCCCGGGCGTAAGCTTACCCGCGCCCTC HindIII 
Prommut2
New F 
87.8 0C CCTCGCCGGGTGAATGGGGCTTCGGCG - 
Prommut2
New R 
87.8 0C CGCCGAAGCCCCATTCACCCGGCGAGG - 
Prommut3
New F 
93.2 0C GGCGCGCCGGGACCGCGCGGGGTCAAG - 
Prommut3
New R 
93.2 0C CTTGACCCCGCGCGGTCCCGGCGCGCC - 
Prommut4 
F 
81.4 0C 
CTCCTCCTCCTCCGCAAGCTTGTCTTCACACA
GAC 
HindIII 
Prommut4 
R 
81.4 0C 
GTCTGTGTGAAGACAAGCTTGCGGAGGAGGA
GGAG 
HindIII 
Prommut 
5New F 
79.20C GTCAAGTAGGGGGACGAGGAGGAGCAGGC - 
Prommut 
5New R 
79.20C GCCTGCTCCTCCTCGTCCCCCTACTTGAC - 
InrmutF 79.60C CAGCTGGGACCTTCTCCGGGCTTGG - 
InrmutR 79.60C CCAAGCCCGGAGAAGGTCCCAGCTG - 
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4.1.6.4 Primers for RACE PCR 
Primer 
Annealing 
temperature 
5’-3’ primer sequence 
AP1 71 0C CCATCCTAATACGACTCACTATAGGGC 
AP2 77 0C ACTCACTATAGGGCTCGAGCGGC 
GLI2Race2 75.2 0C GCTTCTTGCTTCTCGGAGGCAGTGG 
GLI2Race3 81 0C GCTCATCGTCCTGGGTGGCAATCCTTGC 
GLI2Race4 79 0C GCAGACGTCTCCATCTCAGCCGCTCATC 
GLI3RT1 77.7 0C CATTAGAAGTGGTGCTGGAGGCAACGGC 
GLI3RT2 76.7 0C CTCGCTCACATCTGTTCGAGTGGAGCAC 
 
4.1.6.5 Primers for primer extension 
Restriction 
site tag 
Annealing 
temperature 
5’-3’ primer sequence Modification 
Exten 63.3 0C TTTTGCTTTCTCGCTCCTTC 5’ IRD700 
Lucexten 62.70C TCCATCTTCCAGCGGATAG 5’ IRD700 
 
4.1.6.6 Primers for sequencing 
Primer 
Annealing 
temperature 
5’-3’ primer sequence 
GLI2spec F 71 0C CACCAAGAAGCAGCGCAATGAC 
GLI2spec R 68.8 0C TTCTCCTTCTTGAGCTGCTCGAAC 
Rvprimer3 56.5 0C CTAGCAAAATAGGCTGTCC 
GLprimer2 63.3 0C CTTTATGTTTTTGGCGTCTTCC 
M13 F 57.5 0C GTAAAACGACGGCCAG 
M13 R 50.6 0C CAGGAAACAGCTATGAC 
NFATP F 81.8 0C GCGAATTCCTGCTGGTTCCGCCCACTTG 
NFATP R 82 0C GCGAATTCCTGTTGCTGGTAGCGGGCGTC 
b-actin F 70.2 0C GACTTCGAGCAAGAGATGGCCAC 
b-actin R 61.4 0C CTTCATGATGGAGTTGAAGGTAG 
LacZ F 71.8 0C CAACAGTTGCGCAGCCTGAATG 
LacZ R 72.3 0C GTGGGAACAAACGGCGGATTG 
 
4.1.7 DNA size standards 
100 bp DNA ladder     Gibco BRL, Eggenstein 
λ/HindIII/ EcoRI     MBI Fermentas, St Leon- 
Rot 
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4.1.8 Reaction kits 
BigDye Terminator v1.1 Cycle Sequencing Kit Applied Biosystems, Warrington, 
UK 
Dual-Luciferase Reporter Assay System  Promega, Madison, WI, USA 
DYEnamic ET Terminator Cycle Sequencing Kit Amersham, Buckinghamshire, UK 
Effectene Transfection Reagent    QIAGEN, Hilden 
Human Total RNA Master Panel II   BD, Le Pont de Claix, France 
Marathon-Ready cDNA    BD, Le Pont de Claix, France 
QIAfilter Plasmid Maxi Kit     Qiagen, Hilden 
QIAGEN Plasmid Midi Kit    Qiagen, Hilden 
QIAprep Spin Miniprep Kit     Qiagen, Hilden 
QIAquick Gel Extraction Kit    Qiagen  Hilden 
QIAquick PCR Purificiation Kit   Qiagen, Hilden 
QuikChange Site Directed     
Mutagenesis Kit     Stratagene, Cedar Creek, US 
Ready-To-Go- PCR Beads    Amersham Pharmacia Biotech, 
       Piscataway, USA 
RNeasy MinElute Cleanup Kit   Qiagen, Hilden 
TOPO TA Cloning Kit    Invitrogen, Groningen,    
  Netherlands 
 
4.1.9 Plasmids used in this work 
Nr. Name Comment Reference 
1 pGLI2 N2222 
5’ upstream region of already published cDNA human GLI2 
sequence, TA cloned in PCR 2.1 vector, 1379 bp size of insert 
This work 
2 
pGL3basic-1.9 
kb StuI-DpnI-
luc 
1.97 kb region containing 1,4 kb upstream of Exon1, Exon1 
and  0.5 kb downstream of Exon1 of human GLI3, cloned in 
Sma-I site of pGL3basic vector in (+) orientation 
This work 
3 
pGL3basic-3.7 
kb StuI-StuI-luc 
3.7 kb region containing 1,4kb upstream of Exon1, Exon1 and  
2,2 kb downstream of Exon1 of human GLI3, cloned in Sma-I 
site of pGL3basic vector in (+) orientation 
This work 
4 
Hom3a(-) – 
p1230 
Hom3 region (386 bp) cloned in HindIII site of p1230 vector 
in (-) orientation. A is exchanged to T in 1st nt of Hom3 region. 
This work 
5 p1230 
The b-globin promoter/lacZ reporter gene- fragment was 
inserted into the SmaI site of pBluescript II KS vector. B 
This work 
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globin promoter is residing downstream of the T3 promoter. 
6 
Hom3a(+) – 
p1230 
Hom3 region (386 bp) cloned in HindIII site of p1230 vector 
in (+) orientation. No mutation. 
This work 
7 
Hom4a(+) – 
p1230 
Hom4 region (172 bp) cloned in HindIII site of p1230 vector 
in (+) orientation. A is deleted in 6th nt of Hom4 region. 
This work 
8 
Hom4a(-) – 
p1230 
Hom4 region (172 bp) cloned in HindIII site of p1230 vector 
in (-) orientation. No mutation. 
This work 
9 
pGL3basic-
promGLI3-600-
luc 
686 bp region containing 619 bp upstream of presumed 
initiation of human GLI3 as well as exon1, cloned in (+) 
orientation in XhoI site of pGL3basic vector 
This work 
10 
Hom3a(-) – 
p1230 
Hom3 region (386 bp) cloned in HindIII site of p1230 vector 
in (-) orientation. No mutation. 
This work 
11 
Hom4a(+) –
p1230 
Hom4 region (172 bp) cloned in HindIII site of p1230 vector 
in (+) orientation. No mutation. 
This work 
12 
pGL3basic-
promGLI3-300-
luc 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1, cloned in (+) 
orientation in XhoI site of pGL3basic vector. 
This work 
13 Hom2New (-) 
Hom2 region with more information (434 bp) cloned in 
HindIII site of p1230 vector in (-) orientation. No mutation. 
This work 
14 
pGL3basic-
Hom3(+)-luc 
Hom3 region (386 bp) cloned in HindIII site of pGL3basic 
expression vector in (+) orientation. No mutation. 
This work 
15 
pGL3basic-
Hom3(-)-luc 
Hom3 region (386 bp) cloned in HindIII site of pGL3basic 
expression vector in (-) orientation. No mutation. 
This work 
16 
pGL3basic-
Hom3(+)-
promGLI3-300-
luc 
Hom3 region (386 bp) cloned in KpnI site of pGL3basic-
promGLI3-300-luc construct in (+) orientation. No mutation. 
This work 
17 
pGL3basic-
Hom3(-)-
promGLI3-300-
luc 
Hom3 region (386 bp) cloned in KpnI site of pGL3basic-
promGLI3-300-luc construct in (-) orientation. No mutation. 
This work 
18 
pGL3basic-
Hom4(+)-luc 
Hom4 region (172 bp) cloned in HindIII site of  pGL3basic 
expression vector in (+) orientation. No mutation. 
This work 
19 
pGL3basic-
Hom4(-)-luc 
Hom4 region (172 bp) cloned in HindIII site of  pGL3basic 
expression vector in (-) orientation. No mutation. 
This work 
20 
pGL3basic-
Hom4(+)-
promGLI3-300-
luc 
Hom4 region (172 bp) cloned in KpnI site of pGL3basic-
promGLI3-300-luc construct in (+) orientation. No mutation. 
This work 
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21 
pGL3basic-
Hom4(-)-
promGLI3-300-
luc 
Hom4 region (172 bp) cloned in KpnI site of pGL3basic-
promGLI3-300-luc construct in (-+) orientation. No mutation. 
This work 
22 
pGL3basic-
Hom2(+)-luc 
Hom2 region with more information (434 bp) cloned in 
HindIII site of pGL3basic vector in (+) orientation. No 
mutation. 
This work 
23 
pGL3basic-
Hom2(-)-luc 
Hom2 region with more information (434 bp) cloned in 
HindIII site of pGL3basic vector in (-) orientation. No 
mutation. 
This work 
24 
pGL3basic-
Hom2(+)-
promGLI3-300-
luc 
Hom2 region with more information (434 bp) cloned in KpnI 
site of pGL3basic-promGLI3-300-luc construct in (-) 
orientation. No mutation. 
This work 
25 
pGL3basic-
Hom2(-)-
promGLI3-300-
luc 
Hom2 region with more information (434 bp) cloned in KpnI 
site of pGL3basic-promGLI3-300-luc construct in (-) 
orientation. No mutation. 
This work 
26 Hom2New (+) 
Hom2 region with more information (434 bp) cloned in 
HindIII site of p1230 vector in (+) orientation. No mutation. 
This work 
27 
pGL3basic-
3’Hom(+)-luc 
Hom3 region lacking  part of its 5’ sequence (273 bp) cloned 
in KpnI site of pGL3basic vector in (+) orientation. No 
mutation. 
This work 
28 
pGL3basic-
3’Hom(-)-luc 
Hom3 region lacking  part of its 5’ sequence (273 bp) cloned 
in KpnI site of pGL3basic vector in (-) orientation. No 
mutation. 
This work 
29 
pGL3basic-
3’Hom3(+)-
promGLI3-300-
luc 
Hom3 region lacking  part of its 5’ sequence (273 bp) cloned 
in KpnI site of pGL3basic-promGLI3-300-luc construct in (+) 
orientation. No mutation. 
This work 
30 
pGL3basic-
3’Hom3(-)-
promGLI3-300-
luc 
Hom3 region lacking  part of its 5’ sequence (273 bp) cloned 
in KpnI site of pGL3basic-promGLI3-300-luc construct in (-) 
orientation. No mutation. 
This work 
31 
pGL3basic-
5’Hom3(+)-
promGLI3-300-
luc 
Hom3 region lacking  part of its 3’ sequence (267 bp) cloned 
in KpnI site of pGL3basic-promGLI3-300-luc construct in (+) 
orientation. No mutation. 
This work 
32 
pGL3basic-
5’Hom3(-)-
Hom3 region lacking  part of its 3’ sequence (267 bp) cloned 
in KpnI site of pGL3basic-promGLI3-300-luc construct in (-) 
This work 
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promGLI3-300-
luc 
orientation. No mutation. 
33 
Exon I 5’ 
extended 
A fragment of human GLI3 (225 bp) containing sequence of 
exonII, exonI and part of the promoter region adjustent 5’ to 
exonI. Fragment was amplified using RACE pcr on human 
placenta cDNA and cloned with T-A cloning in the pcr2.1 
vector (INVITROGEN). No mutation. 
This work 
34 
p1230promGLI
3-300-lacZ 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1 and 22 bp of 
intron1, cloned in (+) orientation in PstI site of p1230 vector 
This work 
35 
pGL3basic-
Hom2mut1-luc 
Hom2 region with more information (434 bp) cloned in 
HindIII site of pGL3basic vector in (+) orientation. A mutation 
has been created in the 161-163 nt exchanging aaa with tcc, 
creating a BamHI site. 
This work 
36 
pGL3basic-
Hom2mut2-luc 
Hom2 region with more information (434 bp) cloned in 
HindIII site of pGL3basic vector in (+) orientation. A mutation 
has been created in the 180-185 nt exchanging aaggaa with 
ggatcc, creating a BamHI site. 
This work 
37 
pGL3basic-
Hom2mut3-luc 
Hom2 region with more information (434 bp) cloned in 
HindIII site of pGL3basic vector in (+) orientation. A mutation 
has been created in the 215-219 nt exchanging aggaa with 
gatcc, creating a BamHI site. 
This work 
38 
pGL3basic-
promGLI3-300-
mut1-luc 
425bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1 and 22 bp of 
intron1, cloned in (+) orientation in XhoI site of pGL3basic 
vector. A mutation has been created in the 36-40 nt exchanging 
gacatc with aagctt, creating a HindIII site. 
This work 
39 
pGL3basic-
promGLI3-300-
mut4-luc 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1 and 22 bp of 
intron1, cloned in (+) orientation in XhoI site of pGL3basic 
vector. A mutation has been created in the 145-153 nt 
exchanging cggggaggg with aagctt, creating a HindIII site. 
This work 
40 
pGL3basic-
promGLI3trunc
-luc 
299 bp region containing 232 bp upstream of presumed 
initiation of human GLI3 as well as exon1, cloned in (+) 
orientation in XhoI site of pGL3basic vector. 
This work 
41 
pGL3basic-
promGLI3-300-
mut2-luc 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1, cloned in (+) 
orientation in XhoI site of pGL3basic vector. A mutation has 
been created in the 72-73 nt exchanging gg with aa. 
This work 
42 pGL3basic- 425 bp region containing 358 bp upstream of presumed This work 
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promGLI3-300-
mut3-luc 
initiation of human GLI3 as well as exon1, cloned in (+) 
orientation in XhoI site of pGL3basic vector. A mutation has 
been created in the 95-96 nt exchanging gg with cc. 
43 
pGL3basic-
promGLI3-300-
mut5-luc 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1 and 22 bp of 
intron1, cloned in (+) orientation in XhoI site of pGL3basic 
vector. A mutation has been created in the 118 nt exchanging a 
with c, creating a HindIII site. 
This work 
44 
PGL3basic-
Inrmut 
425 bp region containing 358 bp upstream of presumed 
initiation of human GLI3 as well as exon1 and 22 bp of 
intron1, cloned in (+) orientation in XhoI site of pGL3basic 
vector. A mutation has been created in the 343 – 344 nt, 
exchanging each of the two nt of the int site predicted with 
primer extension in skeletal muscle cDNA bank with a t. 
This work 
45 PCR2.1-TOPO Vector for T-A cloning Invitrogen 
46 pGL3basic Firefly Luciferase Reporter vector Promega 
47 pGL3prom Firefly Luciferase Reporter vector Promega 
48 pRLSV40 Renilla Luciferase Reporter vector Promega 
49 pGBKT7  BD 
 
The vectors used for creating the constructs to be used for the cell assays or to be 
injected in the mice are shown in figure 4-1 and figure 4-2. 
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Figure 4-1: Vectors for transient cell transfection assays 
pGL3basic is the vector in which all the fragments have been cloned to be tested for their ability in 
regulating the luciferase reporter gene expression. pGL3promoter is the same vector as pGL3basic 
containing the SV40 promoter to drive expression of the luciferase reporter gene. It is used as a 
positive control and its activity is used as a measure for the activity of the cloned fragments in the 
pGL3basic vector . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2: p1230 vector 
The pBluescript II KS + was used to create the p1230 construct with an 80 bp region of the b-globin 
promoter with TATA box cloned next to the lacZ gene with an ATG and SV40 polyA signal. This 
combination is contained on an approximately 3,7 kb Sma fragment which is cloned into the Bluescript 
Sma site. The b-globin promoter is cloned just downstream of the T3 promoter. The vector shows very 
little ectopic expression and is preferred for testing enhancer elements in transgenic work. 
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4.1.10 Organisms 
 
4.1.10.1 Chemically competent bacteria 
TOP10 
Genotype: F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 
∆(araleu) 7697 galU galK rpsL (StrR) endA1 nupG (INVITROGEN). 
 
4.1.10.2 Cell lines 
NCI-H441 
Origin: Claracells, not small cellular lung cancer (NSCLC) 
Source: American Type Culture Collection (ATCC HTB-174) 
Growth Medium: RPMI 1640, 4% FCS 
GLI3 mRNA undetected in Northern Blot (Jacobsen 1996) 
 
NCI-H661 
Origin: Not small cellular lung cancer (NSCLC) 
Source: American Type Culture Collection (ATCC HTB-183) 
Growth Medium: RPMI 1640, 10% FCS 
GLI3 mRNA detected in Northern Blot (Jacobsen 1996) 
 
U2OS 
Origin: Osteosarcoma cells, epithelial bone cells 
Source: American Type Culture Collection (ATCC HTB-96) 
Growth Medium: RPMI 1640, 10% FCS 
GLI3 mRNA detected in Northern Blot (Topp 1997) 
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4.1.11 Data banks and online software 
 
Databank/On line software Application Internet address 
Pubmed Literature search http://www.ncbi.nlm.nih.gov/entrez 
OMIM (Online Mendelian 
Inheritance in Man) 
Genetic disorders 
catalogue 
http://www.ncbi.nlm.nih.gov/OMIM 
NCBI (National Center for 
Biotechnology Information) 
Genome resource http://www.ncbi.nlm.nih.gov/ 
UCSC Genome Bioinformatics Genome data bank http://genome.ucsc.edu/ 
TESS  Transcription factor 
binding site search 
http://www.cbil.upenn.edu/cgi-
bin/tess/tess 
Vista DNA alignment  http://genome.lbl.gov/vista/index.shtml
ClustalW Protein alignment http://www.ebi.ac.uk/clustalw/ 
Expasy Translate Tool DNA to protein 
translation 
http://www.expasy.org/tools/dna.html 
HGMP Resource Centre Bioinformatics resource 
centre 
http://www.hgmp.mrc.ac.uk/ 
Elektronische Zeitschriften 
Bibliothek 
Literature source http://rzblx1.uni-regensburg.de/ezeit 
 
 
4.2 METHODS 
 
4.2.1 Single strand conformation analysis (SSCA) 
 
4.2.1.1 PCR amplification of fragments of the GLI3 coding region 
 PCR was used for amplifying DNA fragments in tandem of the coding region 
of the GLI3 gene using different pairs of primers.  The genomic DNA-template was 
extracted from blood of patients with GREIG syndrome. PuReTaq Ready To Go PCR 
beads of Amersham Biosciences were used for the PCR. Each bead contains 
stabilizers, BSA, dNTPs, 2.5 units of puReTaq DNA polymerase and reaction buffer.  
 For every PCR one PCR bead, 50 ng of DNA template, 50 ng of each primer, 
eventually 1 μl formamid and aqua dest water (final volume 25 μl) were used. 
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4.2.1.2 Non-denaturating polyacrylamide gel for mutation analysis 
 For the mutation analysis through SSCA, vertical 12% polyacrylamide gels 
were used. The size of the gels was 16 cm x 18 cm x 0.075 cm. 7.5 ml of 40% 
acrylamid, 3 ml of 2% bisacrylamid, 2.5 ml of 5x TBE, 235 μl of 10% APS and 15 μl 
of temed were mixed in a final volume of 25 ml by adding sterile H2O. 
 The glass plates were washed thoroughly with aqua dest and isopropanol. 
After the cast of the gel, combs were used to create 1.2 cm x 2.5 mm x 0.75 mm 
wells. The gel was let to polymerize for 3hr and in the meantime the DNA probes 
were prepared (3.5 μl PCR product, 3.5 μl aqua dest and 8 μl loading buffer) and 
denatured at 95°C for 5’. After removing the comb, the wells were washed with 0.5x 
TBE and the probes were loaded with a Hamilton pipette. All probes were let to run 
for 10’ at 200 V and 90’ at 600 V in 10°C and 20°C. 
 
4.2.1.3 Silver staining of the native polyacrylamide gels 
 The visualization of the bands occurred through silver staining of the 
polyacrylamide gel, which was washed for 5’ in 1 l of 10% EtOH and 0,5% acetic 
acid and oxidized for 10’ in 1 l of 1% HNO3. The gel was washed with Milli Q H2O, 
stained for 20’ with 1 l of 12 mM AgNO3 and washed again with Milli Q H2O. The 
gel was developed with 2 l of 280 mM Na2CO3 and 0,019% Formaldehyd and 
stabilized for 5’ in 1 l of 10% acetic acid and approximately 10 ml glycerin. Finally, 
the gels were wrapped in plastic foils, stretched in plastic frames and allowed to dry 
overnight. 
 
4.2.1.4 Isolation of DNA from polyacrylamide gels 
 The extra bands that appeared because of a change in the DNA sequence were 
cut out and soaked in 100 μl of HPLC-H2O for 5-6 hours at 4oC and overnight at 
37οC. 3-5 μl of the eluate were used for reamplifying the mutated fragment through 
PCR. The PCR product was purified using the QIAquick PCR purification kit. 
 
4.2.1.5 Sequencing PCR 
 The sequencing PCR reactions were done by using the DYEnamic ET 
Terminator Cycle Sequencing Kit (Amersham), containing the labeled dNTPs. 40 ng 
  Materials and methods 
  40 
of DNA was amplified with 3.2 pmol primer and 4 μl of the sequencing reagent 
premix in a final volume of 10 μl.  
   
4.2.1.6 Sequencing PCR precipitation 
To precipitate the sequencing PCR product, 10 μl of water and 2 μl of sodium 
acetate/EDTA buffer were added to each tube. Then, 80 μl of 95% EtOH were added 
in each reaction which were incubated for 20 min in RT in darkness. The reactions 
were centrifuged for 15’at 14000 rpm and the pellets were washed with 300 μl of 70% 
EtOH. After a second centrifugation at 14000 rpm for 10’ the supernatant was 
removed and the pellets were air dried.  
 
4.2.1.7 Sequencing electrophoresis and data analysis 
The precipitated pellets were resuspended in 4 μl of formamide loading dye and 
analyzed on a 5% denaturing polyacrylamide gel in an ABI 377 automated sequencer. 
The sequencing data was obtained from the ABI 377 automated sequencer by 
Sequence Analysis Software ver 3.4.1 and was analyzed by Sequencher software ver 
4.2.   
 
4.2.2 Reverse transcription PCR (RT-PCR)  
RT-PCR generates cDNA fragments from RNA templates. In an autoclaved tube 5 μl 
total-RNA (1 ng/μl) (Clontech) was mixed with 1 μl (500 ng) Oligo(dT)12-18 primer 
and 5 µl RNAse free H2O  in a total volume of 10 µl. To avoid the possible secondary 
structure of the RNA, which might interfere with the synthesis, the mixture was 
heated at 70°C for 10’, and then quickly chilled on ice. After a brief centrifugation, 4 
µl of 5x 1st Strand Buffer, 2 µl of 10 mM dNTPmix, 2 µl of 100 mM DTT and 1 µl of 
PowerScript Reverse Transcriptase (Clontech) were added in the reaction mix. The 
content of the tube was mixed gently and incubated at 42°C for 90’ and then at 70°C 
for 15’.  
 
4.2.3 Polymerase chain reaction - PCR 
The amplification cycles were performed either in a PE2400 or PE9600 automatic 
thermocycler. The PCR reaction contained in general 10 ng of DNA, 0.2 pmol/μl 
of each primer, 0.2 μM dNTPs, 1x PCR buffer and 2.5 u of Taq DNA Polymerase 
in a final volume of 25 µl.  
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4.2.4 Agarose gel electrophoresis of DNA 
Usually, 0.5 – 1 g of agarose was added in 50 ml 1.0x TAE buffer, and boiled in the 
microwave to dissolve the agarose, then cooled down to about 60°C before adding 
ethidium bromide (10 mg/ml). This 1 - 2% agarose gel was poured into a horizontal 
gel chamber. 
 
4.2.5 5’ RACE PCR 
RACE PCR (Rapid Amplification of cDNA Ends) is a technique for amplifying the 
5’, the 3’ end or the whole sequence of a specific cDNA fragment. 5’ RACE was used 
to amplify further the already published cDNA of human GLI2 and GLI3 towards the 
5’ direction. As a starting template, Marathon-Ready cDNA (BD Biosciences) of 
human placenta was used. The characteristic of this cDNA library is that each cDNA 
fragment contains an adaptor sequence at its 5’ end. Two different adaptor specific 
primers, AP1 and the nested AP2 primer, can anneal on this sequence. PCR 
amplification of this domain is feasible, by using a primer that anneals on the 3’ part 
of the cDNA fragment. The primers must be 23-28 nt long, 50-70 % GC and Tm > 
700C. The ones that were used in this work can be found in the primer list for RACE-
PCR in the Materials section. The PCR was carried out according to the 5’RACE 
PCR protocol of BD Biosciences. 5 μl of Marathon-Ready cDNA were mixed with 
0.2 μM AP1 primer and 0.2 μM gene specific antisense primer, 1x Advantage 2 
Polymerase Mix in a final volume of 50 μl containing 1x cDNA PCR Reaction 
Buffer. The cycler conditions (for a PE9600 automatic cycler) are given below: 
 
980C : 30’’ 
980C : 5’’                                                            
720C : 4’       x 5cycles 
980C : 5’’ 
700C : 4’       x 5cycles 
980C : 5’’ 
680C : 4’       x 27cycles 
 
The PCR product was diluted 25 times and 5 μl of it were mixed with 0.2 μM AP2 
primer and 0.2 μM nested gene specific antisense primer, 1x Advantage 2 Polymerase 
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Mix in a final volume of 50 μl containing 1x cDNA PCR Reaction Buffer. The cycler 
conditions (for a PE9600 automatic cycler) for this nested PCR are given below: 
 
980C : 30’’ 
980C : 5’’                                                            
720C : 4’       x 5cycles 
980C : 5’’ 
700C : 4’       x 5cycles 
980C : 5’’ 
680C : 4’       x 17cycles 
  
4.2.6 Plasmid isolation using QIAGEN QIAprep spin miniprep kit 
To obtain plasmid of high purity for DNA sequencing, the target clone was inoculated 
in 5 ml of LB liquid medium containing 50 μg/ml ampicilin at 37°C while shaking at 
225 rpm for 12-16 hours. The culture was then centrifuged at 3000 rpm for 10’ at 40C 
and the pelleted bacterial cells were resuspended in 250 µl Buffer P1 and transferred 
to a microcentrifuge tube. Then 250 µl Buffer P2 were added, and the tube was gently 
inverted 4–6 times to mix. After 2’-5’ 350 µl Buffer P3 was added, the samples were 
mixed again by inversion and centrifuged for 10’ at 13,000 rpm (~17,900 x g) in a 
table-top microcentrifuge. The supernatants were applied to the QIAprep spin column 
by decanting or pipetting and centrifuged for 30’’–60’’. The flow-through was 
discarded and the QIAprep spin column was washed by adding 0.75 ml Buffer PE and 
centrifuging for 30’’–60’’. The flow-through was removed and the samples were 
centrifuged for an additional 1 min to remove residual wash buffer. Finally the 
QIAprep column was placed in a clean 1.5 ml microcentrifuge tube. DNA was eluted 
by adding 50 µl or water to the center of each QIAprep spin column, letting stand for 
1’, and centrifuging for 60’’. 
 
4.2.7 Medium-scale preparation of plasmid DNA (Qiagen Midi- Kit) 
A single clone was inoculated in 2 ml LB medium with appropriate antibiotic as a 
pre-culture for 8 hrs in 37°C shaker. This starter culture was diluted 1/500 – 1/1000 
into 100 ml of selective LB medium and incubated 12-16 hrs at 37°C with shaking 
(300 rpm). The saturated culture was centrifuged for 15 min at 6000 x g at 40C. The 
pellet was resuspended in 4 ml of solution P1 and cells were lysed with 4 ml P2 and 
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neutralised with 4 ml P3. The precipitated solution was incubated on ice for 15’ and 
centrifuged at 20.000 x g for 30’ and the supernatant once more for 15’ at 4°C. 
Meanwhile, the column (Qiagen-tip) provided with the Midi preparation kit was 
equilibrated with 4 ml of QBT solution. After centrifugation the lysate was poured 
into this equilibrated column thus allowing the DNA to bind with the resin present in 
the bed of the column. The column was then washed twice with 10 ml of solution QC. 
Finally, the DNA was eluted with 5 ml of QF solution. To precipitate the DNA, 3.5 
ml of room temperature isopropanol was added and mixed thoroughly and centrifuged 
at 14000 x g for 30’ at 4°C. The DNA pellet was washed with 2 ml 70% room 
temperature ethanol and dissolved in 60 µl of TE or H2O.  
 
4.2.8 Large-scale preparation of plasmid DNA (Qiagen Maxi- Kit) 
A single clone was inoculated in 2 ml LB medium with appropriate antibiotic as a 
pre-culture for 8 hours in 37°C shaker. In 100 ml LB medium with appropriate 
antibiotic this pre-culture was added in a dilution of 1/100 fold and incubated 
overnight at 37°C with shaking. The saturated culture was centrifuged for 15 min at 
6000 g at 40C. The pellet was resuspended in 10 ml of solution P1 and cells were 
lysed with 10 ml P2 and neutralised with 10 ml P3. The precipitated solution was 
incubated on ice for 20’ and then centrifuged at 10,000 rpm for 30’ at 4°C. The 
supernatant was transferred in a fresh tube and centrifuged again at 10,000 rpm for 
15’ at 4°C. Meanwhile, the column (Qiagen-tip) that was provided with the Maxi 
preparation kit was equilibrated with 10 ml of QBT solution. After centrifugation the 
supernatant was poured into the equilibrated column thus allowing the DNA to bind 
with the resin present in the bed of the column. The column was then washed twice 
with 30 ml of solution QC. Finally, the DNA was eluted with 15 ml of QF solution. 
To precipitate the DNA, 10.5 ml of isopropanol was added and mixed thoroughly and 
centrifuged at 14000 g for 30’ at 4°C. The DNA pellet was washed with 70% ethanol 
and dissolved in 200 µl of TE or H2O. 
 
4.2.9 RNEASY Mini Protocol for total RNA isolation from cells 
All the steps were carried out in room temperature and in RNAse free conditions. 
First, 106 cells in PBS were pelleted by centrifugation at 1500 rpm for 5’. The 
supernatant was removed and the pellet was diluted in 350 μl buffer RLT (10μl β-
mercaptoethanol were added in 1ml RLT buffer). The mixture was homogenized by 
  Materials and methods 
  44 
pipetting 5-10 times with a 20-gauge needle. Next, the RNA was precipitated with 
equal volume of room temperature 70 % EtOH and the sample was applied on the 
column. After centrifugation for 15’’ at 10000 rpm the flowthrough was discarded 
and the column was washed with 700 μl RW1 buffer (15’’ – 10000 rpm) and then, 
after removing the flowthrough, it was washed again twice with 500 μl RPE buffer 
(first 15’’ – 10000 rpm, then 2’ – 10000 rpm). The flowthrough was discarded, and 
the column was placed in a clean 1.5 ml Eppendorf tube. 30 μl of RNAse-free H2O 
were added on the column, which was then centrifuged for 1’ at 10000 rpm.  
The concentration of the RNA was determined with a photometer at 260 nm.  
 
4.2.10 QIAquick Gel Extraction method  
This method is designed to extract and purify DNA of 70 bp to 10 kilobase pair (kb) 
in length from agarose gels. Up to 400 mg agarose can be processed per spin column. 
The principle of this method depends on selective binding of DNA to uniquely 
designed silica-gel membrane. The excised DNA fragment in an agarose slice was 
weighed, and three volumes of QG buffer were added and incubated at 50°C for 10-
15 min. After the gel slice was completely dissolved, 1 gel volume isopropanol was 
added to the sample, mixed and then applied to a QIAquick column and centrifuged 
for 1’. The flow through was discarded and the column was washed with 750 µl of PE 
buffer. After drying the column it was placed into a fresh microcentrifuge tube. To 
elute DNA, 35-50 µl of EB buffer or water was applied to the centre of the QIAquick 
membrane and centrifuged for 1’.  
 
4.2.11 Restriction enzyme digestion of DNA  
Restriction enzyme digestions were performed by incubating double-stranded DNA 
with an appropriate amount of restriction enzyme in its respective buffer as 
recommended by the supplier, and at the optimal temperature for that specific 
enzyme. Standard digestions included 2-10 u enzyme per microgram of DNA. These 
reactions were usually incubated for 1-3 hrs to ensure complete digestion at the 
optimal temperature for enzyme activity, which was typically 37°C.   
 
4.2.12 Klenow treatment 
The isolated DNA fragment was incubated with 1x Buffer O+ (MBI Fermentas), 0.05 
mM dNTPs and 1.5 u of Klenow enzyme in a final volume of 20 μl.  
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4.2.13 CIP treatment of digested vector 
10 u of CIP (NEB) were added to the digested vector, and the reaction took place at 
370C for 1 hour. 
  
4.2.14 Ligation (Invitrogen) 
To calculate the necessary amount of insert and vector, which should be used in the 
ligation reaction, the following formula was used: 
 
Insert (ng) = 5 x vector (ng) x insert (bp) / vector (bp)  
 
The necessary amount of vector and insert were mixed with 5 u T4 DNA ligase in a 
reaction volume of 10 μl containing 1x ligation buffer. The ligation reaction was 
carried out at 140C overnight. 
 
4.2.15 TOPO TA Cloning 
4 μl of PCR product were incubated with 1 μl of salt solution and 1 μl of pCR2.1-
TOPO vector at RT for 5’. If necessary, prior to the cloning, the PCR product was 
incubated with 5 u of taq polymerase and 0.3 mM dNTPs at 720C for the addition of 
the A residues. 
 
4.2.16 Chemical transformation of TOP 10 E.coli competent cells 
In order to obtain plasmid DNA in large amounts for further experiments, the ligation 
product was transformed into an aliquot of TOP 10 E.coli competent bacterial cells. 
The competent cells were removed from a –80°C freezer and thawed on ice. Next, 6 
μl of the ligation product were added to the aliquot of the cells. The tube was gently 
tapped to mix and then incubated on ice for 30’. To heat shock the cells after the 
incubation, the sample was placed in a 42°C water bath for 30’’, and then placed on 
ice for two minutes. 250 µl of SOC medium was added, and the cells were incubated 
for 1 hour at 37°C while shaking at 225 rpm. 50 µl of the culture was spread out on 
LB agar growth plates containing 50 μg/ml ampicilin. The plate was incubated in a 
bacterial cell incubator at 37°C overnight. Transformed bacteria form a single colony 
growing on the appropriate antibiotic selective medium. The growth plates were 
stored at 4°C. 
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4.2.17 Liquid culture 
Single bacterial clones that grew on the LB-Agar Amp growth plate were picked with 
plastic pipet tips and incubated in 3 ml of LB liquid medium containing 50 μg/ml 
ampicillin at 37°C while shaking at 225 rpm for 12-16 hours.  
 
4.2.18 Small-scale isolation of plasmid DNA  
1,5 ml of the grown cultures in the liquid medium were transferred in 1.5 ml 
Eppendorf tubes and sedimented by centrifugation for 30’’ at 14.000 rpm. The pellet 
was re-suspended in 250 µl of solution P1. The bacterial cells were lysed with 250 µl 
of P2 solution and then neutralised with 250 µl of solution P3, which precipitates the 
proteins. The precipitated solution was incubated on ice for 5’, and centrifuged at 
14000 rpm at 4°C. The supernatant was transferred into a new tube, and 0,8 ml of ice 
cold 100% isopropanol was added to precipitate the DNA. It was then centrifuged for 
15’, and finally the pellet was washed with 70% ethanol. After air-drying the plasmid-
DNA pellets were dissolved in 50 µl of dH2O. 
 
4.2.19 Plasmid DNA sequencing 
In order to control clones for the presence of any point mutations generated during the 
process of amplification, appropriate DNA preparations were sequenced. Plamids 
were prepared using the QIA plasmid prep kit as described above. The purity and 
concentration were analysed spectroscopically. For sequencing a plasmid insert, 
plasmid concentrations of 100 ng/kb were used in a reaction mix of 10 µl which 
contained 0.4 µl of 10 μM primer and 2 µl of termination mix (Big Dye Terminator 
v1.1 Cycle Sequencing Kit). A standardized PCR reaction program was used with an 
initial denaturation at 95°C for 5’, 24 cycles of denaturation at 94°C for 20’’, primer 
annealing at Tm of maximum 600C for 15’’, extension at 60°C for 45’’, and 
terminated with 60°C for 4’ to facilitate the completion of extension reaction. After 
PCR completion, the products were precipitated with 75% isopropanol for 1hour in 
darkness and centrifuged for 20’ at 14000 rpm. The pellet was washed with 70% 
ethanol. The sample was dried in a thermoblock at 90°C for 2’ and resuspended in 15 
µl High Dye Formamide before subjecting to analysis by the ABI 310 sequence 
analyser. 
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4.2.20 Cell techniques 
 
4.2.20.1 Culture of eukaryotic cells 
Handling and propagation of all cell lines were performed in a cell and tissue culture 
laminar-air flow under sterile conditions. All solutions were stored at 4°C and 
warmed up to 37°C in a water bath before using. All solutions were only opened 
under sterile conditions in a laminar flow. The adherent H661 (lung cancer) cells were 
grown in RPMI medium, 10% FCS, 1% non essential amino acids, 2% 
Penicillin/Streptomycin and 1% L-glutamine cultivated in the incubator at 37° C, 5% 
CO2 and 88% moisture.  
 
4.2.20.2 Freezing cultured eukaryotic cells 
 To freeze cells for long term storage, they were harvested (at least one T 75 flask of 
80% confluent cells) and centrifuged at 1,000 g for 5’. The media was then aspirated, 
the cells were re-suspended in 1 ml of cell cryoprotective medium and frozen in cryo-
vials at  –800C. 
 
4.2.20.3 Splitting the eukaryotic cell cultures 
All cell lines were grown in a 37°C incubator and split in certain ratios depending on 
the stage of confluence and the proliferation rate of each cell line. The amount of 
medium added to the flask was dependent on its size. 10 ml were added into medium 
sized flasks (T75). The medium was changed every second day. To split cells, the 
medium was completely aspirated from the flask. In order to detach adhering cells 
PBS/EDTA (half the amount of culture medium) was added to a culture flask. The 
cells detached after about 5’ at 370C with occasional gentle tapping, and after removal 
of PBS/EDTA by centrifugation an aliquot of the resuspened cells was transferred 
into a flask containing fresh medium.  
 
4.2.20.4 Maintenance of human cell lines 
The cell line aliquots were stored in 1 ml cryoprotective medium at -80°C. To grow 
up a cell line, the frozen cells were thawed quickly in a 37°C water-bath then 
transferred into a 15 ml tube and mixed with 10 ml of medium. The suspended cells 
were centrifuged at 1,000 g for 5’ in order to isolate a cell pellet free of DMSO 
residues from the freezing medium. After removing the supernatant, the pellet was 
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resuspended in 10 ml medium and transferred into a cell culture flask. The cells were 
stored in a 5 % CO2, 37°C incubator.  
 
4.2.20.5 Cell counting 
The cells were detached using 5 ml of PBS/EDTA and incubation for 5’ at 370C, 
centrifuged for 5’ at 1200 rpm in a 15 ml Falcon tube. The supernatant was removed 
and the cells were resuspended in 5 ml PBS. This washing step was repeated once 
more, and finally one aliquot of the resuspended cells was used for counting. The 
counting of the cell density was performed in a Neubauer cell counting chamber.  
 
4.2.20.6 Transient transfection of adherent cells 
Transient transfection is a technique used for inserting DNA constructs in cell cultures 
usually to express a specific protein or to test the potential of promoters or other cis 
regulatory elements to drive expression of reporter genes in specific cell lines.  
The day before transfection, in each well of a 12-well plate a sufficient number of 
cells were plated (2 x 105 H661, 1.5 x 105 U2OS cells or 3.5 x 105 H441 cells) in 2ml 
suitable growth medium to reach on the next day, when the transfection was to be 
performed, 60-80% confluency. The day of transfection, 500 ng of total DNA in 5 µl 
TE buffer pH 7-8  (200 ng test construct, 100 ng Renilla construct, pRLSV40, 200 ng 
stuffer DNA) (table 4-1) were mixed with the DNA-condensation buffer, Buffer EC, 
to a total volume of 75 µl. 4 µl of enhancer were added, and the mixture was vortexed 
for 1’’. The mix was incubated at room temperature (15–25°C) for 2–5’ and then spun 
down for a few seconds to remove drops from the top of the tube. Finally, 6 µl 
effectene transfection reagent were added to the DNA-enhancer mixture, mixed by 
pipetting and incubated for 5–10’ at room temperature (15–25°C) to allow 
transfection-complex formation. In the meantime, the cells were washed with 4 ml 
PBS and provided with 0.8 ml fresh growth medium (can contain serum and 
antibiotics). 0.4 ml growth medium (can contain serum and antibiotics) were added to 
the tubes containing the transfection complexes, mixed by pipetting and immediately 
the transfection complexes were added drop-wise onto the cells in the 12 well plate. 
The plates were gently swirled to ensure uniform distribution of the transfection 
complexes and incubated under normal growth conditions for 48 hr for transfection to 
occur and for the expression of the transfected gene.  
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Each of the constructs had been purified with QIAquick mini/midi prep kit and 
brought to a concentration of 100 ng/μl. The DNA mixtures used for the transient 
transfections are given in the following table: 
 
 pGL3basic pGL3prom Sample pRL-SV40 pGBKT7 
Negative 
control 
2 μl (200 ng) - - 1 μl (100 ng) 2 μl (200 ng) 
Postitive 
control 
- 2 μl (200 ng) - 1 μl (100 ng) 2 μl (200 ng) 
Sample - - 2 μl (200 ng) 1 μl (100 ng) 2 μl (200 ng) 
 
Table 4-1: Concentrations of each construct necessary for transient cell transfection 
 
On the next day, 1.5 ml of complete medium was added to each well and culture was 
continued at 37°C. 
For each construct 3-6 transfection experiments were performed in parallel. 
 
4.2.20.7 Protocol for dual luciferase assay on a 12 well plate 
The transfected adherent cells in each well were washed with 1ml PBS and then 
treated with 250 μl of 1x PLB (Passive Lysis Buffer). The culture plates were placed 
on an orbital shaker with gentle shaking to ensure complete and even coverage of the 
cell monolayer with 1X PLB for 15’. Then, the lysate was transferred into a 1.5 ml 
Eppendorf tube and centrifuged for 30” at top speed in a refrigerated microcentrifuge. 
20 μl of the cleared lysate were transferred into a clean polypropylene tube. 1.2 ml of 
LAR II buffer and 1.2 ml of Stop and Glo buffer were mixed with 200 μl water, each. 
LAR II and Stop and Glo are necessary for the light emission of the firefly and the 
renilla luciferase respectively. To the Stop and Glo buffer, 12 μl of 100X Stop & 
Glo® substrate were added. The luciferase activity was measured with the AutoLumat 
LB 953 luminometer. 
 
4.2.21 Primer extension assay 
The primer extension assay is a useful method for determining the transcription start 
site of genes. A primer 22-30 nt long marked with IRD-700 on its 5’ end is used to 
reverse transcribe mRNA to cDNA. The primer must be specific for the gene of 
interest, must anneal not further than 200 – 300 nt of the presumed transcription 
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initiation site and must have an extension direction towards the 5’ end of the gene. 
The resulting product is precipitated like a sequencing PCR reaction product. A 
genomic fragment, which contains at least the sequence where the marked primer 
anneals and the presumed initiation site is undergoing a sequencing PCR reaction with 
the same primer used for the primer extension and precipitated. Both the cDNA that 
resulted from the marked primer and the genomic sequence are let to run parallel in a 
sequencing gel. The marked cDNA should give a signal right next to the nucleotide of 
the genomic sequence, where the cDNA sequence stops. By this way, the 
transcription initiation site of a gene is determined.  
 
4.2.21.1 Primer extension reaction 
For the primer extension, total RNA was used that expresses the gene of interest. 5 μg 
of total RNA in RNAse free H2O were mixed with 2 pmol of 5’ IRD700 modified 
primer and incubated for 10’ at 700C in a final volume of 11 μl. Then, to the reaction 
were added 1 mM dNTP mix, 2 μl of DTT, 1 u of Powerscript RT and first strand 
buffer in a final concentration of 1 μl. The mixture was incubated for 90’ at 420C and 
for 15’ at 700C. 
 
4.2.21.2 Precipitation of primer extension product 
The product of the primer extension (20 μl) was diluted in 175 μl of TES buffer (10 
mM Tris-Cl, pH 7.5; 1 mM EDTA, pH 7.5; 0.1% (w/v) SDS). To remove all the 
proteins from the mixture, it was mixed with 50 μl phenol, 48 μl chloroform and 2 μl 
of isoamylalcohol and centrifuged for 5’ at 13000 rpm. The supernatant was 
transferred into a clean Eppendorf tube, and 1 μl of glycogen (10 μg/μl) was added to 
enhance the precipitation together with 600 μl of ice cold absolute ethanol. After at 
least 1 hr incubation in –800C the sample was centrifuged for 15’ at 13000 rpm and 
the supernatant was removed. After the pellet was vacuum dried, it was diluted in 6 μl 
of HPLC water and stored at 40C.  
 
4.2.22 Transgenic mice  
Transgenic mice are produced by the microinjection of DNA constructs into the 
pronuclei of 0.5 dpc (days post coitum) one-cell fertilized eggs and the injected eggs 
are transferred to the oviducts of 0.5 dpc pseudopregnant foster mothers. The DNA 
construct integrates randomly into the genome of the egg and the resulting founder 
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mice will contain one or more copies of the transgene in every cell. By this way, the 
integrated construct of cis regulatory element – reporter gene drives expression of the 
reporter gene in the tissues in which the element specializes.  
 
4.2.22.1 DNA isolation and precipitation prior to injection 
The constructs that contained the fragments to be injected were double digested with 
Not/XhoI (NEB). The digestion product of each reaction was run in a 1% agarose gel 
and the DNA band corresponding to the insert was extracted with the QIAquick Gel 
Extraction method. The isolated, linearized DNA fragment was then precipitated with 
1/10 volume of sodium acetate, double volume of 100% EtOH and incubated for 30’ 
at   -800C. The mixture was centrifuged at 14.000 rpm for 15’, the supernatant was 
removed and the pellet was washed with 200μl of 70% EtOH. 
 
4.2.22.2 Mice injection 
The isolated DNA fragments were diluted in 10 mM Tris, pH 7.5, 0.1 mM EDTA, pH 
8.0 buffer in a final concentration of 1-3 µg/ml. The amount of DNA injected cannot 
be determined absolutely, but it is estimated that 1-2 pl are microinjected into each 
male pronuclei of fertilized eggs. These eggs were then transferred in the oviduct of 
pseudopregnant female mice, which give birth to transgenic mice. These mice have 
integrated the DNA fragment into their genomic DNA of almost all of their cells. 
However, because the integration happens randomly, the same construct can cause 
different staining in the different mice, as the transcription of the reporter gene 
depends on the region of the chromosomes in which it is integrated. Therefore, if 
interesting staining is observed, it is preferred to create a stable line of mice 
containing the fragment inserted in the same chromosomal region. 
 
4.2.22.3 Analysis of embryos 
The time of gestation was calculated taking noon of the day of detection of a vaginal 
plug as embryonic day 0.5 (E 0.5). Expression of the transgene was detected by 
staining staged embryos overnight in X-gal buffer. Embryos were dissected free of 
extraembryonic membranes (which were retained for genotype analysis) then fixed in 
4% paraformaldehyde at 40C for 30’ to 2 hours, depending on their developmental 
stage, washed in detergent wash (2 mM MgCl2, 0.05% BSA, 0.1% sodium 
deoxycholate, 0.02% NP-40 in 0.1 M sodium phosphate buffer, pH 7.3), and stained 
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overnight in detergent wash containing 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 
0.085% NaCl with 0.1% Xgal at 370C. The staining reaction was stopped by washing 
the embryos in detergent wash then in phosphate–buffered saline. The embryos were 
postfixed overnight in 4% paraformaldehyde at 40C. 
 
Detergent wash:  
2 mM MgCl2 
0.05% BSA 
0.1% sodium deoxycholate 
0.02% NP-40 
in 0.1 M sodium phosphate buffer, pH 7.3 
 
Sodium phosphate buffer: 
Na2HPO4/NaH2PO4 mixed in right ratio 
 
Staining: 
2 mM MgCl2 
0.05% BSA 
0.1% sodium deoxycholate 
0.02% NP-40 
in 0.1 M sodium phosphate buffer, pH 7.3 
5 mM K3Fe(CN)6 
5  mM K4Fe(CN)6  
0.085% NaCl  
0.1% Xgal (add at last moment) 
 
4.2.22.4 DNA isolation from mice 
The yolk sac of each transgenic mouse embryo was incubated in 300 μl of a 50 mM 
Tris pH 8.0, 5 mM EDTA, 0.5% SDS buffer and 10 μl of 10 mg/ml proteinase K at 
550C overnight. The next day, 100 μl of 6 M NaCl was added and the samples were 
vortexed and centrifuged at 14.000 rpm for 10’’. The supernatant was transferred in a 
new tube and 300 μl of isopropanol were added. The mixture was centrifuged at 
14.000 rpm for 5’, the supernatant removed, and the pellet was washed with 250 μl of 
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75% EtOH, air dried and dissolved in 25-100 μl water, depending on the size of the 
starting material. 
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5 RESULTS 
 
Point mutations, translocations and deletions throughout the GLI3 gene can 
cause various autosomal dominant polysyndactyly syndromes summarized as GLI3 
morphopathies (Vortkamp et al. 1991; Wild et al. 1997; Kalff-Suske et al. 1999). In 
patients with these phenotypes, which do not show mutations affecting their GLI3 
coding sequences, regulatory sequences might be affected. In order to search GLI3 
regulatory sequences for mutations, a collection of cases with potential GLI3 
morphopathies without mutations in coding sequences has to be established. Towards 
this end, the DNA of appropriate patients was analysed for mutations in the GLI3 
coding sequences. 
GLI3 is a large gene (cDNA 5055 bp) extending over 250 kb on chromosome 7p13. 
Therefore, mutations were searched in a two-step procedure: First, exonic fragments 
including intron-exon boundaries were screened for changes in the DNA sequence 
affecting single strand electrophoretic mobility. Subsequently, fragments with 
differing electrophoretic behaviour were sequenced to identify the underlying 
mutation. 
 
5.1 Search for mutations in individuals with putative GLI3 morphopathies 
 
DNA was extracted from the blood of 24 patients with GLI3 morphopathies 
using standard procedures. The coding exons 2 to 15 of GLI3 including the intron-
exon boundaries were amplified by PCR using the primer pairs described above, and 
subjected to single strand conformation analysis (SSCA) at two different conditions. 
Exon one was not included as the translation of GLI3 starts from the second exon. 
The separated strands of PCR-amplified DNA fragments were screened by 
electrophoresis in a native (non-denaturating) polyacrylamide gel. Point mutations 
result in a variant three-dimensional structure of the single strand DNA molecules, 
which influences their electrophoretic behavior.   
 The sensitivity of SSCA depends on: 
• The length of the PCR-fragments (best results are obtained for fragments 
smaller than 300 bp) 
• The GC-content of the sequence 
• The kind and the position of the mutation 
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• The electophoretic conditions (buffer concentration, temperature) 
Large exons were split into conveniently sized, overlapping fragments. Amplicons, in 
which at least one of the patients showed an electrophoretic band with deviating 
mobility, were screened in 100 unaffected, unrelated control individuals. Non-
polymorphic variants were extracted from the gel and sequenced. 
The mutation analysis detected a series of DNA polymorphisms in exons 5, 4, 14, and 
15, which had already been described, previously.  
Three non-polymorphic missense mutations and one nonsense mutation were 
observed among the patients. 
In a patient with syndactyly in all the limbs, polysyndactyly in the left and right foot, 
high forehead and bregma, frontal bossing, hypertelorism and broad nasal root a 
mutation in exon 13 (c.1873 C>T; R625W) was found. In the second case, a patient 
with hexadactyly featured a mutation in exon 15 (c.3664 C>T; P1222S). Both 
missense mutations had been previously described in other patients. 
Two novel mutations were detected (figure 5-1). One change was identified in the 13th 
exon (c.2058_2059 GG > AT; R686R, E687X), which represents one silent and one 
nonsense mutation next to each other. This patient showed a mild syndactyly, 
postaxial polysyndactyly and broad terminal phalanges in both hands, hypertolorism, 
broad nasal root, short structure, growth hormone deficiency and hypothalamic 
hamartoblastoma. The second novel, a missense mutation in exon 15 (c.4675 A>G; 
I1559V) was detected in a patient reported to show an acrocallosal syndrome.   
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Figure 5-1: Novel mutations detected in the GLI3 gene of patients with GLI3 morphopathies 
1) SSCA gel (a) comparing the pattern of exon 13 from the patient (M) and an unaffected control 
individual (N). The corresponding DNA and protein sequences around the observed mutation are 
aligned (b).  
2) Exon 15 of a Greig syndrome patient (M) and of an unaffected control individual (N). a): SSCA 
pattern, b): aligned sequences of the mutated region. 
Arrows depict the deviating band in the patients. The mutated nucleotides and the resulting amino acids 
are shown in red. 
  
 acc     tca    aag    cgg    gaa    gaa    tgc     ctc 
 acc     tca    aag    cga     taa     gaa    tgc    ctc 
 T        S        K        R         X        E        C       L 
T          S        K          R         E         E        C          L 
N 
M 
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For the mutation in exon 13, the first nucleotide exchange does not alter the amino 
acid due to the wobble effect but the neighboring alteration creates a premature stop 
codon. In the 15th exon, the missense mutation leads to an exchange of isoleucine by 
valine. The position of the novel mutations is shown in figure 5-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2: Position of the novel mutations on the GLI3 protein  
Diagrams of the genomic structure of GLI3 (above) and the protein sequence (below). Exons are 
indicated with Roman numbers. Above the bar representing the GLI3 protein, amino acids flanking 
functionally important, conserved domains are shown in red. Below this bar, the position and the type 
of mutations observed in different GLI3 morphopathies are depicted. The two novel mutations are 
described individually. (GCPS = Greig cephalopolysyndactyly syndrome; PAP-A/B: polydactylies A 
and B; PPD-IV: postaxial polydactyly type IV; PHS: Pallister-Hall syndrome). 
 
5.2 Experimental control of the published human GLI2 cDNA sequence 
 
5.2.1 Human GLI2 5’RACE PCR 
 
 The overlapping and distinct expression of human GLI2 and GLI3 speaks 
for the existence of both similar and different transcriptional regulation of these genes. 
As the promoter region of GLI2 has not been yet identified, it was decided to find 
additional upstream sequence by amplifying and sequencing of the 5’ region of this 
gene.  
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RT-PCR was performed on human placenta and fetal lung total RNA. The resulting 
cDNA served as a template for GLI2 specific PCR (primers “GLI2specF” & 
“GLI2specR”).  Figure 5-3 shows that placenta expresses GLI2 in abundance, thus 
this tissue was chosen to proceed with 5’ RACE PCR. 
 
 
Figure 5-3: PCR with GLI2 specific primers using cDNA 
generated by RT PCR on human placenta and fetal lung total 
RNA  
The electrophoretic separation shows that a product of 423 bp is 
observed in greater abundance from placenta cDNA. 
 
 
 
 
 
 
For 5’ RACE PCR, commercially RACE-ready human placenta cDNA was used as a 
template to investigate the upstream region of GLI2. This cDNA library is already 
ligated with the necessary adaptors to perform the PCR.  The single intense PCR 
fragment obtained by the 5’ RACE PCR using the gene specific primers  (primers 
“GLI2Race2”, “GLI2Race3”, “GLI2Race4”), which anneal in the 2nd exon of GLI2 
according to the published sequence (NM_030381) is shown in figure 5-4. 
 
 
 
 
Figure 5-4: Electrophoresis of the RACE PCR product 
After the nested PCR reactions one single DNA band with a size 
larger than 1 kb is observed. 
 
 
 
 
 
100 bp    Nested       
Marker   RACE PCR 
100 bp                  Fetal 
Marker  Placenta  lung 
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The resulting PCR product was cloned in the TOPO-TA cloning vector that was 
transformed into TOP 10 E. coli competent cells. Positive clones were isolated and 
sequenced. 
The sequence of this amplified region was aligned using the “bl2seq” program from 
NCBI (http://www.ncbi.nlm.nih.gov/) and the “BLAT” program from the USCS 
database (http://genome.ucsc.edu/) with the published GLI2 cDNA and the 
corresponding genomic sequence.  It extended from the GLI2 specific published exon 
2, on which the primers for the 5’ RACE PCR annealed, into the published 1st exon 
and continued for 1195bp further upstream. The sequence ended with the adaptor 
sequence of the MARATHON RACE READY cDNA LIBRARY, indicating that it 
did not represent a genomic DNA contamination.  
The extended cDNA sequence matches the published genomic sequence of this 
chromosomal region upstream of the previously determined start of transcription, 
indicating that it is part of the first exon. However, this region neither shows any 
similarity with mouse GLI2, nor does it contain an ORF that is compatible with the 
published exons of human GLI2. All of the possible ORFs end with a stop codon, not 
allowing the GLI2 protein to be produced. Using the NIX program of the HGMP 
Resource Centre (http://www.hgmp.mrc.ac.uk/), a genomic fragment containing the 
1st and the 2nd exon, the 1st intron and 2000 bp upstream of the 1st exon (according to 
the published sequence [NM 030381]) was searched for potential promoter elements. 
A CpG island of 208 bp could be identified residing inside the GLI2 cDNA sequence 
that was expanded in this work. The only predicted promoter element located 
upstream of the expanded cDNA is a TATA box 682 bp upstream of the cDNA start. 
Searching for promoter elements in the upstream region of the murine Gli2, 93 bp 
upstream of its 1st exon ends a 331 bp long CpG island. Another, 452 bp long, CpG 
island is located 382 bp downstream of the start of this exon. Inside the first CpG 
island there are predicted two inr sites and a TATA-less promoter. These predicted 
promoter elements of human and mouse GLI2 do not share any similarity. Sequence 
comparison between the upstream region of human GLI2 and GLI3 did not reveal any 
similarity either, suggesting that the promoter regions of these genes are completely 
different. 
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5.3 Identification and functional analysis of the GLI3 promoter 
 
5.3.1 Determination of transcription start site of human GLI3 
 
The 1st exon as well as the promoter region of human GLI3 is not well 
characterized. The published sequence of the first exon might not to be complete since 
there is no transcription start site determined.   
Human placenta cDNA was used to amplify the 5’ upstream region of GLI3 by 
5’RACE PCR, as this gene is also expressed in this tissue. The reverse primers were 
designed to anneal to the published 2nd exon of human GLI3 and directing towards the 
5’ end of the cDNA. The first primer (“GLI3RT1”) anneals 123 nt and the nested 
primer (“GLI3RT2”) anneals 92 nt downstream of the ATG with which the ORF of 
GLI3 starts. The PCR product of the nested PCR reaction is shown in figure 5-5. 
 
 
 
. 
Figure 5-5: Electrophoresis of the products of 5’RACE PCR 
A 200-250 bp product is demonstrated. 
 
 
 
 
 
 
 
After the 1st and the nested PCR, a 200-250 bp product was obtained and cloned in a 
TOPO-TA cloning vector. 
A number of clones were isolated and sequenced. The longest transcript using this 
method was found two times and starts 133 nt upstream of the ATG. The extra 
sequence that can be found in the placenta cDNA bank is: 
 
 
100 bp   Nested     
Marker  RACE PCR 
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CctcgcagctgggacccactccgggcttggggacccggcgggcgggagaagcgggggctcccggcgcggcctgG
AAGGAGCGAGAAAGCAAAAGGGCATTTTTGGTCGAAGAGAGCTGAAGTA
ATGAGAAGACATCATG 
 
The sequence in black capital letters represents part of the already published sequence 
of exon 2 (including the ATG (bold black capital letters) with which the translation 
starts) and exon 1 of human GLI3, and the sequence in black small letters represents 
the extra sequence that was read in the cDNA library of human placenta with the 5’ 
RACE PCR. Using the NIX analysis program of the HGMP Resource Centre 
(http://www.hgmp.mrc.ac.uk/), a transcription start site was predicted at “CCT” just 
upstream to the new start sequence of exon 1. This start site is indicated above in bold 
red letters. 
 
One transcript was found to start 119 nt upstream of the ATG and its sequence is 
shown with small black letters, upstream of the 1st exon and 2nd exon (counting starts 
with the A of the ATG (bold black capital letters), with which the translation starts) 
that are depicted in black capital letters.  
 
CcactccgggcttggggacccggcgggcgggagaagcgggggctcccggcgcggcctgGAAGGAGCGA
GAAAGCAAAAGGGCATTTTTGGTCGAAGAGAGCTGAAGTAATGAGAAGA
CATCATG 
 
There is a strong prediction for an initiator site found exactly in this sequence, 
CCACTCC, which includes two nucleotides more (red bold letters) than this 
transcript (Jacobsen, 1996) 
One transcript was found to start 100 nt, one 46 nt, three transcripts started 44 nt, one 
42 nt and one 21 nt upstream of the ATG. One transcript was found to start 25 nt 
downstream of the ATG. 
The whole procedure (RACE PCR, cloning and sequencing) was repeated. The 
longest transcript started again 136 nt, one transcript 54 nt, four transcripts started 44 
nt, one 43 nt, one 42 nt, one 41 nt, one 32 nt and one 20 nt upstream of the ATG with 
which the ORF of GLI3 starts.  
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5.3.2 Experimental determination of the transcription start site with the primer 
extension assay 
 
 A primer was designed with a 5’ IRD-700 modification directing towards the 
5’ end of the GLI3 gene. This primer (“Exten”) anneals approximately 90bp 
downstream of the presumed initiator site and was used to synthesize cDNA by RT-
PCR from human skeletal muscle total RNA, which also expresses GLI3. This 
product was used to identify the transcription start site of the GLI3 using the primer 
extension assay.  
The resulting cDNA was precipitated and run in a sequencing gel next to the 
sequencing reaction of the pGL3basic-promGLI3-300-luc construct which was 
sequenced with the same primer that was used for the primer extension assay (figure 
5-6). 
     
 
 
 
Figure 5-6: Primer extension analysis of the GLI3 transcription 
start site 
The primer extension product next to the sequence of the pGL3basic-
promGLI3-300-luc construct. The signal from the primer extension 
band marks the nucleotide with which the cDNA, thus the mRNA, of 
GLI3 begins 
 
 
 
 
 
 
 
 
The 5’ part of the sequence that was amplified with the primer extension 
procedure is shown below: 
 
              Primer 
   A C G T  Extension 
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CCACTCCGGGCTTGGGG 
 
The black bold capital letter depicts the nucleotide at which the primer extension 
stopped. Thus, according to the primer extension assay, the 1st exon of the human 
GLI3 starts with this nucleotide.  
There is a strong prediction for an initiator site found exactly in this sequence, 
CCACTCC, which includes one nucleotide more (red bold letter) than the primer 
extension showed (Jacobsen, 1996). This GLI3 start site resides 13 nt downstream to 
the site where the 5’ RACE PCR stopped and 123 nt upstream of the ATG with which 
the ORF of the GLI3 starts. Interestingly, a transcript with almost the same length 
(one nt less) was found also with the 5’ RACE PCR. 
 
5.3.3 Cloning of promoter constructs 
 
 In order to be able to test the complete promoter region in transient cell 
culture assays for their regulatory activity on a luciferase reporter gene, two promoter 
fragments were cloned. The promoter elements used in this thesis are depicted in 
figure 5-7. 
 
 
 
 
 
 
 
Figure 5-7: Location of GLI3 promoter elements 
The GLI3 5’ Region including exon I and part of intron I is depicted. The constructs used in this work 
are shown in red 
 
The corresponding promoter regions including the published 1st exon were amplified 
with PCR. The forward primer (“Ex1cut for”) anneals 397 bp upstream of the 
published 1st exon for the first construct and 658 bp upstream of the published 1st exon 
(primer “Ex1cut forwnew”) for the second construct. The reverse primer (“Ex1cut 
rev”) starts 4 nt before the end of the 1st exon for both constructs. The primers 
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included XhoI restriction sites. The fragments used to generate the promoter 
constructs are shown in figure 5-8. 
 
 
Figure 5-8: Electrophoresis of the promoter PCR products: 
PCR products used to generate the 1st (A) and the 2nd (B) 
construct. c: PCR control; M: 100bp Marker 
 
 
 
 
 
 
These PCR products were digested with the XhoI restriction enzyme and were cloned 
into the respective site of the digested pGL3basic reporter vector. The 1st construct is 
named “pGL3-promGLI3-300-luc” and the 2nd construct “pGL3-promGLI3-600-luc” 
(figure 5-9). Isolated clones were sequenced to confirm the presence of the correct 
insert in the correct orientation.  
 
 
 
 
 
 
 
 
Figure 5-9: Promoter constructs for transient transfection assays: 
The two promoter constructs were cloned in front of the luciferase gene of the pGL3basic-luc vector. 
The arrow depicts the starting ATG of the luciferase reporter gene.  
 
5.3.4 Analysis of the capability of the promoter constructs to drive reporter 
gene expression in cell culture 
 
pGL3-promGLI3-300-luc and pGL3-promGLI3-600-luc were tested for their 
ability to drive luciferase reporter expression in cell cultures and compared to the 
SV40 promoter. The constructs were transiently transfected for two days into H661, a 
M       A       c      B   c 
 
LuciferasepromGLI3-300  pGL3basic-promGLI3-300-Luc 
Luciferase             promGLI3-600  pGL3basic-promGLI3-600-Luc 
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non-small cellular lung cancer cell line expressing endogenous GLI3. After 48hrs, the 
cells were lysed and the amount of the produced luciferase from each construct was 
measured in a dual luciferase assay and expressed in light units (LU). The activities of 
the constructs are shown in figure 5-10. 
 
 
 
 
 
 
 
  
 
 
 
Figure 5-10: Capability of promoter constructs to drive luciferase reporter expression 
The pGL3basic construct, which does not contain any element to control its expression, is the vector in 
which the promoter fragments have been cloned and serves as a negative control. pGL3promSV40-luc 
is pGL3basic containing in addition the SV40 promoter. Its activity is set to 100%. The clone 
containing the smaller GLI3 promoter fragment (pGL3basic-promGLI3(300)-luc) shows higher activity 
than the larger fragment of the GLI3 promoter (pGL3basic-promGLI3(600)-luc).   
 
Since pGL3basic-promGLI3(300)-luc showed a higher activity than the larger 
fragment, it was used preferentially for the subsequent experiments and was regarded 
as the GLI3 minimal promoter that can drive sufficient expression of the reporter 
gene. To compare its activity on different cellular backgrounds, its ability to drive 
luciferase expression was tested 48 hrs after transfection also in U2OS cells, which 
are osteosarcoma cells and express GLI3, and in the H441 cell line which are Clara 
cells, non-small cellular lung cancer cells and do not show endogenous GLI3 
expression. The potential to drive reporter expression is shown in figure 5-11. 
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Figure 5-11: Activity of a minimal GLI3 promoter in cultured cells 
The activity of the pGL3basic-promGLI3-300-luc construct is slightly higher in the U2OS cells, which 
are osteosarcoma cells and express GLI3, and decreased in the H441 cell line, which are Clara cells, 
non-small cellular lung cancer cells and without endogenous GLI3 expression. 
 
5.3.5 Search for critical transcription factor binding sites in the GLI3 minimal 
promoter 
 
 The sequence of the GLI3 minimal promoter was searched for possible 
transcription factor (TF) binding sites, which enhance or repress its activity using the 
TESS online program (http://www.cbil.upenn.edu/cgi-bin/tess/tess). TESS is a web 
tool for predicting transcription factor binding sites in DNA sequences. It can identify 
binding sites using site or consensus strings and positional weight matrices from the 
TRANSFAC, IMD, and the CBIL-GibbsMat database. The search was filtered to 
show only the human TF binding sites (figure 5-12).  
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Figure 5-12: Potential TF binding sites in the GLI3 minimal promoter 
The possible TF binding sites of the GLI3 minimal promoter are shown with red or blue arrows 
depending on their orientation. In red circles are the five mutations (mut1 to mut5), which have been 
introduced in order to test their influence in the activity of the promoter. The black vertical lines show 
the TF binding sites that could not be predicted anymore in the mutated sequence. The sequence that 
was removed to create a truncated minimal promoter is shown in the black box. The start of the 1st exon 
according to the 5’ RACE PCR and the Primer Extension analysis is indicated. 
 
 
mut3 mut5 mut4 
mut1 mut2 
1st exon – 5’ 
RACE PCR 
1st exon – primer 
extension 
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Five different sites were mutated using the QuickChange Site-Directed Mutagenesis 
Kit of Stratagene (mut 1 to 5). The primers (“prommut1F” & “prommut1R”, 
“prommut2newF” & “prommut2newR”, “prommut3newF” & “prommut3newR”, 
“prommut4F” & “prommut4R”, “prommut5newF” & “prommut5newR”, for the 
mutations 1 – 5 respectively) for creating the mutations were designed in such a way 
that the TF binding sites could not be predicted anymore by the TESS tool and that no 
other new TF sites were created (prommut 1 to 5). Each mutation was tested 
individually for its effect on the activity of the pGL3basic-promGLI3-300-luc 
construct by transiently transfecting it after culture for 48 hrs in the GLI3-expressing 
H661 cell line.  
In addition the GLI3 promoter was truncated at its 5’ end by 126 bp in order to 
define more strictly the region, which is important for its activity. By PCR 
amplification (primers “Ex1cut rev” & “Ex1promAtrunc F”) the truncated promoter 
was amplified and cloned in the XhoI site of the pGL3basic-luc vector. This construct 
was purified and was transiently transfected in H661 cells to test its activity. 
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Figure 5-13: Capability of mutated minimal GLI3 promoters to activate reporter gene expression 
in H661 cells 
The majority of the mutations had only a minor negative effect on the activity of the pGL3basic-
promGLI3-300-luc. Mutation 4 did not have any effect at all. The truncated construct showed a weaker 
activity than the original minimal promoter, but still did not lose its activity.  
 
The site directed mutagenesis of the sites 1, 2, and 5 each had a minor effect on the 
activity of the GLI3 minimal promoter. However, the truncation of its upstream 
sequence reduced its activity by half (figure 5-13). Obviously, this effect is not due to 
the loss of function of a single site from the tested ones.  
Two nucleotides of the initiator site identified with the primer extension method were 
also altered (primers “InrmutF” & “InrmutR”) to test if this element plays an 
important role in the promoter activity. The sequence of the initiator site and the 
adjacent 1st exon according to the primer extension are shown below. 
 
CCACTCCgggcttggggacccggcgggcgggagaagcgggggctcccggcgcggcctggaaggagcgagaa
agcaaaa 
 
The initiator site is shown in capital letters and each of the nucleotides in bold italics 
was exchanged with a T to create the mutation. The adjacent first exon is shown in 
small letters. This construct was purified and was transiently transfected in H661 cells 
to test its activity. However, no difference in the activity could be observed between 
the mutated (pGL3basic-Inrmut) and the un-mutated construct (pGL3basic-
promGLI3-300-luc) (figure 5-14). 
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Figure 5-14: Capability of mutated initiator site of GLI3 promoter to activate reporter gene 
expression in H661 cells 
The pGL3basic-Inrmut construct containing the mutated initiator site predicted by the primer extension 
does not affect the activity of the GLI3 minimal promoter.  
  
5.4 Identification of conserved elements downstream of GLI3 promoter 
 
 A 4 kb region downstream of the 1st exon shows high similarity (>75%) 
between the human and mouse genomic sequence of GLI3. The similarities were 
identified using the VISTA alignment program 
(http://genome.lbl.gov/vista/index.shtml), which calculates in a window of 60-100bp 
the similarity between given sequences and finally provides the user with a graph in 
which the conservancy is depicted in figure 5-15.  
A 4 kb region with high homology between the species is shown with a black arrow. 
It resides approximately 1.9 kb downstream of the first exon of human GLI3, inside 
the first intron. The restriction site map was used to select suitable fragments for 
cloning into a reporter vector and for testing of their regulatory potential.  
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Figure 5-15: Highly conserved genomic sequences around GLI3 exon 1 
Above: restriction map of a cosmid encompassing the GLI3 exon 1, the upstream region, and part of 
intron 1. Below: Vista plot comparing this human sequence with the homologous mouse sequence. 
Regions of homology higher than 75% are red. 
A 4 kb region with high homology between the species is shown with a black arrow. It resides 
approximately 1.9 kb downstream of the first exon of human GLI3 (small arrow), inside the first intron. 
The fragment between the circled EcoRI sites was used as a template for cloning. 
 
Such highly conserved non-coding regions may play a regulatory role. Therefore it 
was decided to clone parts of this region and test their regulatory activity on the 
luciferase reporter gene.  
The circled EcoRI sites in figure 5-15 encompass an 8.8 kb fragment that was used for 
enzymatic digestions to isolate and clone two different fragments shown in figure 5-
16. 
The enzymes StuI and DpnI were chosen to digest the 8.8 kb fragment as these 
enzymes produce blunt ends and allow the inserts to be cloned into the SmaI site of 
the pGL3basic vector. Blunt end ligation was chosen because no other suitable 
enzymes could be found for digestion and cloning. 
StuI digestion of the 8.8 kb fragment generated a 3.7 kb product and StuI/DpnI 
digestion resulted in a 1.97 kb element.  
The 3.7 kb fragment includes 1.5 kb upstream of exon 1 of human GLI3, the 1st exon, 
and 2.2 kb downstream into the 1st intron, thus including the potential minimal 
promoter and the first peak of the high homology region marked in figure 5-16. 
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The 1.97 kb fragment contains 1.5 kb upstream of 1st exon of human GLI3, the 1st 
exon and 0.5 kb from the 1st intron.  
The two fragments have the same upstream sequence, but one of them lacks the 
sequence corresponding to the 1st peak of the high homology region. 
 
 
 
 
 
 
  
 
 
 
 
Figure 5-16: Subcloning of sequences around GLI3 exon 1 
The blue lines show the regions that were isolated from an 8,8 kb EcoRI fragment and cloned into 
pGL3basic to be tested for their regulatory potential. Both originate at the same 5’ upstream StuI site 
but have different 3’ ends. 
 
The blunt-end digested fragments were isolated and cloned in the SmaI, CIP treated 
pGL3basic reporter vector. Positive clones with the correct orientation of inserts were 
identified and tested for their ability to drive expression of the luciferase reporter gene 
after transfection into the H661 cell line and culturing for 2 days (figure 5-17).  
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Figure 5-17: Activating potential of  GLI3 5’ sequences 
Luciferase activity in cells transfected with cloned GLI3 5’ fragments. The 1.9 kb construct shows a 
very high potential of driving the expression of the luciferase reporter gene, whereas the 3.7 kb 
construct, which includes the 1.9 kb region and additional downstream sequence, has a low activity.  
 
The results show a very high activating potential of the short fragment in comparison 
to the SV40 promoter and in particular in comparison to the larger fragment.  
Addition of extra sequence from intron 1 down-regulates the activity considerably. 
 
5.5 Highly conserved intronic regions of GLI3 
 
By comparing orthologs between evolutionary distant species, the most 
conserved regions can be identified. To detect further regions of high conservancy 
between distantly related species, which might pinpoint regulatory elements, the 
genomic sequence of human GLI3 was compared with the VISTA alignment program 
with its ortholog sequence of Mus musculus and Fugu rubripes.  For the human-
mouse comparison, 200 kb upstream and downstream of the GLI3 gene were included 
in the comparison. The fugu sequence was available with 24 kb upstream and 2.5 kb 
downstream of the gene for the comparison. The fugu GLI3 sequence was kindly 
provided by Dr. Greg Elgar, London, who also identified fugu sequence elements, 
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which showed high conservancy when compared with the human and mouse GLI3. 
The comparison between the different GLI3 orthologs identified numerous highly 
conserved regions (figure 5-18). It is obvious, that the exonic sequences are highly 
conserved, however there is also high conservancy between a great number of intronic 
sites in the human-mouse comparison. The number of non-exonic regions of high 
homology between all three species is considerably smaller and mainly restricted to 
intronic areas. Three of those sequence elements were chosen to be tested for their 
regulatory potential based on their size and their high degree of conservancy in all 
three species.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-18: Vista plot comparing exon I to intron VII of the GLI3 genes of fugu, mouse, and 
human 
Exons and the peaks representing their sites of homology are shown in light blue. The colored blocks 
above the plot lines indicate different types of repetitive elements. Sequence homologies of > 50% are 
indicated as red peaks. Three intronic regions Hom2, Hom3, Hom4, conserved in all three species, 
were selected for further study (red circled peaks). 
 
The first of these homology regions, Hom2, is a 434bp segment residing 
approximately 70 kb downstream of exon 2, in the 2nd intron of human GLI3. It shows 
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100% identity between human and mouse and more than 80% between human and 
fugu. 
The second homology region, Hom3, is 386 bp long and begins approximately 23 kb 
downstream of the 3rd exon, in the 3rd intron of human GLI3. It shows more than 80% 
identity between human and mouse and around 70% between human and fugu. 
Finally, the third homology, named Hom4, is a 172 bp long region residing 
approximately 3 kb downstream of the 4th exon, in the 4th intron of human GLI3. It 
shows around 90% identity between human and mouse and more than 75% between 
human and fugu. 
These three homologous regions were PCR amplified (figure 5-19) from genomic 
DNA of a healthy person with primers containing HindIII restriction site tags (primers 
“Hom2New F” & “Hom2New R”, “Hom3fornew” & “Hom3 rev” and 
“Hom4forwnew” & “Hom4 rev”), and then cloned in the HindIII site of the 
pGL3basic vector. They were also amplified with the same primers containing KpnI 
restriction site tags (“Hom2NewKpnI F” & “Hom2NewKpnI R”, “Hom3KpnIfor” & 
“Hom3KpnIrev” and “Hom4KpnIfor” & “Hom4KpnIrev”) and cloned in the KpnI 
site of the pGL3basic-promGLI3-300-luc construct (figure 5-20).  
 
 
         100bp          100bp     100bp 
         Marker Hom2            Marker Hom3    Marker Hom4 
 
 
 
 
 
 
 
 
Figure 5-19: PCR products used to clone regions of high conservancy within GLI3 
The PCR products of the Hom2, Hom3, and Hom4 are shown after electrophoresis in 2% agarose gels. 
The size of the bands is slightly larger than the actual length of each homologous region because of the 
restriction site tags on the primers necessary for the cloning in reporter vectors. 
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Figure 5-20: Homology constructs 
Schematical representation of the homology constructs created. The 3 homologies were cloned in the 
pGL3basic-luc vector, upstream of the luciferase gene in the HindIII site and in the pGL3basic-
promGLI3-300-luc construct in the KpnI site upstream of the minimal GLI3 promoter in both 
orientations. The GLI3 promoter is cloned in the XhoI site and the translation start of the luciferase is 
depicted with a black arrow.  
 
The constructs were used to test the regulatory activity of the three conserved regions 
by themselves and in combination with the minimal GLI3 promoter.  
In order to test their ability to drive expression of the luciferase reporter gene, 
constructs were isolated who had the homologous regions in positive and negative 
orientation cloned in the pGL3basic and in the pGL3-promGLI3-300-luc vectors. 
These constructs were sequenced to exclude unwanted mutated fragments and were 
transiently transfected for two days in the H661 cells, the cell line that expresses 
endogenous GLI3 (figure 5-21, 5-22).  
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Figure 5-21: Expression of a luciferase reporter under the control of different regulatory 
elements from the GLI3 region 
The luciferase activity of the transfected constructs is compared to the activity of the reporter under the 
control of the SV40 promoter. Homology 2 by itself shows an activation of the luciferase reporter gene 
in the positive orientation only. The other homologies by themselves do not seem to have an activity in 
either orientation.  
 
The homology regions influenced the reporter activity:  
 
Hom2 conserved region showed a very high up regulatory potential when cloned 
without additional promoter in (+) orientation upstream of the luciferase gene whereas 
in the (-) orientation it didn’t show any activity. In the first 3 times that its activity 
was measured (3 assays each time), this homology had very high activity as shown in 
figure 5-21 but after that its activity was fixed down at 40-50% of the SV40 activity. 
 
Hom3 and Hom4 didn’t show any significant activity in either orientation when 
cloned by themselves in the pGL3basic-luc vector.  
  Results 
  78 
 
 
 
Figure 5-22: Expression of a luciferase reporter under the control of different regulatory 
elements from the GLI3 region 
The luciferase activity of the transfected constructs of the 3 homologies cloned upstream of the 
minimal GLI3 promoter is compared to the activity of the reporter under the control of the SV40 
promoter. Homology 2 in either orientation doesn’t show any effect whereas the other two homologies 
down-regulate the GLI3 promoter in both orientations, with Hom3 showing stronger negative effect 
than Hom4.  
 
The homology regions influenced the reporter activity:  
 
Hom2 didn’t have any positive or negative effect when cloned in either orientation 
upstream of the GLI3 minimal promoter.  
 
Hom3 and Hom4 in either orientation reduced the activity of the GLI3 minimal 
promoter when cloned upstream to it down to 40% and to 65 – 70% of the SV40 
activity respectively.  
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5.5.1 Transcriptionally important sites within the Hom2 region 
 
 The first of the investigated homologies, Hom2, showed the strongest 
regulatory effects and was able to drive by itself high expression of the luciferase 
reporter gene. 
Therefore it was further analyzed for potent transcription factor (TF) binding sites 
using the TESS program. The search was filtered so that only human binding sites are 
shown in figure 5-23. 
 
 
Figure 5-23: Potential transcriptional factor binding sites within Hom2 
TESS prediction of possible human TF binding sites on the sequence of the Hom2. Three mutations 
(mut1, mut2 and mut3) introduced to the sequence of the Hom2 regions are circled. The vertical black 
lines mark TF binding sites that could not be predicted anymore in the mutated sequence. 
 
To test for functionality of potential transcriptional factor binding sites, mutations 
were introduced at three locations within the Hom2 construct with the positive 
orientation of the insert using the QuickChange Site-Directed Mutagenesis Kit 
(Stratagene Inc.).  
 
mut1 
mut3 mut2 
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In the case of mut1, a mutation has been created in the 161-163 nt of Hom2 
exchanging aaa with tcc (primers “Hom2mut1F” & “Hom2mut1R”).  
In mut2 a mutation has been created in the 180-185nt of Hom2 exchanging aaggaa 
with ggatcc (primers “Hom2mut2F” & “Hom2mut2R”). 
In mut3 a mutation has been created in the 215-219 nt of Hom2 exchanging aggaa 
with gatcc (primers “Hom2mut3F” & “Hom2mut3R”).  
In all cases, the exchange of the target base pairs resulted in the loss of the prediction 
of the potent TF binding sites by the TESS program and in the creation of a BamHI 
site for easier detection of the mutated constructs. The novel constructs were also 
verified by DNA sequencing.  
 
5.5.2 Reporter gene regulation by Hom2 mutants in H661 cells 
 
 To test the effect of the mutations, the altered Hom2 constructs were 
transfected transiently into the GLI3 expressing H661 cell line, and the luciferase 
activity was measured after 48 h in culture. Each of the three mutations blocked the 
up-regulatory potential of the Hom2 region (figure 5-24). 
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Figure 5-24: Luciferase assay showing the potential of mutated Hom2 elements to activate 
transcription of a reporter gene 
Each of the three mutations decreases the potential of the pGL3basic-Hom2(+)-luc construct to induce 
luciferase gene transcription in H661 cells considerably. 
 
5.5.3 Reporter gene regulation by Hom2 in different cell lines 
 
The usage of a potential cis regulatory element of transcription in cells 
depends on the presence of the appropriate factors binding to this segment. To 
elucidate the role of Hom2 region as a GLI3-specific regulatory element, the 
pGL3basic-Hom2(+)-luc construct was tested in two other cell lines, U2OS and 
H441.  
The construct was transiently transfected for 48hr in all three cell lines and, after 48 
hrs in culture, luciferase was quantified, and so the activity of the same construct in 
the different cell lines was measured (figure 5-25).  
 
 
Figure 5-25: Reporter gene regulation by Hom2 mutants in different cell lines 
Luciferase activity indicates the ability of the Hom2 region to drive expression of the reporter gene in 
the construct GL3basic-Hom2(+)-luc in different cell lines. The activity the U2OS cell line is about one 
quarter of the one observed in H661 whereas no measurable activity is observed in the H441 cell line. 
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. 
The cell lines that express endogenous GLI3 (H661, U2OS) do not allow the same 
activity of Hom2. The pGL3basic-Hom2(+)-luc construct shows its highest activity in 
the H661 line, a relatively low activity in the U2OS cell line and no activity at all in 
the no GLI3 expressing H441 cell line. Interestingly, the activity of Hom2 region in 
driving the expression of the reporter gene in the U2OS cell line is similar to the 
activity of the mutated Hom2 constructs in the H661 cell line. 
 
5.5.4 NFATP as a candidate transcription factor to interact with Hom2 
 
 All of the three artificially created mutations in the Hom2 sequence had as a 
result the decrease of its activity to the same extent. Taking a closer look at the 
various TF binding sites that are predicted by the TESS program, the only factor that 
is shared in all three sites is the NFATp factor. To elucidate whether this TF is 
involved in the regulation of Hom2, first it had to be investigated whether it is 
expressed in the H661, U2OS and H441 cell lines, in which the Hom2 showed 
different potential of transcription activity. For this reason, NFATp specific primers 
were designed to anneal on the cDNA sequence of this gene (“NFATp F” & “NFATp 
R”). These primers were used for PCR amplification on cDNA that was reverse 
transcribed from total RNA that was isolated from the three different cell lines (figure 
5-26).  
 
           M     1       2      3       4      5      6      M 
 
 
 
 
 
 
 
 
 
 
Figure 5-26: RT-PCR of transcription factor NFATp mRNA from different cell lines 
1-3: NFATp specific fragments, 4-6: beta-actin specific fragments; H661 cell line, 1+4; U2OS cell line, 
2+5; H441 cell line, 3+6. M = 100bp marker 
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NFATp cDNA could be amplified most strongly in the H441 cell line, in which the 
Hom2 did not show any activity on reporter gene expression. U2OS, which showed a 
weak expression of Hom2, allowed a very weak amplification of the NFATp 
fragment, whereas the same fragment was amplified in a sizeable amount in the H661 
cell line, in which the Hom2 fragment showed the highest activity. A fragment of 
beta-actin cDNA was PCR amplified (“b-actin F” & “b-actin R”) as a control for the 
efficiency of the reverse transcription of total RNA from all the cell lines and the 
equal amount of template applied. 
The NFATp fragments were sequenced to verify that the amplification was indeed 
NFATp specific. 
 
5.5.5 Search of a transcriptional start by primer extension analysis on Hom2  
 
 Hom2 by itself shows high potential of driving expression of the luciferase 
gene, and this only in the positive orientation. This independency of any promoter 
means that the sequence must contain sites that enable the initiation of transcription. 
Therefore, a primer was designed with a 5’ IRD-700 modification annealing within 
the luciferase gene 71bp downstream of the 3’ HindIII site in which Hom2 is cloned. 
This primer directs towards the 3’ end (“Lucexten”) of the Hom2 and was used to 
synthesize cDNA by RT-PCR from H661 total RNA, which before had been 
transfected transiently for 48hr with the pGL3basic-Hom2(+)-luc construct. This 
product was used to identify the transcription start site that is used for the expression 
of the luciferase from Hom2. 
The resulting cDNA was precipitated and run in a sequencing gel next to the 
sequencing reaction of the pGL3basic-Hom2(+)-luc construct, which was sequenced 
with the same primer that was used for the primer extension assay (figure 5-27). 
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         Primer 
   A C G T  Extension  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-27: Primer extension analysis of the Hom2 transcription start site 
The primer extension product next to the sequence of the  pGL3basic-Hom2(+)-luc construct. The 
signal from the primer extension band marks the nucleotides with which the cDNA, thus the mRNA, 
of the reporter construct begins. 
 
Part of the sequence that was amplified with the primer extension procedure is shown 
below. 
 
GGGTGAATTGAGCTGAGCGGCTAGCTGG 
 
The primer extension resulted in three different bands that correspond to the sequence 
depicted in bold letters. Since the sequence in the critical region was difficult to read 
it does not allow the exact identification of the transcription start. However, the data 
show that there exists a transcription start region within a 13 nt sequence that resides 
35 nt upstream of the 3’ HindIII cloning site, inside the sequence of Hom2 region 
(figure 5-28).  
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Figure 5-28: pGL3basic-Hom2(+)-luc construct with predicted inr sites 
The Hom2 region is cloned in the HindIII sites of the pGL3basic-luc vector, upstream of the luciferase 
gene. The three black arrows represent the three different sites at the 3’ end of Hom2 sequence with 
which the transcription initiates from this construct according to the primer extension assay.  
 
5.5.6 Deletion mapping of functionally important segments of Hom3 
 
 In order to delimit the region that is responsible for the action of Hom3, the 
fragment, which showed stronger down-regulation of the GLI3 minimal promoter, its 
sequence was tested after deletion of either the 5’ - or the 3’ end. Primers were 
designed to amplify the Hom3 sequence from its 1st until the 268th nucleotide (5’-
Hom3) (primer “3’cutHom3rev”) and from its 114th to its last, the 386th nucleotide 
(primer “5’cutHom3for”) (figure 5-29). In this way, two partially overlapping 
fragments have been amplified, purified and cloned in both orientations in the KpnI 
site of the pGL3basic-promGLI3-300-luc construct, upstream of the minimal 
promoter of the human GLI3 gene.  
 
 
 
 
 
 
 
 
 
 
 
 
LuciferaseHom2 
Hind Hind
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Figure 5-29: The sequence of Hom3, potential TF binding sites, and description of subclones 
Prediction of potent TF binding sites in the sequence of the Hom3 region as determined with the TESS 
program. The sequence was split in two parts overlapping in the boxed area from nt 114 to nt 268. 
 
The desired clones were isolated and transiently transfected and expressed for 48 hrs 
in the GLI3 expressing H661 cell line (figure 5-30). They delineate three segments, 
the 5’- and 3’ parts present in one clone each, and the middle part present in both 
constructs. 
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Figure 5-30: Effect of Hom3 truncation 
Reporter constructs with a 5’Hom3 fragment and a 3’Hom3 fragment upstream of the minimal GLI3 
promoter in a luciferase assay after transient transfection into H661 cells. 
 
Both the 5’ and 3’ Hom3 constructs have almost the same inhibiting influence on the 
minimal GLI3 promoter as the whole Hom3 region. They decrease by half the activity 
of the minimal GLI3 promoter to drive expression of the luciferase reporter gene. 
Only the pGL3basic-5’Hom3(-)-promGLI3-300-luc construct represses the human 
GLI3 promoter more than the original Hom3 sequence.  
 
5.6 The potential of the homology regions Hom2, Hom3, and Hom4 to drive 
reporter gene expression in transgenic mice 
  
 Homologies 2, 3 and 4 were cloned in both orientations into the HindIII site of 
the p1230 vector. This vector carries a lacZ reporter gene under the control of the 
murine beta-globin promoter, which is inactive in transgenic mice if transfected 
without additional cis-regulatory sequences. By cloning DNA fragments that are 
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suspected of containing enhancer elements upstream of the b-globin promoter, one 
can test if they can regulate positively this promoter and drive expression of the lacZ 
gene in the tissues for which the enhancer element is specific. The purified constructs 
were digested with NotI/XhoI so that the DNA fragments containing the homology 
attached to the b-globin promoter-lacZgene-SV40polyA tail were excised from the 
p1230 vector.  
The positive orientated Hom2 – lacZ construct as well as Hom3 and Hom4 
constructs in both orientations were isolated, precipitated, and then injected into the 
fertilized eggs.  
With support by Dr. Esther deGraaff, Rotterdam, the reporter constructs were injected 
into the male pronuclei of murine fertilized eggs, each. These were then transferred 
into the oviduct of 3 pseudo-pregnant female mice for Hom2 and of 2 pseudo-
pregnant female mice for each orientation of Hom3 and Hom4. In detail, the donor 
eggs originated from FVB females (approx 3 weeks old and  
superovulated with hormones), which were crossed with FVB males.  
The eggs were transferred in the oviduct of CBA females (crossed with  
sterile CBA males). The numbers of injected eggs for Hom2 were 175 (140 transfers), 
for Hom3 were 264 (220 transfers) and for Hom4 were 128 (120 transfers). 
In this way, the constructs got randomly integrated in the chromosomes of the 
embryos. Around 20 embryos of the mice carrying the Hom3 and Hom4 construct in 
each orientation were removed after 11 days. For Hom2, 12 embryos of one mouse 
were removed after 9 days and of 20 embryos of the other two mice after 11 days. The 
embryos were stained with 4% paraformaldehyde and stained with X-gal according to 
the protocol found in the methods section.  
Only three 11-days old embryos and one 9-days old embryo that had received the 
Hom2 construct expressed the reporter as shown by lacZ staining.  No staining was 
observed in transgenic mice with Hom3 and Hom4 constructs. DNA was extracted out 
of the yolk sac of each transgenic embryo-mouse and was used as a template for PCR, 
which specifically amplifies the lacZ sequence, to test if the injected transgene was 
integrated into the host genome (primers “LacZ F” & “LacZ R”) (figure 5-31).  
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             M      11    13    M      26     30     32         
 
 
.  
 
 
 
 
Figure 5-31: PCR gene integration analysis 
PCR products of the yolk sac of mouse embryos 11, 13, 26, 30 and 32 obtained with lacZ specific 
primers. M: 1kb ladder 
 
Embryo 26 does not show a band (and does not show lacZ staining). Embryo 11 has a 
faint PCR band but shows strong lacZ staining. Mice 13, 30 and 32 also showed lac-Z 
staining. Out of the 20 11-day old embryos that came out of the Hom2 mice, only 15 
were found to contain the lacZ insert in their genome, while out of the 12 nine-days 
old embryos that came out of the 3rd Hom2 mouse, 9 were identified as positive for 
carrying the lacZ sequence. That means that only 10-15% of the embryos that had 
integrated the transgene in their DNA were lacZ stained. Around 75% of the embryos 
obtained out of the Hom3 and Hom4 injected mice were found to contain the lacZ 
fragment but none of them showed any staining.  
 
The staining that was observed in mouse embryo 13 (9-days old) as well as in 
embryos 11, 30 and 32 (11-days old) is shown below. Mice 30 and 32 came from a 
different mother mouse than mouse 11. 
 
5.6.1 Stained embryos 
 
5.6.1.1 Embryo 13 - 9 days 
 
The only 9-day old embryo that showed lacZ staining is demonstrated in figure 
5-32. Strong staining can be observed in the future forebrain region. This region is not 
yet closed in this developing stage.   
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    A         f         B           f          
 
 
 
 
Figure 5-32: LacZ staining of embryo 13 (9-days): 
The arrows show the staining in the developing forebrain (f) from a side view (A) and from a dorsal 
view (B) 
 
5.6.1.2 Embryo 11 – 11 days 
 
The 1st from the three Hom2-lacZ stained 11-days old embryo showed a very 
intense lacZ staining in the telencephalon and diencephalon, the mandibles, nostrils, 
and the somites. In addition, a weaker staining was observed in the midbrain, 
hindbrain and the heart (figure 5-33). This embryo was the only one to show somite 
staining. 
 
                       
         f               mi  
           
 
 
 
 
 
Figure 5-33: Lac-Z staining of embryo 11 (11-days), side view 
The staining in the forebrain (f), midbrain (mi) and hindbrain (h), mandibles (m), heart (he) and 
somites (s) as can be seen in the whole mount embryo preparation. The nostril staining cannot be seen 
here. From this view it is clearly visible that the staining is most prominent in the telencephalon and 
diencephalon (forebrain), the mandibles and the somites. The region covering the cerebellar plate (ce) 
of the metencephalon is also stained. 
 
As described before, the staining was very intense in the forebrain region. The region 
of the telencephalic vesicle and the diencephalon was completely dark, in contrast to 
the region of the midbrain, which was not stained in such a degree. The region 
covering the hindbrain and the cerebellar plate of the metencephalon as well as inside 
s he m h
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the hinbrain was also stained but not as strong as the forebrain region (previous figure 
5-33). In addition, the somites along both sides of the 11-day old embryo and the 
walls of the heart were stained eminently (figure 5-34).  
 
  
 
 
 
 
 
Figure 5-34: Embryo 11, hindbrain and somite staining 
In A the head has been chopped so that the staining in the hindbrain (h) can become visible. The 
staining of the mandibles (m) and the forebrain (f) can also be seen. The right somites (s) are stained 
throughout the side of the embryo. In B the somites can be seen clearly in the right side of the embryo, 
regions of the heart are stained as well (he). C shows the embryo from the top, lacking its head. The 
somites can be seen in both sides as well as the various parts of the heart.  
 
Regarding the front part of the head, staining can be observed in the olfactory pit and 
in the medial nasal process while no staining exists in the lateral nasal process. In the 
mandible, both the maxillary and the mandibulary process are stained. In addition, 
lacZ is expressed also in the developing primary palate (figure 5-35). 
 
 
 
  
 
 
 
Figure 5-35: Embryo 11, forehead staining 
A: The forebrain (f), the olfactory pit (ol) and the mandibles are shown with lacZ staining. B: A 
magnified look into the same region shows staining in the maxillary (mx) and mandibulary (mn) 
process, the olfactory pit, the medial nasal process (me) and the developing primary palate (pa). 
 
Transverse sections from the head of the embryo 11 were analysed for detailed study 
of the regions and the cells that were stained. The walls of the telencephalon showed 
an intense staining, the walls of the diencephalon a weaker one (figure 6-9A). At a 
A B C
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more ventral position in the head, staining could be observed in the trigeminal (V) 
neural crest cells migrating into the maxillary component of the first branchial arch, 
the maxillary component of the first branchial arch, the mandibular component of first 
branchial arch, the trigeminal (V) ganglion, and some staining was seen in parts of the 
wall of the hindbrain (figure 6-9B). 
 
5.6.1.3 Embryo 30 - 11 days  
 
The 2nd from the three Hom2-lacZ stained 11-days old embryos showed again 
a very intense lacZ staining in the telencephalon and diencephalon and a weaker 
staining in the midbrain, hinbrain, the mandibles and the nostrils. This embryo did not 
show somite or heart staining (figure 5-36).  
 
 
 
 
 
 
 
 
Figure 5-36: Lac-Z staining of embryo 30 (11 days), side view  
Lac-Z staining is evident in the diencephalon (di) and telencephalon (te). It can also be observed in the 
midbrain (mi), the hindbrain (h), the cerebellar plate (ce) and the mandibles (m). The blue stain across 
the dorsal part of the embryos body most probably is not a product of lacZ expression at this position 
but a product of dye leakage. 
 
The blue stain observed along the dorsal part of the embryos body is considered to be 
unspecific, most probably due to leakage of the dye from destroyed brain cells that get 
carried away in the neural tube. In addition to the forebrain and midbrain, expression 
of lacZ was observed in the developing hindbrain. By chopping the head at this region 
it could be seen that the staining is not restricted only to the surface but is present in 
the interior of the hindbrain (figure 5-37).  
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Figure 5-37: Embryo 30 head, dorsal aspect 
LacZ staining can be observed in the cerebellar plate and in the hindbrain (h) itself. Part of the 
forebrain (f) is also visible. 
 
In the forehead region, the staining is similar to mouse 11. Staining can be observed in 
the maxillary and mandibulary process, in the medial nasal process, the olfactory pit 
and the developing primary palate. Again, no staining in the lateral nasal process as in 
mouse 11 (figure 5-38). 
 
  
    
 
 
 
 
Figure 5-38: Embryo 30, head, ventral aspect 
A: The forebrain (f) and the mandibles (m) are shown with lacZ staining. B: A magnified look in the 
same region shows staining within the maxillary (mx) and mandibulary (mn) process, the olfactory pit 
(ol), the medial nasal process (me) and the developing primary palate (pa). 
 
5.6.1.4 Embryo 32 - 11 days 
 
The 3rd Hom2-lacZ stained 11-days old embryo showed again a very intense 
lacZ staining in the telencephalon and diencephalon and a weaker staining in the 
midbrain, hinbrain, the mandibles and the nostrils (figure 5-39). In addition it showed 
also staining in the heart and weak staining in the somites, similar to embryo 11, but 
also in the Wollfian duct and the second brachial arch that develops to cartilage 
derivatives.  
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Figure 5-39: Lac-Z staining of embryo 32, (11 days), side view 
Lac Z staining can be seen in the diencephalon (di) and telencephalon (te). It can also be observed in 
the midbrain (mi), the hindbrain (h), the cerebellar plate (ce), the mandibles (m), the second brachial 
arch (b) and the Wollfian duct (wo). In addition, lacZ staining appears again in the heart (he) and 
weaker in the somites (s). 
 
In the forehead region, the staining is similar to the one observed in the other 
embryos. The maxillary and mandibulary process, the medial nasal process, the 
olfactory pit and the developing primary palate were lacZ stained. No staining can be 
observed in the lateral nasal (figure 5-40A). The inner parts of the hindbrain as well as 
the cerebellar plate were also stained weakly like in the other mice. The second 
branchial arch was labelled at both sides behind the hindbrain (figure 5-40B) 
 
       
 
 
 
 
Figure 5-40: Embryo 32, forehead and hindbrain, ventral aspect 
A: Ventral view of the forehead of the embryo. Staining can be observed in the telencephalon (t), the 
maxillary (mx) and mandibulary (mn) process, the olfactory pit (ol), the medial nasal process (me) and 
the developing primary palate (pa). Also part of the right second branchial arch  (b) is shown with 
staining. B: Superior view of the hindbrain (left part of figure) and the cerebellar plate (ce) of the 
chopped head (right part of the figure). The stained second brancial arch is also visible at both sides 
behind the brain. 
 
The Wolffian duct is a paired organ found in mammals including humans during 
embryogenesis. It connects the primitive kidney Wolffian body to the cloaca and 
serves as the anlage for certain male reproductive organs. This organ was found 
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stained in the embryo 32. In addition, the heart was stained again as in mouse 11 
(figure 5-41).         
 
           
  
 
 
 
Figure 5-41: Embryo 32, wollfian duct and heart staining 
A: Ventral view of embryo. Staining can be observed in the heart (he) and the Wollfian duct (wo). The 
head and tail were chopped for better visualization of the stained organs. B: magnified dorsal view 
showing part of the heart and the Wollfian duct stained.  C: Different ventral view of the embryo 
showing the stained heart and part of the Wollfian duct.  
 
Embryo 32 was the only one to show a faint staining in the upper limbs. The staining 
was restricted only to the anterior part of the developing limb bud (figure 5-42). 
Interestingly, this is the region of the limb bud to which the expression of GLI3 is 
restricted. 
 
 
 
  
 
 
Figure 5-42: Embryo 32, upper limbs staining. 
A: Weak lacZ staining in the anterior part of the left developing limb bud (ll) left side view. The 
stained heart can be seen at the left part of this image (he). B: Weak lacZ staining in the anterior part of 
the right developing limb bud (rl). The stained heart can be seen at the upper part of this figure, where 
the embryo is lying on its back, the head towards the right side of the image (not shown), right side 
view. 
 
The comparison of the stained regions in the three 11-days old embryos demonstrates, 
that Hom2 is an element that can drive specific reporter expression in the fore-, mid- 
and hindbrain, the somites, the mandibles, parts of the nose and the heart.  
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6 DISCUSSION 
 
 Since the sequencing of the human genome was accomplished by the Human 
Genome Project, the study of gene regulation and function remains a major task. 
Elucidating the mechanisms of transcriptional regulation provides insight into the 
selective expression of genes in different tissues, the differentiation of the cells, and 
finally the development of complex organisms, such as humans, from a single cell. 
Since humans are not amenable to experimental genetic variation, mutations leading 
to altered phenotypes provide valuable hints at normal gene function. They can affect 
coding sequences, thus impairing normal protein function, or they might disturb 
promoters and other cis-regulatory elements which control time, location, and 
quantity of gene expression (Lalioti et al. 1997). Whereas mutations in coding 
sequences have been studied in detail in a multitude of genes, cis-regulatory 
sequences have been identified only for few genes in sufficient detail to include them 
in mutation analysis. The availability of more or less complete genome sequences 
from many eucaryotes or procaryotes in public databases and of biocomputing tools to 
compare and annotate these treasures is offering the option to focus the search for 
regulatory sequences on relatively short, highly conserved sequence intervals outside 
the coding parts. 
 
To apply this strategy for the analysis of GLI3, a key transcription factor transmitting 
hedgehog signaling during human embryonal development, the promoter region 
immediately 5’ to the transcriptional start was identified and examined, and other 
potentially cis-acting sequence elements were studied among highly conserved non-
coding elements within GLI3 exons.  
Mutation of such elements in patients with GLI3 morphopathies, developmental 
defects attributed to defective GLI3 function, would give credit to their expected 
function. It was one task of this thesis to contribute new cases to a resource of probes 
from patients with appropriate phenotypes, which are not mutated within GLI3 coding 
sequences. 
Based on studies in animals, the paralogous gene GLI2 is expressed near GLI3 in a 
highly coordinated fashion and appears to share with this factor overlapping 
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functions. Gli2 and Gli3 gene knockout experiments in the mouse indicate that they 
may have different roles, but also possess functional redundancy (Mo et al. 1997). 
If these results would apply to humans as well, one could expect to observe 
homologous, even paralogous regulatory sequences in addition to conserved protein 
sequences. Thus, mutations affecting regulatory or coding sequences of GLI3 might 
only result in a recognizable phenotype if GLI2 could not compensate for the missing 
function of this factor. However, GLI3 haploinsufficiency in humans, in contrast to 
the mouse, shows a phenotype comparable to the homozygous situation in the 
animals. Thus, regulation and/or function of human GLI2 might differ from the one 
encountered in GLI3, a notion supported by homology searches in sequence databases 
that predicted DNA sequence differences in the 5’ and upstream GLI sequences. 
This problem of potentially parallel expression and function of the human GLI2 and 
GLI3 proteins was considered critical enough to include a coarse analysis of the GLI2 
5-region in this thesis in parallel with the more detailed study of GLI3 regulation. 
 
6.1 GLI3 morphopathies without mutations in transcribed sequences are 
candidates for defects in regulatory sequences 
 
 To search for patients with GLI3 morphopathies not associated with mutations 
in coding sequences, 24 patients were screened for changes affecting sites of the GLI3 
protein that are essential for its function. Such samples are very useful candidates for 
mutation screening in elements residing upstream, downstream or in the intronic 
regions of GLI3 that may play an important transcriptional regulatory role. Previously, 
in one Greig syndrome patient with a translocation dissecting chromosome 7 about 10 
kb downstream of GLI3, a positional effect involving regulatory elements was 
predicted (Vortkamp et al. 1991). In the mouse, the anterior digit deformity phenotype 
(add) is caused by a transgene integration ~40 kb upstream of Gli3 which causes the 
expression of this gene to decrease (Schimmang et al. 1993; van der Hoeven et al. 
1993). Similar observations were reported for other developmental genes. For 
instance, the Ssq mouse, that shows pre-axial polydactyly (PPD), is caused by a 
mutation in a conserved region inside the Lmbr1 gene which affects the correct spatial 
expression of the distantly located gene sonic hedgehog (Shh), coding for the 
signaling factor upstream of GLI3 (Lettice et al. 2002).  
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The patients studied in this project for point mutations in their coding exons, 
previously, had been analyzed for cytogenetic alterations. No abnormalities had been 
detected. Among the 24 cases four showed point mutations. Two of those had been 
detected previously in unrelated individuals: A missense mutation in the 13th exon 
(c.1873 C>T; R625W) was diagnosed in a GCPS patient with syndactyly in all the 
limbs, polysyndactyly in the left and right foot, high forehead and bregma, frontal 
bossing, hypertelorism and broad nasal root. A C is exchanged by a T in the 1873rd nt 
of the ORF, which results in the substitution of an arginine with a tryptophan. The 
mutation altered the 625th amino acid of GLI3 within the zinc finger domain. This 
mutation was transmitted to the daughter of the patient, which shows the same clinical 
features. In both cases, the mutation is heterozygous. The second previously reported 
missense mutation in the 15th exon (c.3664 C>T; P1222S) was identified in another 
GCPS patient with hexadactyly. A C is exchanged by a T in the 3664th nt of the ORF, 
which results in a substitution of a proline with a serine. The mutation altered the 
1222nd amino acid within the transactivation domain 1, TA1. The mother of this 
patient is heterozygous for the mutation but does not show any phenotype whereas the 
father’s coding sequence is unaffected.  
In the first case, the amino acid exchange from R to W occurred in a region highly 
conserved between human, mouse, dog and zebrafish protein sequences, with the R 
present at this position in all the species (CAB59315 for human, NP 032156 for 
mouse, XP 540363 for dog (predicted) and NP 991291 for zebrafish GLI3). 
The high conservation of this site suggests that it is important for the protein function. 
Since this mutation is located in the zinc finger domain it is possible that it alters the 
DNA binding ability of GLI3. In the second case, the exchange of the P to an S 
occurred at a site that is conserved between human and mouse, however, a 
corresponding sequence cannot be found in the dog or the zebrafish. Possibly, this 
mutation affects a site that may be less essential for the function of the GLI3 protein 
as evolution did not conserve this part of the protein between more distantly related 
species. The region where this mutation occurred is in the transactivation domain 1, 
and it is possible that a minor variation in protein sequence does not affect the 
function of this domain of GLI3. It must also be noted that the mutation in the zinc 
finger region is associated with the phenotype in the family, whereas the second 
mutation is not strictly correlated with the phenotype. The patient’s mother is reported 
as unaffected although she carries this mutation.  
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In a previous, unrelated case, a missense mutation of the 808th amino acid exchanged 
an I with an M, residing in a region for which no functional domain is predicted, 
although the I is conserved between the human, mouse and dog. This mutation was 
also found in the phenotypically unaffected mother of this patient. Therefore, this 
amino acid exchange seemed not to affect the function of GLI3.  
Both this variant and the one detected in this thesis do not occur as a polymorphism in 
the general population. It is possible that we are detecting in these cases very rare 
mutations, which are not functionally associated with the limb phenotype. 
Alternatively, they may represent mutations predisposing to GLI3 morphopathies if 
combined with a second, unidentified GLI3 mutation or a change in a different, 
functionally interacting factor.  
The first novel mutation that has been identified in this work affects two base pairs 
altering two neighbouring codons. This generates a double mutation, one silent and 
one nonsense in the 13th exon (c.2058_2059 GG > AT; R686R, E687X). The 
truncating mutation at the 2059th nucleotide of the GLI3 open reading frame disrupts 
the protein in the 687th amino acid, immediately after the zinc finger domain. 
Mutations in this region have been found to cause mostly Pallister-Hall syndrome 
(PHS) (Johnston et al. 2005). Indeed, this patient features mild syndactyly, postaxial 
polydactyly and broad terminal phalanges in both hands, hypertelorism, broad nasal 
root, short structure, growth hormone deficiency and hypothalamic hamartoblastoma, 
characteristic for PHS. This mutation has occurred de novo, as it could not be 
identified in the parents. The observation of this novel mutation supports the notion of 
a genotype-phenotype correlation of PHS with truncations of GLI3 leaving zinc finger 
region and the putative N-terminal repressive region intact while eliminating the rest 
of the protein (Johnston et al. 2005). The silent mutation, which does not change the 
amino-acid sequence of the protein, most probably does not play any role in the 
creation of the GCPS phenotype.  
The second novel mutation (c.4675 A>G; I1559V) is a missense one in the 15th exon, 
and the patient shows an acrocallosal syndrome (ACS). An A is exchanged with a G 
in the 4675th nt of the ORF, which results in the substitution of an isoleucine with a 
glycine in the 1559th amino acid in the transactivation domain 2, TA2. This amino 
acid and the protein sequence of this region are highly conserved between human, 
mouse, dog, and zebrafish. Thus, this part of the protein can be predicted to have an 
essential function. The sequence of TA2 is more conserved between distant species 
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than the sequence of TA1, which was mutated in a case discussed above. Perhaps, 
TA2 is functional in GLI3 proteins of distant species whereas the role of TA1 is 
restricted to a closer range of related species like human and mouse.  
The parents of the patient are phenotypically normal and appear not to be carriers for 
this mutation, i.e. this mutation most likely has occurred de novo.  
The detection of this mutation associated with an acrocallosal syndrome is noteworthy 
because this phenotype, previously, has been reported not to be linked to GLI3 
(Brueton et al. 1992). Only recently, a case of a child with agenesis of the corpus 
callosum and severe retardation, both cardinal features of ACS and rare in GCPS, has 
been reported, who similarly has a mutation in GLI3 (Elson et al. 2002). To clarify 
this issue, functional studies will have to prove in each case of ACS that the mutation 
changes the function of GLI3 and could be causal for the phenotype. The repeated, 
although rare, observation of GLI3 mutations in ACS could indicate genetic 
heterogeneity of this phenotype. 
The majority of potential GLI3 morphopathies studied for this work did not reveal 
mutation in coding sequences that could explain the phenotypes. They are valuable 
candidates for mutation searches in regulatory elements.  
 
6.2 Human GLI2 is lacking DNA sequence homology with GLI3 in the 5’ 
region and the promoter 
 
Both GLI2 and GLI3 from human and mouse code for proteins with an 
extended N-terminal domain, followed by the zinc finger domain, and ending with the 
transactivation domain at the C-terminus (http://genome.ucsc.edu/), (Roessler et al. 
2005), in contrast to the human and murine GLI1 that does not possess most of this 
part.  However, no functional promoter element or an initiator site has been yet 
identified for human GLI2. In order to understand the transcriptional regulation of this 
gene, and in view of the fact that GLI2 and GLI3 show overlapping and distinct 
expression patterns, a search for an unreported transcribed sequence upstream of the 
previously published 1st exon of GLI2 was initiated at the RNA level.  
For RT-PCR, placenta cDNA was chosen as a starting template to perform 5’ RACE 
PCR starting from the second published GLI2 exon. The PCR product contained, in 
addition to the known exonic sequence, a 1.2 kb sequence element that is identical to 
the published genomic sequence upstream of the first GLI2 exon. This sequence, 
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which is annotated as non-RNA, could be amplified in one fragment with the 1st and 
2nd exon of GLI2. That proves that this 1.2 kb region is part of the cDNA together 
with the already annotated exons (figure 6-1). It remains to be elucidated whether the 
RT-PCR identified the definite start of transcription or if more upstream sequence 
exists in the GLI2 cDNA in other tissues. 
 
 
Figure 6-1: Location of the human GLI2 5’RACE product  
The position of the GLI2 5’ RACE PCR product is depicted in comparison to the annotated GLI2 
sequence of the UCSC Genome Bioinformatics site. The similarity starts with the 2nd GLI2 exon, where 
the GLI2 specific reverse primers annealed, continues upstream into the 1st exon and extends 
approximately 1.2 kb further upstream. Human mRNAs from GenBank as well as an intraspecies 
comparison are also shown.  
In addition, conserved regions are highlighted in the exonic as well as in the intronic regions. 
Conserved intronic sequences cannot be found in the fish but only in more related species such as 
chimp, mouse, rat and chicken. Further experiments can show whether these homologies contain 
regulatory elements or are in any other way functional.  
 
The newly identified GLI2 cDNA sequence as well as a 1 kb upstream genomic 
fragment was searched in silico for potent promoter elements. The predicted promoter 
elements upstream of the human and mouse GLI2 genes differ in their sequence, their 
position and their characteristics (figure 6-2).  
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Figure 6-2: Location of predicted promoter elements in human and mouse Gli2 upstream 
sequences 
Genomic DNA 2 kb upstream and 1kb downstream of the published 1st exon of human and mouse 
GLI2 were scanned by making use of the NIX analysis resource of the HGMP Resource Centre, 
Hingston, UK, (http://www.hgmp.mrc.ac.uk/) with the “GRAIL-CpG” program and with “TSSW” to 
predict promoters and inr sites. The bold black lines represent genomic DNA, the boxes depict the 1st 
exons of both genes and the red box is the expanded part of the GLI2 1st exon using the 5’RACE PCR. 
TATA-less and TATA-containing promoters are shown with black and green triangles, respectively, 
inr-sites with yellow triangles and CpG islands with blue lines.  
 
The human GLI2 has one 208 bp long predicted CpG island that resides inside the 
newly identified sequence and a predicted promoter element containing a TATA box 
that resides 682 bp upstream of the site where the 5’ RACE PCR stopped. CpG 
islands are regions of a high CpG dinucleotide content and are regarded as useful 
landmarks in the genome for the presence of genes (Larsen et al. 1992). CpG islands 
can start upstream of the 1st exon of a gene and stretch into the 1st intron, as is the case 
for the GLI3 gene (Vortkamp et al. 1995). The functionality of the predicted TATA 
box containing promoter element has to be experimentally confirmed. Both GLI1 and 
GLI3 genes are regulated by TATA-less promoters, therefore it would be an exception 
1 kb 2 kb 3 kb 
Human 
GLI2 
Mouse 
Gli2 
4 kb 
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if GLI2 transcription would be driven by a TATA-containing promoter. The murine 
Gli2 contains two putative CpG islands. The first is 331 bp long ending 93 bp 
upstream of the 1st exon and contains two predicted inr sites and a predicted TATA-
less promoter element. These elements still have to be experimentally verified for 
their function. The second CpG island is 452 bp long and resides 382 bp downstream 
of the 1st exon. Comparing the genomic DNA sequence of these 3 kb regions (2 kb 
upstream and 1 kb downstream of the 1st exon of each gene) between human and 
mouse Gli2, no significant similarity can be found.   
The upstream DNA sequences of the Gli3 genes share to some extent homologies 
between human and mouse: Two homologous regions can be found, one 40 bp long 
and of 70 % identity located just upstream of the potential initiator site determined for 
the human gene with the primer extension method, and another one 52 bp long and of 
77 % identity further upstream that resides inside a trinucleotide repeat ([GGA]7 GAA 
[GGA]6 [GGC]9 ). The cDNA start of the murine Gli3 is located 97 bp further 
upstream of this second homology (Jacobsen 1996), and its sequence does not 
resemble the cDNA starts of human GLI3 identified with either method. In addition, a 
1.5 kb CpG island is found in the upstream region of the murine Gli3, including the 
promoter region and reaching until inside the 1st intron (figure 6-3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[GCA]7 GAA [GGA]6 [GGC]9
100bp 200bp 300bp 
Human 
GLI3 
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Gli3 
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Figure 6-3: Comparison of the promoter regions between human and murine GLI3. 
The bold black lines represent genomic DNA, the black dots are the conserved regions between the two 
promoters. The black semitransparent boxes are the 1st exons of both genes and the yellow triangles 
depict the experimentally identified inr sites. The CpG islands are depicted with blue lines; their 
complete length is not shown is this figure.  
 
The differences between the upstream regions of human and mouse Gli3 as well as 
between the Gli2 genes of these species suggest that during evolution non-coding but 
regulatory important sequence elements of the GLI genes were not conserved in spite 
of their similarity in expression patterns.  
The additional cDNA sequence amplified from placenta cDNA was checked also for 
the presence of open reading frames. However, in none of the three frames an ORF 
could be found that is compatible with the annotated GLI2 sequence.  
Such a large, untranslated cDNA fragment upstream of the 1st published GLI2 exon 
can be explained by a chromosomal rearrangement such as a translocation or a 
deletion of a DNA fragment in this region specific for the evolution of primates. This 
event might have attributed to GLI2 novel functions or might have restricted its 
potential to regulate target genes, thus playing a role in the specifities of the human 
phenotype.  
 
6.3 Analysis of the GLI3 minimal promoter 
 
 A 3.3 kb region upstream of the predicted start of the GLI3 1st exon had 
previously been deleted successively. The fragments were tested for their potential to 
drive expression of the luciferase reporter gene in transient transfection cell assays. 
By this way, a fragment containing 300 bp upstream of the 1st exon was identified as 
the minimal promoter of GLI3 (Jacobsen 1996). Unfortunately, the previously 
generated constructs were no longer available for this study. To avoid ambiguities 
originating from different transcription start sites, two further promoter fragments 
corresponding to the previously defined “–600 bp SacI 5’ deletion” and to the “-300 
bp ApaI 5’ deletion” constructs but reaching further into exon 1 were now generated 
and used throughout in this project (figure 6-4). The construct fragment “promGLI3-
300” contained the previously defined minimal promoter. 
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Figure 6-4: Luciferase expression achieved using different promoter deletion constructs 
Luciferase activity obtained in H661 cells transiently transfected with constructs expressing the gene 
under the control of human genomic fragments extending from GLI3 exon I upstream (upper part).  
The length of the promoter fragments and their name is indicated in the bottom part. Results from 
Jacobsen (1996; bottom part black lines, upper part blue bars) are integrated with recent results (red 
lines and bars).  
 
When compared to the activity of an SV40 promoter construct, the activity of the 
GLI3 promoter including part of the 1st exon of GLI3 appears to be decreased relative 
to the –300 bp ApaI/PvuII construct from (Jacobsen 1996), which ended 61 bp 
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upstream of the old cDNA sequence. This might be attributed to the additional 
sequence cloned in the pGL3basic-promGLI3-300-luc construct.  
However, since the original constructs were unavailable for comparison the difference 
might likewise be attributed to different experimental conditions. This notion is 
corroborated by a similarly decreased activity of the pGL3basic-promGLI3-600-luc 
construct compared to the previous measurements (figure 6-4).  
To eliminate the ambiguities originating from the lack of an experimental definition 
of the transcription start site it was decided to determine the initiator (inr) site. 
Interestingly, the primer extension method and the 5’ RACE PCR identified two 
different sites where mRNA synthesis of GLI3 starts. According to the primer 
extension cDNA starts 123 nt upstream of the ATG within exon 2 with which the 
ORF of GLI3 starts, whereas after the 5’ RACE PCR the longest transcript was found 
to start 133 nt upstream of this site, and exactly at the start site position predicted by 
the “TSSW” program. The site that was used to clone the promoter fragments by 
Jacobsen 1996 resides 2 nt downstream of the site where the 5’ RACE PCR 
terminates. Therefore, these previously used fragments can be considered to contain 
the complete GLI3 promoter.  
Human skeletal muscle cDNA was used for the primer extension whereas placenta 
cDNA was analysed by the 5’ RACE PCR. In these tissues, the GLI3 gene may use 
different inr sites to start its transcription. Genes using two or more inr sites are not 
unusual such as in the promoter of Emilin1 (Fabbro et al. 2005). The transcription 
start site according to the primer extension overlaps with another predicted inr site 
that follows the consensus py-c-a-n-t-py-py (py stands for pyrimidine) (Javahery et al. 
1994). The C and the A of this consensus sequence were each exchanged with a T. 
The “pGL3basic-promGLI3-300-luc” construct carrying the GLI3 minimal promoter 
with the initiator site containing the two mutated nucleotides was transfected into the 
H661 cell line but the mutation did not show any effect on the promoter activity. 
Possibly, the second initiator site is used in this cell line. Therefore the mutation does 
not influence the activity of the promoter. The extent to which each inr site is used for 
the transcription of GLI3 still has to be determined also in other cell lines. No 
downstream promoter element (DPE) can be identified downstream of either inr site.  
No TATA-box or a CAAT-motif could be identified in the GLI3 promoter. TATA-
less promoters usually belong to genes that encode "housekeeping" enzymes, 
oncogenes, growth factors and their receptors, and transcription factors. For the 
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transcription of such genes, the E2F and the YY1 transcription factors have been 
reported to play a major role (Azizkhan et al. 1993). However, binding sites for either 
element could not be identified in the GLI3 minimal promoter.  
Individual mutation of five predicted transcription factor binding sites within the 
pGL3basic-promGLI3-300-luc construct reduced the activity of the promoter only 
slightly, if at all (figure 5-13). These sequences contain sites for TFs that are usually 
involved in promoter regulation, such as Sp1, HiNF-C, c-Ets2, CREB, AP-1, MAZ 
and CACCC-binding factors (Xie et al. 2005). In contrast, the further truncation of the 
promoter by 126bp caused the decrease of its activity by half (figure 5-13). 
Obviously, sites contained in the deleted sequence are important for the activity of the 
GLI3 promoter, but due to the fact that most of these TFs bind in many different sites 
on the promoter, a single mutation in one site cannot infer a sizeable decrease in the 
activity of the construct. The residual activity of the truncated promoter can be 
attributed to the existence of further TF binding sites in the remaining sequence. A 70 
bp long fragment residing just upstream to the newly identified start of the GLI3 
cDNA had shown very low activity in transient transfection assays (Jacobsen 1996). 
Therefore, the remaining promoter activity after the truncation of the minimal 
promoter resides in a 142 bp fragment situated between the truncation site and the 
start of the 70bp fragment that showed very low activity. Binding sites for SP1, 
PPUR, CUP, EGR2 and WT1-KTS factors dominate in this 142 bp promoter 
fragment. Since its sequence is abundant in G/C, it was impracticable to design 
primers for site directed mutagenesis of these binding sites in order to test their 
involvement in the regulation of GLI3 expression. In addition, these factors could 
bind repeatedly along this sequence. Hence further deletion of small fragments might 
be the best strategy to elucidate the regulation of the GLI3 minimal promoter. 
 
The activity of the GLI3 minimal promoter that is contained in the pGL3basic-
promGLI3-300-luc construct in the different cell lines is correlated to their 
endogenous GLI3 expression. When transfected into the GLI3 expressing H661 and 
U2OS cell lines, the minimal promoter shows a high activity. These cell lines express 
endogenously necessary factors for the GLI3 expression. The measurements did not 
reveal a significant difference in the potential to promote reporter gene expression in 
these two cell lines (figure 5-11). The H441 line, which does not express GLI3, 
showed a very low activity of the pGL3basic-promGLI3-300-luc construct. The lack 
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of elements in these cells, which are necessary for the endogenous GLI3 expression, 
appears to affect the ability of the transfected construct to express the luciferase 
reporter gene.  
 
6.4 A region in the 5’ part of intron 1 enhances the action of the GLI3 
minimal promoter  
 
 Two constructs were studied which contain the same upstream region of the 
GLI3 promoter but extend to different lengths into intron 1 (figure 5-16). The larger 
one (pGL3basic-3.7kbStuI-StuI-luc) includes a region which is highly conserved 
between human and mouse DNA and is situated 2-2.2 kb downstream of exon 1 
whereas the shorter one ends 500bp downstream of the 3’ end of the 1st exon.  
The shorter one (pGL3basic-1.9kbStuI-DpnI-luc) shows a very high activity up to 
400% of the minimal GLI3 promoter activity (320% of the SV40 promoter activity), 
whereas the larger construct shows just 63% of the minimal GLI3 promoter activity 
(50% of the SV40 promoter activity) (figure 5-17). The very high potential of the 
short construct to drive expression of the luciferase gene, in comparison to the activity 
of the minimal promoter, may be attributed to the existence of TF binding sites 
downstream of the 1st exon, which are necessary for the up-regulation of the GLI3 
minimal promoter. These factors can be contained in short sequences that may be 
conserved between human and mouse but they are probably too short to be identified 
with the VISTA program.  
The “TSSW” program predicts promoters and transcription inr sites in this intronic 
region downstream of the 1st exon. This could suggest that the expression of GLI3 can 
be regulated by an alternative promoter, which resides or expands until inside the 1st 
intron. An alternatively spliced 90 bp-long exon of GLI3 is predicted to start 724 bp 
downstream of the 3’ end of the 1st exon, according to the UCSC Genome Browser 
database. The expansion of the CpG island up to 722 bp downstream of the 1st exon as 
well as the prediction of a good promoter and initiator site 80 bp upstream of this 
predicted exon offers the possibility that an alternative promoter would be able to 
drive expression of a transcript that would give full length, functional GLI3 protein as 
the ORF starts from the 2nd exon (figure 6-5). This predicted alternative promoter was 
not tested for its activity in this work.  
 
  Discussion 
  109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-5: Position of predicted alternatively spliced promoter. 
The bold black line represents genomic DNA. The black boxes depict exons whereas the 
semitransparent one is the predicted alternatively spliced exon. The yellow triangles are the 
experimentally identified inr sites, the green and black triangle the predicted inr site and promoter 
respectively. The arrow depicts the start of the GLI3 ORF. The CpG island is drawn with blue lines, 
and its complete length is not shown is this figure. 
 
The low activity of the larger construct may be explained by the existence of down-
regulators in the extra sequence.  An interesting candidate for this function might be 
the highly conserved sequence between human and mouse DNA that resides 2 – 2.2 
kb downstream of the 1st GLI3 exon (figure 6-6).  
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Figure 6-6: Potential transcriptional factor binding sites within a highly conserved region of the 
additional insert sequence of the pGL3basic-3,7 kb StuI-StuI-luc construct 
TESS plot of an evolutionarily conserved region within the pGL3basic-3,7 kb StuI-StuI-luc construct 
predicting TF binding sites (arrows). 
 
However, the factors that are predicted to bind in this homologous sequence are 
considered to be mainly activators, therefore it is likely that the observed reduced 
activity of the GLI3 minimal promoter may be caused by factors binding elsewhere in 
this sequence.  
 
6.5 Effect of highly conserved intronic regions on the expression of a 
luciferase reporter gene 
.  
A Vista plot comparing GLI3 of fugu, human, and mouse revealed a number 
of very highly conserved non-coding sequence elements within the introns. Three of 
these elements were selected for the analysis of their potential to act as transcriptional 
regulators (figure 5-18). The 1st of those regions (Hom2, 434 bp) resides 
approximately 70 kb downstream of the 2nd exon in intron 2 of human GLI3. It shows 
100% identity between human and mouse and more than 80% conservancy between 
human and fugu. When cloned upstream of the GLI3 minimal promoter, this region 
does not affect its activity in either orientation (figure 5-22). However, in a series of 
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experiments this fragment showed a very high potential of driving reporter gene 
expression (~140% compared to the SV40 promoter) without the addition of a 
promoter when cloned in the positive orientation, but almost no activity when 
negatively oriented. In further series of experiments the activity of this construct 
reached only 40% of the activity of the SV40 promoter although seemingly no 
experimental variable had been altered. Even with the decreased activity, Hom2 
shows a 4 times higher potential to drive expression of the luciferase gene than the 
promoterless pGL3basic-luc construct.  
To test, whether Hom2 contains promoter elements and the transcription of the 
luciferase gene starts inside the Hom2 sequence when transfected in the H661 cell 
line, primer extension was used to identify the transcription initiation site of this 
construct. The primer extension analysis on total RNA extracted from H661 cells 
transfected with the pGL3basic-Hom2(+)-luc construct resulted in three bands. (figure 
5-27). Unfortunately, the sequencing results are insufficient in the critical interval, 
however, it is evident that the transcription from this construct starts from a region 
~40 bp upstream of the 3’ end of the Hom2 sequence. In the 13 nt of the Hom2 to 
which the primer extension bands correspond, only one weak inr site can be predicted 
that does not match absolutely the inr site consensus sequence.  
 
Inr consensus sequence : py-c-a-n-t-py-py 
    Predicted in Hom2:        t-g-a-a-t-t-g 
 
The red, bold letters are the nucleotides from the Hom2 sequence that do not match 
the consensus of an inr site. It is difficult to characterize this sequence as a promoter 
as there are three different, closely situated, possible transcription initiator sites and 
no other promoter elements predicted in it. In addition, this homology is identified in 
the 2nd intron, ~4.5kb upstream of the 3rd exon. Another alternatively spliced GLI3 
can be identified to start 330 bp downstream of the 3’ end of Hom2. This exon is 
predicted in the AceView database, which is developed by NCBI. Such alternative 
exons originate from cDNAs that have been submitted to the GenBank and have been 
aligned with the genomic DNA. Interestingly, the conservancy of this region between 
human and mouse expands up to the beginning of the 1st exon of this alternative 
transcript. This alternatively spliced gene would start from the 3rd exon of the original 
GLI3, thus missing part of its upstream repressor domain of the protein (figure 6-7).  
  Discussion 
  112 
 
 
    
Figure 6-7: Location of Hom2 within the GLI3 gene 
A: The position of the Hom2 is depicted in comparison to the annotated GLI3 sequence (blue line) of 
the UCSC Genome Bioinformatics site and to a predicted alternatively spliced GLI3 model (mauve 
line).  The sequence conservation between different species is also shown. B: The region in the 
rectangle in A is shown with more detail. The difference in the length of the conservation (thick black 
line) of this region between human and mouse and between human and fugu can be seen clearly. The 
conservancy between human and mouse stops just upstream of the alternatively spliced exon. The 
direction of transcription is from right to left, and the exons are shown with Latin numerals. The 
predicted alternatively spliced exon is circled.  
 
However, no other promoter elements could be predicted in Hom2 or in the intronic 
sequence between this region and this alternative exon.  
 
To identify a transcription factor that might interact with Hom2 driving reporter gene 
expression, binding sites predicted by the TESS program were inactivated by 
mutagenesis (figure 5-23). The three mutations of the Hom2 sequence in different 
sites, creating each time a new BamHI restriction site, resulted in the same decrease of 
the pGL3basic-Hom2(+)-luc activity (figure 5-24). A TF binding site that is shared by 
all the mutated sequences is NFATp. The nuclear factors of activated T cells (NFAT) 
proteins are a family of TFs, which are activated by calcineurin. They have been first 
A 
B 
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identified as inducers of cytokine gene expression in T cells but they play also various 
roles in other tissues. NFATp participates in the prostaglandin synthesis during 
angiogenesis, in skeletal muscle growth, in inhibition of chondrogenesis, in 
expression of adipocyte specific genes during differentiation, in embryonic axonal 
outgrowth, in the heart valve development and in the myf-5 expression (Horsley and 
Pavlath 2002; Graef et al. 2003). Myf-5 is also a downstream target of GLI3 
(McDermott et al. 2005). Additionally, in order for NFAT proteins to function, they 
must form homo- or heterodimers with FOS and JUN (McCaffrey et al. 1993) and 
binding sites for these TFs exist in the sequence of Hom2. 
 
The identification of binding transcription factors to a given site depends on their 
presence in the cells or tissues to be tested. The potential of Hom2 to promote reporter 
gene expression, therefore, has also been tested in other cell lines. In the U2OS cell 
line, no NFATp expression could be identified with RT PCR analysis in contrast to 
the other two cell lines (figure 5-26). In the GLI3 expressing U2OS cells the activity 
reached 40% of the SV40 promoter activity whereas in the GLI3 negative H441 cells 
its activity was completely diminished (figure 5-25) despite the expression of NFATp. 
Interestingly, the activity of wild type Hom2 in USOS was almost the same as the 
activity of mutated Hom2 constructs in the NFATp expressing H661 cell line (figure 
5-24). Perhaps NFATp needs all of the three binding sites on this region in order to 
regulate the activity of Hom2. This observation is compatible with an involvement of 
NFATp in Hom2 regulation. 
There are other candidates for transcription factors that might bind on Hom2. For 
instance, AML1 (RUNX1) and its family members (RUNX) are factors that regulate 
the expression of genes involved in cellular differentiation and cell cycle progression. 
RUNX1 has repression and gene silencing activities (Durst and Hiebert 2004), thus 
such a protein may strongly repress the activity of Hom2 in the H441 cell line. It 
remains to be determined whether this protein is present in the H441 cell line and is 
absent from the other two. 
 
As will be discussed below, Hom2 acts as a tissue specific enhancer of a reporter gene 
in transgenic mice. The observation that Hom2 cannot up-regulate the GLI3 minimal 
promoter in the cell assays might be explained by assuming that this promoter already 
has reached its maximum activity in this cell line and cannot be further enhanced. An 
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enhancing function of Hom2 may be required in tissues where GLI3 promoter is less 
active and needs to be up regulated in order to express this gene. It is also possible 
that Hom2 interacts with a site of the GLI3 promoter, which is not present in the 
construct used for the cell assays. 
 
The 2nd analysed highly conserved non-coding region (Hom3) resides 23 kb 
downstream of the 3rd exon of human GLI3, inside the 3rd intron. It shows 
approximately 98% homology between human and mouse and around 75% homology 
between human and fugu DNA. Transient transfection assays showed a negative 
regulatory activity of this fragment. When this fragment is cloned upstream of the 
human GLI3 minimal promoter driving the luciferase gene, it decreases the activity of 
the promoter from 80% to 40%, relative to the activity of the SV40 promoter, 
regardless of it’s orientation (figure 5-22). This region was truncated in two 
overlapping fragments. One contains the 5’ sequence and the other the 3’ sequence of 
Hom3, both share the central part. The activity of these constructs reached the same 
level as the whole Hom3 (around 40% of the activity of the SV40 promoter, figure 5-
30), thus the elements that are responsible for the down-regulation of the GLI3 
promoter are expected in the central part of the Hom3 sequence which is shared by the 
two truncated fragments. These observations were obtained with constructs in either 
orientation. The only exception is the negatively orientated fragment that includes the 
5’ region of the Hom3. The observed repression of the promoter in this case is 
stronger and the activity of this construct decreases to 20% of the activity of the SV40 
promoter (figure 5-30). There are reports of cis-regulatory elements that have 
different activities depending on their orientation or which act only in a specific 
direction (Lin et al. 2004; Emoto et al. 2005). Thus, the fragment of the Hom3 
missing its 3’ part may act also differently according to its orientation.  
Within the sequence of the Hom3 binding sites for factors can be identified that might 
have a negative regulatory role. One of them is E4BP4, which contains a C’ terminal 
repressory domain and is expressed in the lung, the tissue H661 is derived from 
(Cowell et al. 1992; Hulme et al. 2000). Another one is GATA1 which is a negative 
regulator of gamma-globin in adults and interacts with its promoter in association 
with Sp1 or CCACC binding proteins (Walters and Martin 1992; Eleouet and Romeo 
1993; Fischer et al. 1993). However, GATA1 is an erythroid–specific transcription 
factor that is expressed in the haematopoietic and the Sertoli cells in mice (Whitelaw 
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et al. 1990; Walther et al. 1996). Therefore, it is difficult to assume that it can play a 
role in GLI3 regulation. Hom3 by itself could not drive expression of the luciferase 
reporter by itself gene when cloned in either orientation upstream of this gene in a 
construct without promoter.  
Like Hom3, also the third analysed highly conserved non-coding sequence element, 
Hom4, showed the ability to reduce the GLI3 minimal promoter activity in both 
orientations (figure 5-22). Hom4 resides 3 kb downstream of the 4th exon, inside the 
4th intron of human GLI3. The negative effect is not as strong as the effect of Hom3, 
but still, when Hom4 is cloned upstream of the minimal GLI3 promoter in both 
orientations, reporter activity falls down to 60% of the SV40 promoter. Negative 
regulatory TFs can be predicted to bind in Hom4 (figure 6-8). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-8: TESS plot for the Hom4 sequence 
The arrows indicate predicted binding sites for various TFs in the Hom4 sequence. 
  
One of them is F2F which is expressed ubiquitously and is most likely a 
transcriptional repressor (Jackson et al. 1992). Another one, the NF-CLE0 contains 
sequence with inhibitory activity (Miyatake et al. 1991). Interestingly, there are also 
NFATp binding sites predicted, for which a positive regulatory role was postulated 
upon Hom2. However, in order for NFAT proteins to function, they must form homo- 
or heterodimers with FOS and JUN, which are not predicted to bind in the Hom4 
sequence, in contrast to Hom2.  
Homology searches did not identify elements corresponding to Hom2, Hom3, or 
Hom4 in the sequences of GLI2 or GLI1 from either human or mouse (data not 
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shown). Thus, apparently no obvious paralogs of these highly conserved sequence 
elements exist within the non-coding parts of the paralog GLI genes. If the analysed 
elements are involved in directing tissue specific gene expression of GLI3, it remains 
to be demonstrated, how the coordinated expression of the paralog GLI genes is 
achieved. 
 
6.6 Hom2 but not Hom3 and Hom4 direct tissue specific expression of a 
reporter gene in transgenic mice 
 
 The three highly conserved non-coding DNA regions from GLI3 introns under 
study were cloned in front of the human beta-globin promoter adjacent to the lacZ 
reporter gene. In transgenic mice, the beta-globin promoter apparently does not drive 
expression of the reporter gene by itself (Simmons et al. 2001). By cloning an 
enhancer element in front of this promoter, the expression is activated, potentially 
exactly in the tissues in which the cis-regulatory element is responsible for switching 
on its target genes. 
 Hom3 and Hom4 were inserted in both orientations in appropriate reporter constructs 
and used to generate transgenic mice. None of them induced any lacZ staining in 9 or 
11 days old mouse embryos, although several embryos were identified by PCR 
analysis to contain the injected lacZ gene in their DNA. This result corroborates the 
observations seen in transiently transfected cell cultures in which these fragments 
showed negative regulation of the minimal GLI3 promoter. As the beta-globin 
promoter by itself does not activate transcription, adding an element with negative 
regulatory properties should not activate expression of lacZ in any tissue.  
Hom2 was injected only in the positive orientation. One out of twelve 9-day embryos 
exhibited whole mount beta-galactosidase staining restricted to specific tissues, in 
particular in the developing forebrain (figure 5-32). Three out of twenty 11-day 
embryos expressed beta-galactosidase specifically, two of them coming from the same 
foster mother. In whole mount preparations all three were stained in the telencephalon 
and diencephalon, the mandibles, nostrils, midbrain and hindbrain (figures 5-33, 5-37, 
5-40). Two of them exhibited reporter gene expression also in the heart and somites 
whereas one of these two also showed staining in the second brachial arch, the 
Wolfian duct and very faint staining in the left and right forelimbs. All the mice with 
beta-Gal staining had integrated the injected fragment in their genome as proved with 
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PCR analysis, however not all mice that had integrated this fragment in their genome 
showed also the staining. The variation in expression between the mice of the same 
developmental stage can be attributed to the fact that the injected construct is inserted 
randomly in the mouse genome. By being positioned in a silent and tightly packed 
chromatin region, it may show less or no expression or, in contrary, it can show 
expression in many tissues if inserted in a very active genomic site.  
 
6.7 The reporter gene expression pattern appears to recapitulate GLI3 
activity 
 
From the beta-galactosidase staining results it can be deduced that human 
Hom2 has the potential to activate at developmental days 9 to 11 in mouse embryos 
reporter gene expression mostly in the brain, mandibles, nostrils and heart. Gli3 plays 
an important role regulating the development of all of these organs and tissues 
(Hardcastle et al. 1998; Balmer and LaMantia 2004). Detailed expression patterns of 
Gli3 in 9 and 11 days mouse embryos are not readily available from publications. Gli3 
antibodies suited for histochemical staining are apparently missing. Therefore, Gli3 
expression had preferentially been studied by in situ hybridisation which detects the 
mRNA but does not prove that the translation product is present (Buscher and Ruether 
1998; Aoto et al. 2002; Zoltewicz et al. 2004). In addition, the interest in Gli3 
expression studies has been focused on limb development.  
The expression patterns of the transgene in the mouse embryos carrying the Hom2 
construct were ascertained with the very sensitive conversion of a chromogenic 
substrate by beta-galactosidase. In addition to the study of the whole mount aspect, 
histological sections were studied which allow assigning the gene expression to 
individual cells or groups of cells (figure 6-9, B). Comparably detailed data are not 
available for Gli3 expression during normal development. Therefore, a firm statement 
about the reporter gene expression recapitulating Gli3 expression can only be made 
concerning a coarse pattern, such as in figure 6-9 A and C, which demonstrate 
similarity between Gli3 expression in the telencephalon and the pattern of transgene 
expression. 
Evolutionarily conserved enhancer elements recapitulating in transgenic constructs 
with reporter genes the expression of the gene that they normally regulate have 
recently been reported for other developmental genes such as the DACH gene. 
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Dissecting these elements allows to assign the regulatory potential for expression in 
individual tissues and at given timepoints very specifically to small subregions 
possibly associated with appropriate transcription factors (Nobrega et al. 2003). 
The results obtained in the present study with the Hom2 region need to be extended to 
more transgenic embryos and to be studied throughout all embryonic stages to 
uncover the complete regulatory potential of the Hom2 enhancer. 
 
  
 
 
 
 
 
 
 
 
Figure 6-9: Head sections of day 10 and 11 mouse embryos comparing Hom2-lacZ activity with 
the pattern of Gli3 and Shh expression 
Horizontal head sections of an 11 day, Hom2-lacZ expressing mouse. A1: Wall of telencephalic 
vesicle. A2: Wall of diencephalon. B1: Trigeminal (V) neural crest cells migrating into maxillary 
component of first branchial arch. B2: Maxillary component of first branchial arch. B3: Mandibular 
component of first branchial arch. B4: Trigeminal (V) ganglion. C: Expression domains of GLI3 (red) 
and Shh (yellow) in the telencephalon; diagram of a horizontal head section of a 10 day embryo (Rallu 
et al. 2002). The expression of GLI3 resembles the beta-galactosidase staining in A. 
 
In addition to the study of the whole mount aspect, histological sections were 
studied which allow assigning the gene expression to individual cells or groups of 
cells (figure 6-9, B). 
Taking a look at the results obtained with transient transfection into cell cultures 
allows to speculate about potential transcription factors which might be associated 
with Hom2 activity in vivo: Strong expression of NFATp, the regulatory candidate for 
Hom2 studied in cell culture, had been detected with northern blots in leukocytes, 
spleen, and placenta, intermediate expression in thymus, prostate, testis, ovary, small 
intestine, lung, liver, muscle, kidney, and pancreas, and very weak expression in heart, 
colon, and brain (Masuda et al. 1995). Thus, the factor is present in some tissues in 
which Hom2 drove expression of lacZ. However, NFATc expression had neither been 
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detected in the brain nor had NFATx been demonstrated in both the brain and the 
heart (Masuda et al. 1995). These two factors were also predicted to bind at the sites 
that were mutated in the sequence of Hom2.  
Other proteins are also predicted to bind to the mutated sites in Hom2. For instance, c-
Ets-2 is highly expressed in the newly forming cartilage, in the skull precursor cells 
and vertebral primordial. Overexpression of this gene results in skeletal and 
lymphocyte abnormalities and in a smaller thymus (Sumarsono et al. 1996; 
Wolvetang et al. 2003). NF1 participates in bone formation and has a general role in 
neural crest–derived tissues (Cichowski and Jacks 2001).  It remains to be seen if 
Hom2 directs reporter gene expression in these tissues at other times during 
development, which would add credibility to the putative involvement of these 
proteins in GLI3 regulation.  
 
In some cases, a cis-acting regulator element may reside at a long distance upstream 
or downstream of its target, even inside an intron of a neighbouring gene (Gilligan 
and Venkatesh 2004). Therefore, the genomic segment around GLI3 needs to be 
scrutinized for potential other regulatory targets of Hom2. GLI3 is located within a 
“gene desert, i.e. few genes are observed in close neighbourhood. Within a segment of 
1Mb telomeric of GLI3 only the genes of two hypothetical proteins and of the inhibin 
beta A (INHBA) are located. The inhibin beta A subunit joins the alpha subunit to 
form a pituitary FSH secretion inhibitor, and its mutation affects craniofacial features 
but not the development or function of the brain and the heart (Matzuk et al. 1995), 
regions in which Hom2 shows transcriptional regulatory activity. 1 Mb centromeric of 
GLI3 two more genes of hypothetical proteins, the mitochondrial ribosomal protein 
L32 (MRPL32) and the proteasome alpha 2 subunit (PSMA2) can be found. The latter 
ones are expressed ubiquitously and, therefore, it is highly unlikely that Hom2 is 
involved in their expression.  
It cannot be excluded that Hom2 is a regulator for an even more distantly located gene 
or that it is an element that acts positively on more than one gene, including GLI3. 
Translocation events at distant sites on a chromosome associated with a specific 
clinical phenotype, such as described for preaxial polydactyly (PPD) (Lettice et al. 
2002) hint at distant regulatory elements of a gene.  However, no clinical phenotypes 
other than GLI3 morphopathies have been associated with translocations affecting 
chromosome 7p within or near GLI3. Therefore, an effect of an element within GLI3 
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upon the neighbouring genes, which are expressed in patterns very different from the 
GLI3 specific pattern, is unlikely.  
  
6.8 Hom2 is a conserved non-genic sequence element acting as transcriptional 
enhancer  
  
The identification of cis-acting regulatory elements, traditionally, used to 
involve the systematic screening of large cloned segments, such as BACs or even 
YACs for their potential to activate gene expression in transient transfection studies 
with cell cultures or after transfer into animals such as mice, rabbits, pigs and other 
mammals (Giraldo and Montoliu 2001; Ristevski 2005). Segments showing this 
property had to be subdivided until the relevant sequences could be cloned and 
confirmed by mutagenesis (Niemann and Kues 2000). 
Since the genomic sequence of many species is becoming available, comparative 
genomics showed that regulatory elements are enriched among highly conserved non-
genic sequence elements. For instance, a report of an injected YAC construct carrying 
a conserved region, three interleukin genes and a non interleukin gene showed 
regulatory control of the conserved region specific for the interleukin genes (Hardison 
2000). Unexpectedly, mammalian genomes contain many highly conserved sequences 
that are not functionally transcribed. They are single copy and comprise 1-2% of the 
human genome. These conserved sequences, which must be over 100 bp long and 
must have a similarity greater than 70% (between human and mouse) in order to be 
classified as CNGs (Conserved Non-Genic sequences), are found in humans, mice, 
dogs and most probably in the majority of mammals (Dermitzakis et al. 2002; 
Dermitzakis et al. 2005). These parameters comprise an arbitrary criterion of 
conservation that is frequently used as a reasonable empirical significance threshold in 
many biological studies. Characteristics of these elements are that the level of 
conservation and the clustering of substitutions are not correlated with distance from 
genes, with location in gene-rich versus gene-poor regions or with location in introns 
or between genes. In CNGs there is a tendency of AT to change into GC. In addition 
there is a higher incidence of CNGs in gene-poor regions, and they are more 
conserved than coding regions. (Dermitzakis et al. 2004; Dermitzakis et al. 2005).  
The homologies studied in this thesis satisfy the conservation criteria to be 
characterized as CNGs. Especially, the sequence of Hom2 had already been identified 
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as an ultra-conserved fragment of chromosome 7 in a previous study in which 481 
fragments of all the human genome were identified with 100% similarity between 
human, mouse and rat for a length greater than 200bp (Bejerano et al. 2004). The total 
sequence of Hom2 (434 bp) aligns un-gapped with the mouse sequence. Hom3 and 
Hom4 sequences have small gaps of inconsistency between human and mouse. 
Therefore they were not predicted under such stringent conditions used by Bejerano 
and colleagues (2004). These authors reasoned that if independent substitutions 
happened at each site, with the slowest neutral substitution rate that is observed for 
any 1 Mb region of the genome, then the chance to find only one of such ultra-
conserved elements in the whole genome would be less than 10-22. This number 
strongly suggests that the existence of such elements is not a phenomenon of chance. 
However, what might be the role for such conserved elements, some of which are 
conserved even down to the genome of fishes, remains an open question that may 
need to be answered for each element individually. 
There are an increasing number of reports on such conserved elements that can 
regulate gene expression. DACH is a gene bracketed by two gene deserts 870 kb and 
1330 kb in length. Its complex expression in numerous tissues speaks for strict 
regulation by distinct regulatory elements. Comparison of the genomic region 
encompassing this gene in man, mouse, frog, zebrafish and two pufferfish species 
identified 32 elements in a 2.6 Mb genomic region containing the DACH gene. Seven 
out of nine tested elements showed staining in transgenic mice in different tissues 
where DACH is also expressed (Nobrega et al. 2003).  
Comparative analysis of the SIM2 gene interval on human chromosome 21 with horse, 
cow, pig, dog, cat and mouse DNA resulted in a number of conserved elements which 
could up-regulate the SIM2 promoter luciferase reporter construct in transiently 
transfected cell assays (Frazer et al. 2004). Hom2 does not seem to up-regulate the 
GLI3 minimal promoter in similar assays but it can function by itself as a promoter. 
However, Hom3 and Hom4 appear to have a negative effect on the activity of this 
promoter.  
The CNGs can also function as structural components of chromosomes. 11% of the 
conserved noncoding DNA consists of predicted MARs (Matrix-scaffold Attachment 
Regions) (Glazko et al. 2003). MARs are involved in the attachment of the chromatin 
to the nuclear matrix, chromatin remodelling and transcription regulation. In addition, 
more than half of the predicted MARs co-occur with one or more independently 
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identified conserved sequence blocks. Most of these predicted conserved MARs are 
found in regions 5’ upstream of genes (Glazko et al. 2003). None of the three tested 
homologies in this work contain any MARs specific sequence motifs.  
Still, the role of most of these highly conserved elements is unclear. As 
discussed above, one potential role of them is the regulation of gene expression, but 
they are considered to be too long and too conserved to contain densely packed 
transcription factor binding sites, which are generally degenerate. In addition, the 
independence from their genic environment makes it less likely that the majority of 
the CNGs are cis-regulatory elements. They might also be structural components of 
chromosomes but the fact that they are so highly conserved and are single-copy 
sequences makes it unlikely that their main role is the structure of chromatin. CNGs 
may regulate genes also in trans, as it is becoming more evident that chromosomes 
have specific locations in the nucleus during the cell cycle in mammalian cells. 
(Johnston and Stormo 2003; Dermitzakis et al. 2004). Although these reports classify 
conserved elements either as regulatory sequences or as structural components there is 
still a great number of such highly conserved regions especially between mammals 
which must be inspected for their role in life.  
Of the three highly conserved elements studied here, Hom2 appears to be an 
autonomous regulatory sequence that can drive expression of the luciferase gene by 
itself, but can also activate the beta-globin promoter to regulate tissue and temporal 
specific lacZ expression in transgenic mice. For the other two conserved elements, 
Hom3 and Hom4, evidence for a negative regulatory potential on the GLI3 minimal 
promoter could only be obtained by transient expression of reporter constructs in cell 
cultures. It remains questionable to what extent cell cultures represent the normal 
situation in animals or humans. It will be difficult to establish transgenic animals that 
allow the analysis of negative regulatory effects. Since the criterion to categorize a 
CNG as a regulatory sequence is mainly detection of an activating potential, sequence 
elements binding in a given test system repressing factors might be missed.  
Even the expression pattern of a transgene observed in animals might not reflect 
reliably the expression pattern of the original target gene. A conserved stem cell 
leukaemia haematopoietic (SCL) transcription factor enhancer has been reported of 
driving reporter gene expression in SCL negative tissues in addition to SCL expressing 
tissues showing that the genomic context of transgene insertion is also important for 
the correct expression of the gene (Gottgens et al. 2000).  
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Which species should be compared in the homology search to identify cis-acting 
regulatory elements for Gli3? In this project elements were analysed that are highly 
conserved between humans, mice and the pufferfish. It can be predicted, that 
regulatory elements detected by this approach might regulate the expression in organs 
or tissues present in fishes and mammals. Sites that were added during the evolution 
of tetrapods, such as hands with fingers might go undetected. It will be interesting to 
see, if the very faint fore limb expression of the transgene under the control of Hom2 
observed at day 11, at later stages will turn into the characteristic expression pattern of 
GLI3 during limb development.  
As reviewed by (Boffelli et al. 2004), homologies obtained by comparison of 
sequences of very distant species (human-fugu) are mostly functional and are good 
candidates of regulating genes which play a pivotal role during the embryonic 
development. Many developmental processes are conserved across the animal 
kingdom, therefore the regulation of the participating genes might have been kept 
unchanged.  
On the other hand, highly conserved sequences like the ones investigated in this work 
are only observed in a subset of the genes. Comparison of distantly related species 
inhibits prediction for elements that are specific for more closely related species. 
Elements governing tetrapod or even primate specific morphology might be hidden in 
sequences conserved between closely related species but missing in distant relatives. 
Comparison of more closely related organisms, such as human and mouse, has the 
problem that non-uniform evolution rates across the human genome lead to a high 
degree of conserved sequences between human and mouse. Thus it is difficult to 
predict which sequences are functional. Comparison of highly related species, such as 
human and other primates, increases dramatically the number of conserved regions. 
However, using phylogenetic shadowing between primates one can identify sites that 
evolve slower and which might harbour regulatory sequences that may be primate 
specific. Phylogenetic shadowing analyses multiple aligned sequences to identify sites 
that evolve slower. Each position in the multiple alignment is fitted to a phylogenetic 
model to calculate the likelihood that the sequence accumulates variations at a fast or 
slow rate. Positions with several differences in different branches of the phylogenetic 
tree are more likely to evolve faster, thus most probably they are less probable of 
containing functional sequences. Even sequences of only four different primates can 
be chosen for alignment as long as they are only distantly related (Boffelli et al. 
  Discussion 
  124 
2004). This method was already used to find regulatory elements for human 
lipoprotein A  (LPA), which is one of a small set of genes that arose recently in the 
primate lineage and consequently found in only a subset of primates (Lawn et al. 
1995; Boffelli et al. 2004).  It might also be used to identify primate specific GLI3 
regulatory elements. Through shadowing it is possible to use even the sequence 
polymorphisms in human populations to annotate the human genome. Through the 
efforts to sequence several different human genomes this may become feasible, and 
regulating elements specific for humans may finally be identified.  
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7 OUTLOOK 
 
 The study of the transcriptional regulation of GLI3 in this thesis has provided 
important insight into the complex regulatory mechanism of this key transcription 
factor of the hedgehog signalling pathway. 
At the same time, it has opened up the avenue to a plethora of urgent questions. In this 
work, two initiator sites have been identified for GLI3, and the activity of its minimal 
promoter as well as the regulatory potential of highly conserved intronic regions have 
been tested in different cell lines. Potent transcription factors that regulate the 
promoter still have to be identified as site directed mutagenesis of 5 different regions, 
individually, did not strongly affect the activity of the promoter. However, when all of 
those sites are deleted the activity decreases. A combination of mutations at these 5 
sites may lead to a better understanding of the GLI3 promoter regulation. In addition, 
more tests with the mutated inr site as well as mutation of the second inr site can show 
if one of them is used preferably for transcription in a given test system.  
Regarding the highly conserved regulatory Hom2 region, the impact of the 
transcription factor NFATp still has to be confirmed. By co-transfecting Hom2 with a 
construct that expresses NFATp it can be tested if the activity of this region is 
proportional to the dosage of this protein. In addition, a stable transgenic line of mice 
expressing lacZ under the control of Hom2 must be obtained to investigate throughout 
mouse development in which tissues and cells this region activates transcription. The 
orientation-dependent activity of Hom2, in combination with the existence of an inr 
site at the 3’ end of its sequence gives this region promoter-like attributes, although no 
other typical promoter features could be found in its sequence. 3’ RACE PCR starting 
from this inr site may help to find out if a hidden gene is located downstream of this 
sequence. In addition, testing the activity of the construct containing Hom2 upstream 
of the GLI3 minimal promoter in different cell lines can help in understanding the 
function of this ultra-conserved region.  
Site directed mutagenesis in the sequence of Hom3 and Hom4 will help to understand 
which factors bind to them and cause the repressive activity of these homologies. The 
sequence residing in the 1st intron, downstream of the promoter adjacent to the 1st 
exon is a further good candidate for a cis-acting regulatory element.  
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Sequencing these regions in the patients with GLI3 morphopathies, which do not 
show any mutation in their transcribed exons, will determine if mutations in those 
regulatory elements are associated with the clinical phenotype of GLI3 morphopathy. 
Finally, the 5’ upstream region of GLI2 still has to be characterized in greater detail 
and searched for a promoter and a transcription initiator site.  
The conserved non-genic regions with regulatory potential identified within GLI3 
appear not to have paralogs anywhere inside, upstream or downstream of GLI1 and 
GLI2. Thus, these paralog genes have evolved regulatory sites of their own, although 
they are expressed a coordinated fashion with each other. Determining if the 
regulatory elements of GLI2 and GLI1, each on its own, share ancient homologies 
with orthologs in evolutionary distant species will cast light on the mechanism of 
speciation and the time point when the functional divergence of these genes evolved. 
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8 ABBREVIATIONS 
 
a/a     aminoacid 
AgNO3   Silver nitrate 
APS    Ammonium peroxodisulfate 
bp    base pair 
BSA     Bovine Serum Albumin 
cDNA    complementary DNA 
DMSO   Dimethyl sulfoxide 
DNA    Deoxyribonucleic acid   
dNTP    Deoxynucleotidetriphosphate 
DTT     Dithiothreitol 
EDTA    Ethylenediaminetetraacetic acid 
FCS     Fetal Calf Serum 
F    forward 
g     gram 
HCl    Hydrochloric acid 
HEPES    1-Piperazineethane sulfonic acid 
HPLC    High Performance Liquid Chromatography 
IPTG     Isopropyl-ß-thiogalactopyranoside 
kb      kilo bases 
kD    kilodalton 
M    Molar 
MgCl2    Magnesium chloride 
mRNA   messenger Ribonucleic acid 
NaCl    Sodium chloride 
Na2CO3   Sodium carbonate 
ng    nanogram 
nt    nucleotide 
OMIM    Online Mendelian Inheritance in Man 
PBS     Phosphate Buffer Saline 
PCR    Polymerase Chain Reaction 
pmol    picomol 
R    reverse 
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RNA    Ribonucleic acid 
RNase    Ribonuclease  
rpm     Revolutions Per Minute 
RT     Room Temperature  
RT-PCR    Reverse Transcription-PCR 
SDS    Sodium Dodecyl Sulfate 
SSCA    Single Stranded Conformational Analysis 
SV 40     Simian Virus 40 
Taq    Polymerase isolated from Thermus aquaticus 
TAE    Tris Acetate EDTA 
TE    Tris EDTA 
TEMED   Tetramethylethylene diamine 
Tris    Tri-hydroxymethyl aminomethane 
u     unit 
UV    Ultra Violet 
V    Voltage 
ver      version 
v/v    volume/volume 
w/v    weight/volume 
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